<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=bd570dc2-48fa-4a43-8028-019d8dcb6a2e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-for-the-next-ad-promo-wg-may-12th-12pm-est</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/2026-04-14-geo-deep-dive-presented-by-havas-health?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/2026-04-14-jason-cobers-fda-enforcement-update?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-00700043foia-wg-mtg-call-in-details</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-00700043foia-wg-mtg-call-in-details-1</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-ctd-community-responses-to-uk-hra-questions?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/presentations-by-stuart-donald-and-greg-shear-1</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=283&amp;MessageKey=5858519b-61eb-4dae-a809-44b73376518f&amp;CommunityKey=fc80e507-13cd-4967-9d9c-9cd2b13faed8</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/usfda-issues-notice-on-clinical-trial-results-non-compliance</loc><lastmod>2026-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monday-community-meeting-agenda-for-april-13-2026</loc><lastmod>2026-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/ctd-community-meeting-agenda-for-april-13-2026?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-summary-uk-transparency-and-disclosure-requirements-ahead-of-april-2026-implementation-2</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-summary-uk-transparency-and-disclosure-requirements-ahead-of-april-2026-implementation-6</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-summary-uk-transparency-and-disclosure-requirements-ahead-of-april-2026-implementation-5</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-summary-uk-transparency-and-disclosure-requirements-ahead-of-april-2026-implementation-3</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-summary-uk-transparency-and-disclosure-requirements-ahead-of-april-2026-implementation</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-summary-uk-transparency-and-disclosure-requirements-ahead-of-april-2026-implementation-1</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-leveraging-ai-in-your-daily-work-1</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-working-smarter-for-faster-regulatory-submissions-09-apr-2026-4</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-working-smarter-for-faster-regulatory-submissions-09-apr-2026-5</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-working-smarter-for-faster-regulatory-submissions-09-apr-2026</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-working-smarter-for-faster-regulatory-submissions-09-apr-2026-1</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-working-smarter-for-faster-regulatory-submissions-09-apr-2026-2</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-working-smarter-for-faster-regulatory-submissions-09-apr-2026-3</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/slides-now-available-presentation-working-smarter-for-faster-regulatory-submissions-09-apr-2026?CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7&amp;tab=librarydocuments</loc><lastmod>2026-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-to-module-7-notices-and-alerts-per-role-of-ctis-training-programme-2</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-to-module-7-notices-and-alerts-per-role-of-ctis-training-programme-3</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-to-module-7-notices-and-alerts-per-role-of-ctis-training-programme</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-to-module-7-notices-and-alerts-per-role-of-ctis-training-programme-1</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=2f88de18-3977-4a7e-8b95-d1c7a4c9006e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-publication-of-harmonised-standards-under-medical-devices-regulations-1</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-publication-of-harmonised-standards-under-medical-devices-regulations-2</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-publication-of-harmonised-standards-under-medical-devices-regulations-3</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=10af5ebb-9151-42a0-a7a2-3620c237e8dc&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-blog-summary-upcoming-uk-clinical-trial-transparency-requirements-7</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-blog-summary-upcoming-uk-clinical-trial-transparency-requirements-5</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-blog-summary-upcoming-uk-clinical-trial-transparency-requirements-2</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-blog-summary-upcoming-uk-clinical-trial-transparency-requirements-3</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-blog-summary-upcoming-uk-clinical-trial-transparency-requirements</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-blog-summary-upcoming-uk-clinical-trial-transparency-requirements-1</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-3</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-4</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-5</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-2</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-1</loc><lastmod>2026-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=d400904c-bdb6-4476-a681-7f127b42b01e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2026-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/no-pec-all-hands-meeting-tomorrow-1</loc><lastmod>2026-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-and-nih-joint-webinar-on-shaping-a-new-nih-policy-on-plss</loc><lastmod>2026-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-minutes-and-recording-policy-00700043foia-mtg-2026-02-19</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-minutes-and-recording-policy-00700043foia-mtg-2026-02-19-1</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-minutes-and-recording-policy-00700043foia-mtg-2026-02-19-2</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/call-recording-policy-0070-0043-foia-mtg-2026-02-19?CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f&amp;tab=librarydocuments</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/policy-0070-0043-foia-mtg-discussion-points-2026-02-19?CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f&amp;tab=librarydocuments</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-4</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-5</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-1</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-2</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-3</loc><lastmod>2026-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/community-mentoring-program-enrollment-is-open</loc><lastmod>2026-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-latest-regulatory-readiness-and-transparency-priorities-1</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-latest-regulatory-readiness-and-transparency-priorities</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-latest-regulatory-readiness-and-transparency-priorities-2</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-latest-regulatory-readiness-and-transparency-priorities-3</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-march-2026-meeting-recording-2</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-march-2026-meeting-recording-3</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-march-2026-meeting-recording</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-march-2026-meeting-recording-1</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trial-highlights-march-2026</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trial-highlights-march-2026-1</loc><lastmod>2026-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/article-11-workaround-unlocks-ctis-flexibility</loc><lastmod>2026-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/article-11-workaround-unlocks-ctis-flexibility-1</loc><lastmod>2026-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/community-member-post-new-message</loc><lastmod>2026-03-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-version-72-4</loc><lastmod>2026-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-version-72-3</loc><lastmod>2026-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-version-72-2</loc><lastmod>2026-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=3fd47118-a0d3-49af-af02-fd48eb804d47&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-version-72-1</loc><lastmod>2026-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=2ba9fa95-083f-4da6-859c-9f3f98348256&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2026-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-launch-of-the-dia-singapore-medical-writing-led-by-community-chair-kavita-garg-director-mw-saliegral-global-1</loc><lastmod>2026-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-sponsor-handbook-and-new-eu-ctis-sponsor-faq-document-26-mar-2026-4</loc><lastmod>2026-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-sponsor-handbook-and-new-eu-ctis-sponsor-faq-document-26-mar-2026-5</loc><lastmod>2026-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-sponsor-handbook-and-new-eu-ctis-sponsor-faq-document-26-mar-2026-2</loc><lastmod>2026-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-sponsor-handbook-and-new-eu-ctis-sponsor-faq-document-26-mar-2026-3</loc><lastmod>2026-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-sponsor-handbook-and-new-eu-ctis-sponsor-faq-document-26-mar-2026</loc><lastmod>2026-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-sponsor-handbook-and-new-eu-ctis-sponsor-faq-document-26-mar-2026-1</loc><lastmod>2026-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-request-for-participation-in-doctoral-research</loc><lastmod>2026-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-introduces-trial-ownership-transfer-functionality-2</loc><lastmod>2026-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-introduces-trial-ownership-transfer-functionality</loc><lastmod>2026-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-introduces-trial-ownership-transfer-functionality-1</loc><lastmod>2026-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/federal-agency-for-medicines-and-health-products-famhp-launches-interactive-dashboard-for-clinical-trials-in-belgium-2</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/federal-agency-for-medicines-and-health-products-famhp-launches-interactive-dashboard-for-clinical-trials-in-belgium-3</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/federal-agency-for-medicines-and-health-products-famhp-launches-interactive-dashboard-for-clinical-trials-in-belgium</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/federal-agency-for-medicines-and-health-products-famhp-launches-interactive-dashboard-for-clinical-trials-in-belgium-1</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-warning-letter-to-patcos-cosmetics-pvt-ltd</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-warning-letter-to-patcos-cosmetics-pvt-ltd-1</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/agenda-for-24-march-2026-icf-wg-call-2?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/agenda-for-24-march-2026-icf-wg-call-3?CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;tab=librarydocuments</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-for-24-march-2026-icf-wg-call-2</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-for-24-march-2026-icf-wg-call-3</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/agenda-for-24-march-2026-icf-wg-call-1?CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860&amp;tab=librarydocuments</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-for-24-march-2026-icf-wg-call-1</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/tctr-recommends-updating-trial-status-to-ensure-who-ictrp-inclusion-2</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/tctr-recommends-updating-trial-status-to-ensure-who-ictrp-inclusion</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/tctr-recommends-updating-trial-status-to-ensure-who-ictrp-inclusion-1</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/obtaining-jrct-research-number-process-update-effective-end-of-march-2026-2</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=e6a4c3fe-0580-41bd-bb7a-cabb4f660389&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/obtaining-jrct-research-number-process-update-effective-end-of-march-2026-1</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-bulletin-preparing-for-upcoming-regulatory-changes-2</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-bulletin-preparing-for-upcoming-regulatory-changes</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-bulletin-preparing-for-upcoming-regulatory-changes-1</loc><lastmod>2026-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/should-irbs-confirm-funding-before-study-approval</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-18-march-2026-2</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-18-march-2026</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-18-march-2026-1</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-4</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-5</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=337&amp;MessageKey=5822a8d4-af73-4335-b578-7a5273d084a7&amp;CommunityKey=167351bf-9b9e-4b85-a40e-0186a8b321c2</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-3</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-1</loc><lastmod>2026-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-icf-working-group-meeting-february-2026-meeting-notes-and-recording-2</loc><lastmod>2026-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-icf-working-group-meeting-february-2026-meeting-notes-and-recording-3</loc><lastmod>2026-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-icf-working-group-meeting-february-2026-meeting-notes-and-recording-1</loc><lastmod>2026-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/should-irbs-confirm-funding-before-study-approval?CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a&amp;tab=librarydocuments</loc><lastmod>2026-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=d8bebb5e-96b0-498c-bc33-019ce43f7d30</loc><lastmod>2026-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=a50fca33-5a89-44e4-a9bc-f8e7637f6439&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2026-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-mar-10-2026-meeting-minutes-4</loc><lastmod>2026-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=db63e0db-a3e7-416d-a326-6537ea8c1d3e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-mar-10-2026-meeting-minutes-1</loc><lastmod>2026-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-ctd-community-meeting-mar-10-2026-meeting-minutes?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-ctd-monthly-meeting-march-2026-presentations?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=df94faae-d10c-4353-ba4e-019cd8d2ac3a&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home</loc><lastmod>2026-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/2026-02-10-regulatory-ad-promo-working-group-slides?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2026-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/2026-03-10-regulatory-ad-promo-working-group-slides-1?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2026-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/2026-03-10-regulatory-ad-promo-working-group-slides?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2026-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/310-regulatory-ad-promo-wg-slides-posted</loc><lastmod>2026-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/3-10-regulatory-ad-promo-wg-slides-posted?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2026-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=8c75f318-b71e-4ed7-916e-c26619b9263b&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2026-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-mar-10-2026-meeting-agenda-4</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=ed50c684-f126-489c-bddd-52e51504f548&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-mar-10-2026-meeting-agenda</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-mar-10-2026-meeting-agenda-1</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-ctd-monthly-meeting-march-2026-meeting-agenda?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-introduces-simplified-staffonly-research-applications-and-announces-upcoming-model-research-agreements-2</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-introduces-simplified-staffonly-research-applications-and-announces-upcoming-model-research-agreements-3</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-introduces-simplified-staffonly-research-applications-and-announces-upcoming-model-research-agreements-1</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=03ded71d-bf2c-4f7a-b5e1-9c0b7549d82a&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-launches-feature-to-update-local-details-for-clinicaltrialsgov-studies-and-releases-key-trial-metrics-reports-2</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-launches-feature-to-update-local-details-for-clinicaltrialsgov-studies-and-releases-key-trial-metrics-reports-1</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-launches-feature-to-update-local-details-for-clinicaltrialsgov-studies-and-releases-key-trial-metrics-reports</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-draft-guidance-conduct-of-clinical-trials-during-public-health-emergencies</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-draft-guidance-conduct-of-clinical-trials-during-public-health-emergencies-1</loc><lastmod>2026-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=0a3b7971-af88-4375-8079-8aa0aa95d775&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2026-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-4</loc><lastmod>2026-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-3</loc><lastmod>2026-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-2</loc><lastmod>2026-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MessageKey=9c7b373b-398f-4459-9cd5-47ed71f6e532&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2026-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-1</loc><lastmod>2026-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2026-content-hubs-and-community-roundtables-submissions-closing-on-march-5th</loc><lastmod>2026-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/accelerated-evaluation-device-for-clinical-trials-in-france-fast-track-2</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/accelerated-evaluation-device-for-clinical-trials-in-france-fast-track-3</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=5550b828-f588-4199-9c39-f1c6f0c83539&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/accelerated-evaluation-device-for-clinical-trials-in-france-fast-track-1</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released-6</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released-7</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released-4</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released-5</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=95ae735f-996d-437b-a42c-7ea515f39f6f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-5</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=343&amp;MessageKey=3061d2ef-cb7b-4070-b077-98df96fc8570&amp;CommunityKey=8519a7c0-e085-4520-be03-0186a8b321be</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-3</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-working-smarter-for-faster-regulatory-submissions-09-apr-2026-1</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MessageKey=79d6bd5d-a6ab-4138-8275-fbf64a1119e0&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2026-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=3d2f091a-f771-4b6c-891b-bedb66e15d09&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2026-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/live-virtual-training-courses-by-dia-1</loc><lastmod>2026-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/request-for-participation-in-doctoral-research</loc><lastmod>2026-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=4aad871d-881b-4710-a110-367335445dc2&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2026-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=5b282d1d-3426-462a-9f20-292713111f76&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trial-highlights-february-2026-1</loc><lastmod>2026-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trial-highlights-february-2026-3</loc><lastmod>2026-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=35ecef29-8c12-415e-84ed-6b8eead9f7c4&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-partners-program-application-is-live-1</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=0897eb7d-020d-4fd0-824a-e9ba7f550d18&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=19a16a45-fc87-430b-b82a-bcdd07ef8efa&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=c3349a71-f41e-462d-bedd-49f195be7a62&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=e73eb79d-c5b1-4227-a9ce-d7afbdeade66&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=f3660b85-ccd5-4014-8da3-3e4acdf14c31&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=0dbdaa41-3166-4b05-a2ca-5e08dc657688&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=36663f2e-9497-4d19-83e5-6db736d85c38&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=5c76459c-189f-4d7c-ac3b-82272d583918&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=8ad06ee8-d6f0-4f51-a8b5-ae35087aa245&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=98cc1c89-96d0-49d6-8b9a-40b30c088623&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=b581b19a-7ba5-46d2-b1b4-ecfe38d4b2c6&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=c3e453df-015c-4a22-bc0a-019c907a543d&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=cb425bda-9179-4ebc-8ce7-064d4bf80367&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fevents%2fcalendar</loc><lastmod>2026-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-17-feb-2026-meeting-key-notes-qna-sheet-and-recordings-1</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-17-feb-2026-meeting-key-notes-qna-sheet-and-recordings</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-eu-ctrctis-wg-meeting-call-rec-4?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288&amp;tab=librarydocuments</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-eu-ctrctis-qa-sheet-17-feb?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288&amp;tab=librarydocuments</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-eu-ctrctis-wg-meeting-minutes-4?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288&amp;tab=librarydocuments</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-feb-2026-2</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-feb-2026-3</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-feb-2026-1</loc><lastmod>2026-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-panelists-for-proposed-panel-ai-and-the-regulatory-medical-writer-whats-it-like-right-now-1</loc><lastmod>2026-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-panelists-for-proposed-panel-ai-and-the-regulatory-medical-writer-whats-it-like-right-now</loc><lastmod>2026-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=40368cc8-95b5-44de-b632-7db43cc419d4&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2026-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/proposed-panel-discussion-ai-and-the-regulatory-medical-writer-whats-it-like-right-now-1</loc><lastmod>2026-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/proposed-panel</loc><lastmod>2026-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/proposed-panel-1</loc><lastmod>2026-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/medcom-community-webinar-this-friday-feb-20-featuring-guest-panelist-lucy-rose-1</loc><lastmod>2026-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2026-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/the-dia-2026-call-for-professional-and-student-posters-is-open</loc><lastmod>2026-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/medcom-community-webinar-in-4-days-featuring-guest-panelist-lucy-rose-1</loc><lastmod>2026-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-white-paper-on-ai-for-aes</loc><lastmod>2026-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-panel-discussion-on-2025-fda-enforcement-actions-featuring-lucy-rose-presidentowner-lucy-rose-and-associates-llc-1</loc><lastmod>2026-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-upcoming-webinar-on-clinical-trials-regulations-countdown-to-implementation-5</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-upcoming-webinar-on-clinical-trials-regulations-countdown-to-implementation-2</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-upcoming-webinar-on-clinical-trials-regulations-countdown-to-implementation-3</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-upcoming-webinar-on-clinical-trials-regulations-countdown-to-implementation</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-upcoming-webinar-on-clinical-trials-regulations-countdown-to-implementation-1</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/january-2026-dia-informed-consent-form-working-group-meeting-notes-and-recording-2</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/january-2026-dia-informed-consent-form-working-group-meeting-notes-and-recording-1</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/january-2026-dia-informed-consent-form-working-group-meeting-notes-and-recording-3</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updates-eudravigilance-training-module-ev-m8-with-respect-to-data-masking-and-international-data-transfers</loc><lastmod>2026-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meeting-materials-from-feb-10-2026-posted</loc><lastmod>2026-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/feb-10-2026-meeting-recodring?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/february-10-2026-meeting-minutes-an?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=3d4009ca-f44e-479c-bfe1-719f78319d21&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meeting-thursday-212-what-can-pec-do-for-you</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/210-ad-promo-working-group?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/210-ad-promo-working-group-slides-posted</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2026-call-for-content-hubs-and-community-roundtables-now-open</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-17-feb-2026-1</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-17-feb-2026</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-eu-ctrctis-wg-meeting-agenda-3?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288&amp;tab=librarydocuments</loc><lastmod>2026-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=d9350752-3be7-4951-b82d-5a5881c25c78&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2026-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-glossary-of-terms-pv-version-24-1</loc><lastmod>2026-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=077d5c2b-9fc3-4945-a412-5a8339a80682&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=3ca858bb-c720-4919-b281-d833851a3166&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=680c9487-d6be-4719-92f9-be0ebd7686ec&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=7a19d02f-1809-464d-8422-59dcf713e97e&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=7f3fcab2-118b-41bd-9b0b-9a46f8a8694a&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=8c25e75a-2c20-4aef-968e-4ec4916cfd9f&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=b3abdcc7-7dcd-49a8-90c0-8f6e3de84594&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=f078163a-02d0-4ff2-a9c9-f13bb1ccbcda&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/download-complimentary-webinar-reimagining-medical-affairs-with-agentic-ai</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/february-10-2026-meeting-agenda?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2026-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-ad-promo-working-group-tuesday-210-noon-est</loc><lastmod>2026-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-invitation-data-access-and-ai-how-do-they-play-together-in-healthcare</loc><lastmod>2026-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-invitation-data-access-and-ai-how-do-they-play-together-in-healthcare-1</loc><lastmod>2026-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=70b96a6d-d9ae-4f6b-943c-019c2f072815&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home</loc><lastmod>2026-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=55f67922-1aa4-4050-9c3e-232d3c9a13b3&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2026-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-consultation-good-lay-protocol-synopsis-practice-5</loc><lastmod>2026-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-consultation-good-lay-protocol-synopsis-practice-3</loc><lastmod>2026-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=303d43f2-7b3e-4f37-b4b0-9e7c0f9c8a3b&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-consultation-good-lay-protocol-synopsis-practice-1</loc><lastmod>2026-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-28-jan-2026-2</loc><lastmod>2026-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-28-jan-2026</loc><lastmod>2026-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-28-jan-2026-1</loc><lastmod>2026-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c11b91a6-fccc-4c36-b73e-d5b1c4808fe2&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-january-2026</loc><lastmod>2026-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-january-2026-1</loc><lastmod>2026-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-january-2026-2</loc><lastmod>2026-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-january-2026-3</loc><lastmod>2026-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-key-regulatory-changes-transparency-initiatives-and-upcoming-webinars-2</loc><lastmod>2026-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-key-regulatory-changes-transparency-initiatives-and-upcoming-webinars-5</loc><lastmod>2026-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-key-regulatory-changes-transparency-initiatives-and-upcoming-webinars</loc><lastmod>2026-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-key-regulatory-changes-transparency-initiatives-and-upcoming-webinars-1</loc><lastmod>2026-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-key-regulatory-changes-transparency-initiatives-and-upcoming-webinars-3</loc><lastmod>2026-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/a-blizzard-of-savings-is-sweeping-through-for-rsidm</loc><lastmod>2026-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/a-blizzard-of-savings-is-sweeping-through-for-rsidm-1</loc><lastmod>2026-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-jan-2026-2</loc><lastmod>2026-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-jan-2026-3</loc><lastmod>2026-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-jan-2026-1</loc><lastmod>2026-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-advanced-therapies-community-quarterly-calls</loc><lastmod>2026-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-advanced-therapies-community-quarterly-calls-1</loc><lastmod>2026-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-advanced-therapies-community-qu-1?CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd&amp;tab=librarydocuments</loc><lastmod>2026-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-advanced-therapies-community-qu?CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;tab=librarydocuments</loc><lastmod>2026-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-22-jan-2026-2</loc><lastmod>2026-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f6d07e80-4b9a-48b8-9c25-82dd333ca02e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-22-jan-2026-1</loc><lastmod>2026-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=8626f6fd-baba-43a7-bd31-30a20447cf48&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=b4f59940-16e2-45eb-9018-742fbaec6200&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=e4f7273a-e60c-4e47-9786-45bc349511d6&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=e8e457b5-2ace-46f2-8bd7-d8406d1216e3&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=09758f24-5d3a-4349-8ada-e8ae717da23d&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=1069c551-6f48-4fb8-ba14-da48c368d4fb&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=28046725-c0f2-44d5-b641-745c059fd67e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=288643fd-bed8-408d-91b7-db016898c230&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=3d78d88c-2c19-4377-b2f9-97b51cdc2c23&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=44f2c41b-3bbc-4180-9dc3-23b0da7af972&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=4fa8cdbc-ce09-4d26-a3ac-a9a9d450d102&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=522eba87-e0c5-43fe-bce4-777415d4ed32&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=5fbb6077-70bc-4d10-8065-8850e2c84ef0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=63abedb8-a38c-4163-a4f3-df98e180fc43&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=65c1a028-ae90-43f5-8764-463a28a02514&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=790864bc-bf65-4ee7-9d79-d9366e3269e1&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=7a55cf47-8642-47d9-802d-303e9a256acc&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=85dcc52f-45fd-40d5-b81a-1e71935f85fa&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=8613dd46-36ea-4ca2-ac52-d3369a2cddd9&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=bf50a86b-b94d-4586-b87b-36bd7949e253&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=bfc0f375-5eeb-4ae6-84d5-90674a05f392&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=ce7c63c6-b922-49d9-869c-4a601f66f26e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=fa6935ce-3d5f-4f97-a94d-3ab5f88c90c5&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=f0d11d09-e68f-4007-9351-83bfb8fda0fd&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=fbd37f25-22d8-4b9c-b9b7-019bdcae7902&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=187&amp;MessageKey=2f5026bf-69bd-4672-8d8c-7239eb419c80&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2026-meeting-series-for-policy-00700043foia-meetings-1</loc><lastmod>2026-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-facilitating-and-accelerating-strategic-clinical-trials-in-the-eueea-4</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-facilitating-and-accelerating-strategic-clinical-trials-in-the-eueea-5</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-facilitating-and-accelerating-strategic-clinical-trials-in-the-eueea-1</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-facilitating-and-accelerating-strategic-clinical-trials-in-the-eueea-2</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-facilitating-and-accelerating-strategic-clinical-trials-in-the-eueea-3</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-facilitating-and-accelerating-strategic-clinical-trials-in-the-eueea</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-february-2026-2</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-february-2026-3</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=63a0b141-7f55-4172-a03b-0d46d8495e02&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-february-2026-1</loc><lastmod>2026-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-16</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=52e6b454-afae-49ae-9e52-ed3a749daecf&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-14</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-13</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-12</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-10</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-11</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-8</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-9</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-6</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-2</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-3</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-4</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-7</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-5</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nominate-a-dia-member-for-one-of-the-americas-region-awards-1</loc><lastmod>2026-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-accelerated-publications-why-and-what-15-jan-2026-5</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-accelerated-publications-why-and-what-15-jan-2026-2</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-accelerated-publications-why-and-what-15-jan-2026-3</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-accelerated-publications-why-and-what-15-jan-2026</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-accelerated-publications-why-and-what-15-jan-2026-1</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/slides-now-available-presentation-5?CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7&amp;tab=librarydocuments</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-15-jan-2026-accelerated-publications-why-and-what-5</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-15-jan-2026-accelerated-publications-why-and-what-3</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-15-jan-2026-accelerated-publications-why-and-what-2</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-15-jan-2026-accelerated-publications-why-and-what-1</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-15-jan-2026-accelerated-publications-why-and-what</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/recording-now-available-accelerate?CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7&amp;tab=librarydocuments</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-series-dia-eu-ctrctis-working-group-1</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-series-dia-eu-ctrctis-working-group</loc><lastmod>2026-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=2d994a07-ab62-41d8-af90-019bc2fbb773&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=e04715f5-98e7-4139-82c2-019bc2fa28eb&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=a567fa0e-9494-4028-81f2-019bc2f8399b&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=ea679c67-f9bf-4e05-9735-019bc2f4f78d&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=84b86334-9781-40ed-a8f8-295d56092eb6&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-and-fda-set-common-principles-for-ai-in-medicine-development-1</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-and-fda-set-common-principles-for-ai-in-medicine-development-3</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-and-fda-set-common-principles-for-ai-in-medicine-development-2</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-change-management-activities-follow-up</loc><lastmod>2026-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-change-management-activities-follow-up-1</loc><lastmod>2026-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-publishes-draft-guidance-to-aid-implementation-of-upcoming-clinical-trials-regulations-5</loc><lastmod>2026-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-publishes-draft-guidance-to-aid-implementation-of-upcoming-clinical-trials-regulations-2</loc><lastmod>2026-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-publishes-draft-guidance-to-aid-implementation-of-upcoming-clinical-trials-regulations-3</loc><lastmod>2026-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-publishes-draft-guidance-to-aid-implementation-of-upcoming-clinical-trials-regulations</loc><lastmod>2026-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-publishes-draft-guidance-to-aid-implementation-of-upcoming-clinical-trials-regulations-1</loc><lastmod>2026-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-ad-promo-working-group-tuesday-113-noon-est</loc><lastmod>2026-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-15-jan-2026-4</loc><lastmod>2026-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-15-jan-2026-3</loc><lastmod>2026-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-15-jan-2026-2</loc><lastmod>2026-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-15-jan-2026-1</loc><lastmod>2026-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-15-jan-2026</loc><lastmod>2026-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-7</loc><lastmod>2026-01-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-8</loc><lastmod>2026-01-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-9</loc><lastmod>2026-01-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-global-inspire-award-nominations-is-open</loc><lastmod>2026-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-discounted-early-bird-pricing-deadline-5</loc><lastmod>2026-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-discounted-early-bird-pricing-deadline-4</loc><lastmod>2026-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-discounted-early-bird-ends-today-1</loc><lastmod>2026-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/no-pec-all-hands-meeting-tomorrow</loc><lastmod>2026-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-15-jan-2026-4</loc><lastmod>2026-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-15-jan-2026-2</loc><lastmod>2026-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-15-jan-2026-3</loc><lastmod>2026-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-15-jan-2026</loc><lastmod>2026-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-15-jan-2026-1</loc><lastmod>2026-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/latest-updates-to-clinicaltrialsgov-prs-2</loc><lastmod>2025-12-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/latest-updates-to-clinicaltrialsgov-prs</loc><lastmod>2025-12-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/latest-updates-to-clinicaltrialsgov-prs-1</loc><lastmod>2025-12-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-16-dec-2025-meeting-key-notes-qna-sheet-and-recordings</loc><lastmod>2025-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-16-dec-2025-meeting-key-notes-qna-sheet-and-recordings-1</loc><lastmod>2025-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-eu-ctrctis-wg-meeting-call-rec-3?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288&amp;tab=librarydocuments</loc><lastmod>2025-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-eu-ctrctis-qna-sheet-16-dec?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288&amp;tab=librarydocuments</loc><lastmod>2025-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-eu-ctrctis-wg-meeting-minutes-3?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288&amp;tab=librarydocuments</loc><lastmod>2025-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/2025-12-adpromo-wg-ai-consideration?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2025-12-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=e069e9a0-649c-49be-907d-788f8bea18d5&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2025-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-meeting-dec-2025-meeting-notes-and-recording-3</loc><lastmod>2025-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-meeting-dec-2025-meeting-notes-and-recording</loc><lastmod>2025-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-meeting-dec-2025-meeting-notes-and-recording-1</loc><lastmod>2025-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-ctd-meeting-dec-2025-meeting-n?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2025-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/dia-ctd-community-presenters-slid?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=librarydocuments</loc><lastmod>2025-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=0cbb6370-66de-46a5-b5e9-91dd1aa1186b&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/big-data-highlights-clinical-study-data-pilot-open-to-new-applications-3</loc><lastmod>2025-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/big-data-highlights-clinical-study-data-pilot-open-to-new-applications</loc><lastmod>2025-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/big-data-highlights-clinical-study-data-pilot-open-to-new-applications-1</loc><lastmod>2025-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=95e548fd-ef4e-4817-bf60-9df9aed83c4c&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revolutionising-clinical-trials-key-changes-under-the-new-biotech-act-1</loc><lastmod>2025-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=9e62e206-d18f-48c8-8c69-96db46249467&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-dec-17-11am-et-rim-wg-ai-automation-team-2026-planning-1</loc><lastmod>2025-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/slides-posted-adpromo-wg-dec-16-ai-1?CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd&amp;tab=librarydocuments</loc><lastmod>2025-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/viewdocument/slides-posted-adpromo-wg-dec-16-ai?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=librarydocuments</loc><lastmod>2025-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-dec-16-ai-considerations-in-adpromo-opdp-uls-in-the-news-and-more</loc><lastmod>2025-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-dec-16-ai-considerations-in-adpromo-opdp-uls-in-the-news-and-more-1</loc><lastmod>2025-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=90d231d9-213e-443b-98fa-65618c511cc6&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2025-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-call-for-poster-deadline-is-today-1</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-call-for-poster-deadline-is-today-2</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-call-for-poster-deadline-is-today-3</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-16-dec-2025</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-16-dec-2025-1</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-december-2025-4</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-december-2025-5</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=e2222683-8796-48fd-b884-2f744f4cd3c9&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-december-2025-1</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-december-2025-2</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-december-2025-3</loc><lastmod>2025-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-dec-16-12-pm-et-ai-considerations-in-the-news-opdp-uls-and-more</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-dec-16-12-pm-et-ai-considerations-in-the-news-opdp-uls-and-more-1</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-cover-letter-templates-for-ctis-users</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-cover-letter-templates-for-ctis-users-1</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=68f36bb8-d6be-4519-8549-9ef69fe82f3a&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/australian-new-zealand-clinical-trials-registry-announces-holiday-closure-period-1</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released-2</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released-3</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogue-new-functionalities-released-1</loc><lastmod>2025-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-rescheduled-session-on-accelerated-publications-why-and-what-28-oct-2025</loc><lastmod>2025-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-rescheduled-session-on-accelerated-publications-why-and-what-15-jan-2026-2</loc><lastmod>2025-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-rescheduled-session-on-accelerated-publications-why-and-what-15-jan-2026-3</loc><lastmod>2025-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-rescheduled-session-on-accelerated-publications-why-and-what-15-jan-2026</loc><lastmod>2025-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-rescheduled-session-on-accelerated-publications-why-and-what-15-jan-2026-1</loc><lastmod>2025-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-release-notes-03-dec-2025</loc><lastmod>2025-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-release-notes-03-dec-2025-1</loc><lastmod>2025-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-release-notes-03-dec-2025-2</loc><lastmod>2025-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-patient-engagement-community-for-our-annual-jolabokaflod-gathering</loc><lastmod>2025-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-patient-engagement-community-for-our-annual-jolabokaflod-gathering-1</loc><lastmod>2025-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=205d66e0-166a-437b-b016-e67b549862b4&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/one-week-to-go-dia-direct-webinarclinical-trials-regulation-eu-5362014-a-missed-opportunity-1</loc><lastmod>2025-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-dec-16-12-pm-et-adpromo-ai-considerations-in-the-news-opdp-uls-and-more</loc><lastmod>2025-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-dec-16-12-pm-et-adpromo-ai-considerations-in-the-news-opdp-uls-and-more-1</loc><lastmod>2025-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-dec-09-2025-2</loc><lastmod>2025-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-dec-09-2025-3</loc><lastmod>2025-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-dec-09-2025</loc><lastmod>2025-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-dec-09-2025-1</loc><lastmod>2025-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-newsletter-november-2025-4</loc><lastmod>2025-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-newsletter-november-2025</loc><lastmod>2025-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-newsletter-november-2025-1</loc><lastmod>2025-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-newsletter-november-2025-2</loc><lastmod>2025-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-newsletter-november-2025-3</loc><lastmod>2025-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudamed-first-four-modules-set-to-become-mandatory-as-of-may-2026-3</loc><lastmod>2025-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudamed-first-four-modules-set-to-become-mandatory-as-of-may-2026</loc><lastmod>2025-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudamed-first-four-modules-set-to-become-mandatory-as-of-may-2026-1</loc><lastmod>2025-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudamed-first-four-modules-set-to-become-mandatory-as-of-may-2026-2</loc><lastmod>2025-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-new-coordinated-fast-track-pathway-for-multinational-trials-in-the-eueea-1</loc><lastmod>2025-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fast-eu-new-coordinated-fast-track-pathway-for-multinational-trials-in-the-eueea</loc><lastmod>2025-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2025</loc><lastmod>2025-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2025-1</loc><lastmod>2025-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updates-guidance-on-post-authorization-safety-studies-and-paediatric-study-results-submissions-2</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updates-guidance-on-post-authorization-safety-studies-and-paediatric-study-results-submissions-3</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updates-guidance-on-post-authorization-safety-studies-and-paediatric-study-results-submissions</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updates-guidance-on-post-authorization-safety-studies-and-paediatric-study-results-submissions-1</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-1113-whats-up-next-for-dia-pec</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-programme-training-document-updated-2</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-programme-training-document-updated-3</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-programme-training-document-updated</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-programme-training-document-updated-1</loc><lastmod>2025-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/survey-on-health-information-seeking-behaviours</loc><lastmod>2025-11-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-to-save-big-gpvrms26-1</loc><lastmod>2025-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-to-save-big-gpvrms26</loc><lastmod>2025-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-informed-consent-form-working-group-meeting-agenda-nov-2025-2</loc><lastmod>2025-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-informed-consent-form-working-group-meeting-agenda-nov-2025-3</loc><lastmod>2025-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-informed-consent-form-working-group-meeting-agenda-nov-2025-1</loc><lastmod>2025-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=8034a06d-1a83-44b2-bb06-457471006763&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-11-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-modernized-prs-updates-5</loc><lastmod>2025-11-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-modernized-prs-updates-3</loc><lastmod>2025-11-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-modernized-prs-updates-4</loc><lastmod>2025-11-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/download-the-white-paper-digital-transformation-in-pharma-why-structured-content-is-the-strategic-foundation-a-strategic-overview-for-decision-makers-economic-buyers-and-regulatory-leaders</loc><lastmod>2025-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/download-the-white-paper-digital-transformation-in-pharma-why-structured-content-is-the-strategic-foundation-a-strategic-overview-for-decision-makers-economic-buyers-and-regulatory-leaders-1</loc><lastmod>2025-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-nov-19-in-the-news-farixga-opdp-ul-part-ii-rwdrwe-in-promotional-materials-1</loc><lastmod>2025-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-nov-19-in-the-news-farixga-opdp-ul-part-ii-rwdrwe-in-promotional-materials</loc><lastmod>2025-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=558083b5-9a4c-4c6a-b2a0-2c0065392c53&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2025-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-reschedule-to-nov-19-12-pm-et-same-agenda-1</loc><lastmod>2025-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-reschedule-to-nov-19-12-pm-et-same-agenda</loc><lastmod>2025-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-nov-18-12-pm-adpromo-ai-considerations-and-more</loc><lastmod>2025-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-nov-18-12-pm-adpromo-ai-considerations-and-more-1</loc><lastmod>2025-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-nov-18-at-12-pm-et-adpromo-ai-considerations-rwerwd-cont-and-more</loc><lastmod>2025-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=3167505f-7c96-43b9-a86c-b7c14e190511&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-adpromo-zoom-issue-no-meeting-1</loc><lastmod>2025-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-icf-working-group-call-for-agenda-topics-2</loc><lastmod>2025-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-icf-working-group-call-for-agenda-topics-3</loc><lastmod>2025-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-icf-working-group-call-for-agenda-topics-1</loc><lastmod>2025-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=d2d87e01-2581-4a3e-9067-b8f847ff3243&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/computer-system-validation-by-ai-1</loc><lastmod>2025-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MessageKey=8de83d55-28ce-4dd5-b63f-a81607b6aa44&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2025-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-webinar-nov-18-w-fda-office-of-orphan-products-development-cber</loc><lastmod>2025-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-webinar-nov-18-w-fda-office-of-orphan-products-development-cber-1</loc><lastmod>2025-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=9e73e822-e6ed-4bf8-a5b3-790b00588b01&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-nov-19-11am-et-rim-wg-meeting-1</loc><lastmod>2025-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-webinar-clinical-trials-regulation-eu-5362014-a-missed-opportunity-1</loc><lastmod>2025-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/take-the-community-survey-before-nov-21st</loc><lastmod>2025-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/november-meeting-notes-with-links-posted</loc><lastmod>2025-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=a0d54119-855a-40b5-9fcd-7166fab391a1&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2025-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/november-csp-call-patient-collaboration-in-the-development-of-armms-1</loc><lastmod>2025-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-webinar-clinical-trials-regulation-eu-5362014-a-missed-opportunity</loc><lastmod>2025-11-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-launches-updated-website-to-enhance-user-experience</loc><lastmod>2025-11-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-launches-updated-website-to-enhance-user-experience-1</loc><lastmod>2025-11-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-launches-updated-website-to-enhance-user-experience-2</loc><lastmod>2025-11-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-launches-updated-website-to-enhance-user-experience-3</loc><lastmod>2025-11-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-november-2025-5</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-november-2025-2</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-november-2025-4</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-november-2025-3</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f4f5d94a-0bce-46fd-a5f8-4bcb849a9e25&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-november-2025-1</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/follow-up-from-dia-pec-october-meeting-information-from-one-cancer-place</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-28-oct-2025</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-28-oct-2025-1</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-28-oct-2025-2</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-28-oct-2025-3</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-28-oct-2025-4</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-28-oct-2025-5</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=761a544b-eee9-494f-b450-01894b896649</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-minutes-and-recording-policy-00700043foia-mtg-2025-10-17</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-to-ctis-transparency-materials-and-sponsor-handbook-1</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=cc81a12a-aeb0-47e0-8724-ada41acf1059&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/germany-new-portal-for-submitting-csr-synopses-per-42b-german-drug-act</loc><lastmod>2025-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/october-2025-dia-informed-consent-form-working-group-meeting-notes-and-recording-2</loc><lastmod>2025-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/october-2025-dia-informed-consent-form-working-group-meeting-notes-and-recording-3</loc><lastmod>2025-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/october-2025-dia-informed-consent-form-working-group-meeting-notes-and-recording-1</loc><lastmod>2025-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-presentation-ctd-oct-2025-meeting-qna-3</loc><lastmod>2025-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-presentation-ctd-oct-2025-meeting-qna-2</loc><lastmod>2025-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-presentation-ctd-oct-2025-meeting-qna</loc><lastmod>2025-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-presentation-ctd-oct-2025-meeting-qna-1</loc><lastmod>2025-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b3a6dc2a-214f-4d84-9b6e-0dbb3cd82014&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-11-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-nov-18-at-12-pm-et-adpromo-ai-considerations-rwerwd-cont-and-more-1</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guidance-documents-2</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guidance-documents-3</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guidance-documents-4</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guidance-documents-1</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=59997999-23f1-49f2-8b80-a8992dc571a0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regpolicy-intel-community-meeting-fireside-chat-with-5-former-fda-chiefs-of-staff-1</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-mtg-with-former-fda-chief-of-staff-nov-6th-at-12-noon-et</loc><lastmod>2025-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-at-12-pm-et-dia-regulatory-policy-fireside-chat-with-five-former-fda-chiefs-of-staff</loc><lastmod>2025-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-at-12-pm-et-dia-regulatory-policy-fireside-chat-with-five-former-fda-chiefs-of-staff-1</loc><lastmod>2025-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=39ef896e-3afc-429a-9063-019a5929c075&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2025-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regpolicy-intel-community-meeting-fireside-chat-with-5-former-fda-chiefs-of-staff</loc><lastmod>2025-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/med-info-guidelines-equivalent-to-the-pipa-guidelines-outside-of-the-uk</loc><lastmod>2025-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/please-take-the-2025-dia-ctd-community-survey</loc><lastmod>2025-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-updated-documents-in-eudralex-volume-10-released-today</loc><lastmod>2025-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-updated-documents-in-eudralex-volume-10-released-today-1</loc><lastmod>2025-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/question-country-of-manufacture-vs-country-of-origin</loc><lastmod>2025-10-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thurs-30-october-cmc-ra-working-group-all-hands-call-ich-q1-3</loc><lastmod>2025-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thurs-30-october-cmc-ra-working-group-all-hands-call-ich-q1-2</loc><lastmod>2025-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-driving-change-in-transparency-and-research-standards-2</loc><lastmod>2025-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-driving-change-in-transparency-and-research-standards-3</loc><lastmod>2025-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-driving-change-in-transparency-and-research-standards-5</loc><lastmod>2025-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-driving-change-in-transparency-and-research-standards</loc><lastmod>2025-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-driving-change-in-transparency-and-research-standards-1</loc><lastmod>2025-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=dc282ab5-9f01-4988-a7d2-937a9fc3ddaf&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-updates-expanded-access-guidance-key-takeaways-for-disclosure-professionals-1</loc><lastmod>2025-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thurs-30-october-cmc-ra-working-group-all-hands-call-ich-q1-1</loc><lastmod>2025-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thurs-30-october-cmc-ra-working-group-all-hands-call-ich-q1</loc><lastmod>2025-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia2026-patient-partners</loc><lastmod>2025-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-109-participant-payment-strategy-for-21st-century-clinical-trials</loc><lastmod>2025-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-accelerated-publications-why-and-what-28-oct-2025-6</loc><lastmod>2025-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-21-oct-2025-meeting-key-notes-qna-sheet-and-recordings</loc><lastmod>2025-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-21-oct-2025-meeting-key-notes-qna-sheet-and-recordings-1</loc><lastmod>2025-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-call-for-posters-professionals-and-fellows-2</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-call-for-posters-professionals-and-fellows-3</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-call-for-posters-professionals-and-fellows-1</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/improving-transparency-mhra-adds-summaries-of-changes-to-clinical-trials-guidance-on-govuk-4</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/improving-transparency-mhra-adds-summaries-of-changes-to-clinical-trials-guidance-on-govuk-5</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/improving-transparency-mhra-adds-summaries-of-changes-to-clinical-trials-guidance-on-govuk</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/improving-transparency-mhra-adds-summaries-of-changes-to-clinical-trials-guidance-on-govuk-1</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/improving-transparency-mhra-adds-summaries-of-changes-to-clinical-trials-guidance-on-govuk-2</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-oct-2025-2</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-oct-2025-3</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informed-consent-form-working-group-meeting-agenda-oct-2025-1</loc><lastmod>2025-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-zoom-link-for-informed-consent-form-wg-monthly-calls-3</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-zoom-link-for-informed-consent-form-wg-monthly-calls-2</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hmaema-multi-stakeholder-workshop-on-artificial-intelligence</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-zoom-link-for-informed-consent-form-wg-monthly-calls-1</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-october-2025-meeting-recording-available-2</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-october-2025-meeting-recording-available-3</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-october-2025-meeting-recording-available</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-october-2025-meeting-recording-available-1</loc><lastmod>2025-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-pharmacovigilance-poster-and-roundtable-moderator-submission-deadline-1</loc><lastmod>2025-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-pharmacovigilance-poster-and-roundtable-moderator-submission-deadline</loc><lastmod>2025-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-28-oct-2025-4</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-28-oct-2025-6</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-28-oct-2025-3</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-28-oct-2025</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-28-oct-2025-2</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-accelerated-publications-why-and-what-28-oct-2025-1</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=d4bc05f9-6333-49b7-9970-b286b4ad75c7&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2025-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-monthly-meeting-october-2025-meeting-minutes</loc><lastmod>2025-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-monthly-meeting-october-2025-meeting-minutes-1</loc><lastmod>2025-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-monthly-meeting-october-2025-meeting-minutes-3</loc><lastmod>2025-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=c29b36b2-bdde-457f-9618-e950718463f4&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-publishes-updated-guide-on-access-to-unpublished-documents-3</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-publishes-updated-guide-on-access-to-unpublished-documents-2</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-publishes-updated-guide-on-access-to-unpublished-documents-1</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-publishes-updated-guide-on-access-to-unpublished-documents</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=04068719-8696-4658-961e-7d8655dffcf0&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=174ece18-bbfb-481f-b298-7cd00c1d119e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=185c1c0e-5216-4a80-a27c-46141294676c&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=1a2d633b-a3f6-4df8-b676-38cd768966ad&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=233245b2-3d29-4cfb-9dbc-1372517a4605&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=557a7e6d-4000-4029-bb8e-201d7556a679&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=5d6b3041-8ab0-4f5c-88f7-2d6f1350b8b5&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=d098d70e-f29c-401c-8f95-f4a39fc35a85&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=f24076df-815a-41eb-83b8-d235d572322b&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=f5710e04-67bd-4504-ab52-09754c26e388&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=fabc6256-e2c9-4097-ba42-6860c8be91cd&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=322707d4-b296-4ba8-9969-48d35f0963a3&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=73a74d41-d87c-4b85-9a85-15674b0eb6be&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=bd63581a-6218-4fc4-9229-ef34c71f7a12&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=cf26a270-3847-425f-9771-9b4c25139759&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-oct-14-sep-9-dtc-enforcement-trends-opdp-ai-capabilities-rwerwd-in-adpromo</loc><lastmod>2025-10-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-oct-14-sep-9-dtc-enforcement-trends-opdp-ai-capabilities-rwerwd-in-adpromo-1</loc><lastmod>2025-10-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-21-oct-2025</loc><lastmod>2025-10-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-21-oct-2025-1</loc><lastmod>2025-10-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/october-csp-community-call-new-ema-guidance-on-embryo-fetal-toxicity</loc><lastmod>2025-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-dia-direct-event-fireside-chat-with-fda-on-cmc-policy-on-oct-14</loc><lastmod>2025-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/insights-from-the-encepp-steering-group-meeting-2</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/insights-from-the-encepp-steering-group-meeting</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/insights-from-the-encepp-steering-group-meeting-1</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/insights-from-the-encepp-steering-group-meeting-3</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-guideline-for-non-interventional-studies</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-guideline-for-non-interventional-studies-1</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-guideline-for-non-interventional-studies-2</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-guideline-for-non-interventional-studies-3</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/oops-adpromo-wg-on-oct-14-recent-enforcement-trends-use-of-ai-and-use-of-rwdrwe-in-adpromo</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/oops-adpromo-wg-on-oct-14-recent-enforcement-trends-use-of-ai-and-use-of-rwdrwe-in-adpromo-1</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-nov-14-recent-enforcement-trends-use-of-ai-and-use-of-rwdrwe-in-adpromo</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-nov-14-recent-enforcement-trends-use-of-ai-and-use-of-rwdrwe-in-adpromo-1</loc><lastmod>2025-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-community-meeting-agenda-14-october-2025-5</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-community-meeting-agenda-14-october-2025-3</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-community-meeting-agenda-14-october-2025-2</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-community-meeting-agenda-14-october-2025</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-community-meeting-agenda-14-october-2025-1</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-global-clinical-trials-forum-gctf-5</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-global-clinical-trials-forum-gctf-3</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-global-clinical-trials-forum-gctf-2</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-global-clinical-trials-forum-gctf-1</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c8b26dab-a1cc-4546-8d4e-bdd60895ba13&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-accelerated-publications-why-and-what-28-oct-2025</loc><lastmod>2025-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-accelerated-publications-why-and-what-28-oct-2025-1</loc><lastmod>2025-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-accelerated-publications-why-and-what-28-oct-2025-2</loc><lastmod>2025-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-accelerated-publications-why-and-what-28-oct-2025-3</loc><lastmod>2025-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-accelerated-publications-why-and-what-28-oct-2025-6</loc><lastmod>2025-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-accelerated-publications-why-and-what-28-oct-2025-7</loc><lastmod>2025-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-october-2025-2</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-october-2025-1</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-october-2025</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-october-2025</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-october-2025-1</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-accelerated-publications-why-and-what-28-oct-2025-5</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-accelerated-publications-why-and-what-28-oct-2025-6</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-accelerated-publications-why-and-what-28-oct-2025-2</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-accelerated-publications-why-and-what-28-oct-2025-3</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-accelerated-publications-why-and-what-28-oct-2025</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-accelerated-publications-why-and-what-28-oct-2025-1</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=960ea278-3b1e-40c2-9ce7-11698a453b30&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/report-on-the-first-3-years-of-the-clinical-trials-regulation-1</loc><lastmod>2025-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dont-miss-this-virtual-short-course-1</loc><lastmod>2025-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dont-miss-this-virtual-short-course</loc><lastmod>2025-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-dia-direct-event-fireside-chat-with-fda-on-cmc-and-ai-policy-on-oct-14</loc><lastmod>2025-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-dia-direct-event-fireside-chat-with-fda-on-cmc-policy-on-oct-14-1</loc><lastmod>2025-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wed-01-october-cmc-ra-working-group-ich-m4qr2</loc><lastmod>2025-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-prs-notice-2</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b6b2a653-88b2-411f-905f-cd0d78395a27&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-prs-notice-1</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c7687d92-28fb-441b-bec5-5af91f838557&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-waiver-request-and-appeal-process-2</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-waiver-request-and-appeal-process-1</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-final-clinical-trials-guidance-and-transparency-guidance-for-sponsors-about-sharing-trial-results-published-4</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-final-clinical-trials-guidance-and-transparency-guidance-for-sponsors-about-sharing-trial-results-published-5</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-final-clinical-trials-guidance-and-transparency-guidance-for-sponsors-about-sharing-trial-results-published-2</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-final-clinical-trials-guidance-and-transparency-guidance-for-sponsors-about-sharing-trial-results-published-3</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=68642cd7-e54e-4615-bc7f-4f3db85e4568&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-final-clinical-trials-guidance-and-transparency-guidance-for-sponsors-about-sharing-trial-results-published-1</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=73467fef-40fa-4155-8b84-441bd357cf52&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-oct-14-opdp-ai-use-reg-considerations-for-use-of-rwe-in-adpromo-1</loc><lastmod>2025-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wed-01-october-cmc-ra-working-group-ich-m4qr2-1</loc><lastmod>2025-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/draft-guidance-e20-adaptive-designs-for-clinical-trials</loc><lastmod>2025-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MessageKey=a84bfb76-9bb1-4160-b8e5-d47babe111bb&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2025-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-informed-consent-form-working-group-meeting-september-2025-meeting-notes-and-recording-3</loc><lastmod>2025-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-informed-consent-form-working-group-meeting-september-2025-meeting-notes-and-recording-1</loc><lastmod>2025-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-multi-stakeholder-platform-annual-meeting-by-ema</loc><lastmod>2025-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-multi-stakeholder-platform-annual-meeting-by-ema-1</loc><lastmod>2025-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wed-01-october-cmc-ra-working-group-all-hands-call-ich-m4qr2-1</loc><lastmod>2025-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wed-01-october-cmc-ra-working-group-all-hands-call-ich-m4qr2</loc><lastmod>2025-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-2</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-1</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-september-2025-progress-on-transparency-initiatives-and-regulatory-readiness-2</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-september-2025-progress-on-transparency-initiatives-and-regulatory-readiness-3</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-september-2025-progress-on-transparency-initiatives-and-regulatory-readiness-4</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-september-2025-progress-on-transparency-initiatives-and-regulatory-readiness</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-september-2025-progress-on-transparency-initiatives-and-regulatory-readiness-1</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-results-submission-form-implementation-date</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-results-submission-form-implementation-date-1</loc><lastmod>2025-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/get-involved-at-the-global-pharmacovigilance-conference-1</loc><lastmod>2025-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/get-involved-at-the-global-pharmacovigilance-conference</loc><lastmod>2025-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-csa-final-guidance-published-on-24-sep-2025</loc><lastmod>2025-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-csa-final-guidance-published-on-24-sep-2025-1</loc><lastmod>2025-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/indonesia-clinical-trial-registry-ina-crr-complete-transition-to-the-new-website</loc><lastmod>2025-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/indonesia-clinical-trial-registry-ina-crr-complete-transition-to-the-new-website-1</loc><lastmod>2025-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/indonesia-clinical-trial-registry-ina-crr-complete-transition-to-the-new-website-2</loc><lastmod>2025-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=9630aeb7-8d50-42ae-9604-3d7d50b7e703&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-and-zoom-link-wednesday-september-24th-at-12pm-et-shared-learning-session-beyond-the-hype-responsible-ai-collaboration-in-regulatory-writing-1</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-targets-set-for-clinical-trials-in-the-european-union-2</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-targets-set-for-clinical-trials-in-the-european-union-3</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-targets-set-for-clinical-trials-in-the-european-union-1</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-core-committee-for-dia-india-medical-writing-community</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-core-committee-for-dia-india-medical-writing-community-1</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-core-committee-for-dia-india-medical-writing-community-4</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-core-committee-for-dia-india-medical-writing-community-7</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/itmctr-update-september-2025-2</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/itmctr-update-september-2025-3</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/itmctr-update-september-2025</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/itmctr-update-september-2025-1</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-core-committee-for-dia-india-medical-writing-community-5</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-core-committee-for-dia-india-medical-writing-community-3</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcing-the-core-committee-for-dia-india-medical-writing-community-2</loc><lastmod>2025-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-new-informed-consent-form-working-group-2</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=187&amp;MessageKey=483ce922-0cb5-42ca-8202-39cc34d1c754&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-new-informed-consent-form-working-group</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-new-informed-consent-form-working-group-1</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctri-update-september-2025-5</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctri-update-september-2025-4</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctri-update-september-2025-3</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=6ba13cfa-b75e-4d37-8c25-c0cedf4b565d&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-this-wednesday-september-24th-shared-learning-session-beyond-the-hype-responsible-ai-collaboration-in-regulatory-writing-1</loc><lastmod>2025-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-dia-working-group-on-informed-consent-forms</loc><lastmod>2025-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-ich-workshop-recording-now-available-1</loc><lastmod>2025-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=ae14193c-e4b5-46ec-9f47-5af8aa7514ed&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f84231e9-78f3-4323-a4cd-c6a0404de31c&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-ich-workshop-recording-now-available-3</loc><lastmod>2025-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-36</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-37</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-38</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-39</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-31</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-32</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-33</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-34</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-35</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-30</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-28</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-29</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-27</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-24</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-25</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-18</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-20</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-22</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-21</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-19</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-13</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-14</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-15</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-16</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-17</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-10</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-11</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-6</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-7</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-8</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-9</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-2</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-3</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-4</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-5</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-registered-to-attend-the-upcoming-dia-direct-community-webinars-1</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MessageKey=7836db21-c799-4ec0-a643-7feed4cc8044&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-for-dia-informed-consent-form-working-group-meeting-23-sep-2025-3</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-for-dia-informed-consent-form-working-group-meeting-23-sep-2025-1</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-publishes-final-version-of-m14-guideline-for-non-interventional-studies-utilizing-real-world-data-3</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-publishes-final-version-of-m14-guideline-for-non-interventional-studies-utilizing-real-world-data</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-publishes-final-version-of-m14-guideline-for-non-interventional-studies-utilizing-real-world-data-1</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-publishes-final-version-of-m14-guideline-for-non-interventional-studies-utilizing-real-world-data-2</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-wednesday-924-shared-learning-session-beyond-the-hype-responsible-ai-collaboration-in-regulatory-writing</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=06e05fa8-8fbf-49b1-82de-019959264d57&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/the-qppvs-role-in-ai-and-regulatory-vigilance-webinar-recording-available</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-advancing-transparency-and-preparing-for-2026-regulatory-reforms-4</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-advancing-transparency-and-preparing-for-2026-regulatory-reforms-2</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-advancing-transparency-and-preparing-for-2026-regulatory-reforms-3</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-advancing-transparency-and-preparing-for-2026-regulatory-reforms</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trials-update-advancing-transparency-and-preparing-for-2026-regulatory-reforms-1</loc><lastmod>2025-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=0b18cae6-7c43-4fb6-8255-019938c79e10&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-09-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-sep-16-12-pm-et-crackdown-on-dtv-guest-presenter-on-onc-clinical-trial-endpoints-and-more-1</loc><lastmod>2025-09-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=d4340c76-f4af-48de-815e-e7b6bb07a5c6&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=57911e90-fa21-420c-bba7-019933bd0313&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/dia-direct-community-webinars</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/network</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/events/dia-direct-webinars</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/events/dia-annual-meeting</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-dtc-crackdown-overview-enforcement-and-h-sulliven-pts-understanding-of-oncology-clinical-trial-endpoints-1</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=6f6d3fef-a80d-4870-a6cb-a2ea74752515&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/tracking-transparency-trends-from-anzctrs-review-of-trial-information-updates-2</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/tracking-transparency-trends-from-anzctrs-review-of-trial-information-updates-3</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/tracking-transparency-trends-from-anzctrs-review-of-trial-information-updates-1</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/tracking-transparency-trends-from-anzctrs-review-of-trial-information-updates</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/due-to-ilness-no-community-call-in-september</loc><lastmod>2025-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-sep-11-noon-et-rim-working-group-veeva-summit-ai-vs-saas</loc><lastmod>2025-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctri-update-september-2025-2</loc><lastmod>2025-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctri-update-september-2025</loc><lastmod>2025-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctri-update-september-2025-1</loc><lastmod>2025-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meeting-notes-with-links-to-slides-from-septembers-meeting</loc><lastmod>2025-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/smarter-trials-stronger-europe-new-targets-for-clinical-research</loc><lastmod>2025-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/smarter-trials-stronger-europe-new-targets-for-clinical-research-1</loc><lastmod>2025-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=6ee5599e-77b9-4ab3-af95-606fd1de39c1&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-modernized-prs-updates-4</loc><lastmod>2025-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-modernized-prs-updates-3</loc><lastmod>2025-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b73d26ad-dfa4-43b8-a734-24afb93516de&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-sep-11-noon-et-rim-working-group-veeva-summit-ai-vs-saas-1</loc><lastmod>2025-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/september-advanced-therapies-community-meeting</loc><lastmod>2025-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MessageKey=8b86262f-1703-4383-b4f3-9973b4c8cad2&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2025-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-protocol-template</loc><lastmod>2025-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dei-community-publications-in-global-forum-in-2024</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/september-pec-all-hands-meeting-cancelled</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/unlock-the-future-of-biosimilars-free-dia-webinar-on-october-1-2025-4</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=98b19ede-7757-41b8-9acf-885a6cb537c2&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/unlock-the-future-of-biosimilars-free-dia-webinar-on-october-1-2025-3</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/unlock-the-future-of-biosimilars-free-dia-webinar-on-october-1-2025-5</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/unlock-the-future-of-biosimilars-free-dia-webinar-on-october-1-2025</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/unlock-the-future-of-biosimilars-free-dia-webinar-on-october-1-2025-1</loc><lastmod>2025-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=89d62237-cb02-40e3-af7b-9923130b9a5c&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-nlm-bulletin-on-modernized-prs-updates</loc><lastmod>2025-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-nlm-bulletin-on-modernized-prs-updates-1</loc><lastmod>2025-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=4508b7e5-1748-4f47-bc4b-d28b8faddfa7&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-for-next-weeks-meeting-has-been-posted-1</loc><lastmod>2025-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/link-to-slide-presentation-for-ai-immersion-for-regulatory-writers-presented-august-27-2025-by-dr-sharon-kim</loc><lastmod>2025-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/link-to-slide-presentation-for-ai-immersion-for-regulatory-writers-presented-august-27-2025-by-dr-sharon-kim-1</loc><lastmod>2025-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-sept-16-includes-guest-presenter-on-patients-understanding-of-oncology-clinical-trial-endpoints</loc><lastmod>2025-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-sept-16-includes-guest-presenter-on-patients-understanding-of-oncology-clinical-trial-endpoints-1</loc><lastmod>2025-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-experienced-medical-writers-to-volunteer-as-mentors</loc><lastmod>2025-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-experienced-medical-writers-to-volunteer-as-mentors-1</loc><lastmod>2025-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-august-2025-upcoming-transparency-webinar-and-updates-on-hra-initiatives-2</loc><lastmod>2025-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-august-2025-upcoming-transparency-webinar-and-updates-on-hra-initiatives-3</loc><lastmod>2025-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-august-2025-upcoming-transparency-webinar-and-updates-on-hra-initiatives</loc><lastmod>2025-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-august-2025-upcoming-transparency-webinar-and-updates-on-hra-initiatives-1</loc><lastmod>2025-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=7c62b51f-3a06-44dc-8b00-4d0c7a9d9314&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2025-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-is-organising-clinical-trials-information-system-ctis-walk-in-clinic-on-ctis-functionalities-1</loc><lastmod>2025-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cheat-sheet-ai-immersion-for-regulatory-medical-writers-presented-by-dr-sharon-kim-27aug2025</loc><lastmod>2025-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-6</loc><lastmod>2025-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-4</loc><lastmod>2025-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-5</loc><lastmod>2025-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-launches-route-b-notification-pilot-as-part-of-clinical-trials-regulations-rollout-1</loc><lastmod>2025-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-launches-route-b-notification-pilot-as-part-of-clinical-trials-regulations-rollout</loc><lastmod>2025-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-modernized-prs-updates-2</loc><lastmod>2025-08-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-modernized-prs-updates-1</loc><lastmod>2025-08-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=73b88275-159f-4dfc-9498-a09b5866ca79&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-08-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MessageKey=c9015026-ee95-4b4a-8f81-54c0d67869a5&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-canada-annual-meeting-6</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-canada-annual-meeting-7</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-canada-annual-meeting-4</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-latin-america-annual-meeting-6</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-latin-america-annual-meeting-4</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-latin-america-annual-meeting-5</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pilot-for-the-uk-hra-and-mhra-inclusion-and-diversity-plan-4</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pilot-for-the-uk-hra-and-mhra-inclusion-and-diversity-plan-3</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pilot-for-the-uk-hra-and-mhra-inclusion-and-diversity-plan-2</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pilot-for-the-uk-hra-and-mhra-inclusion-and-diversity-plan-1</loc><lastmod>2025-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-redesigned-website-and-streamlining-clinical-trials-with-the-national-one-stop-shop-initiative-2</loc><lastmod>2025-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-redesigned-website-and-streamlining-clinical-trials-with-the-national-one-stop-shop-initiative</loc><lastmod>2025-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-redesigned-website-and-streamlining-clinical-trials-with-the-national-one-stop-shop-initiative-1</loc><lastmod>2025-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-19-aug-2025-meeting-key-notes-qna-sheet-and-recordings</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-19-aug-2025-meeting-key-notes-qna-sheet-and-recordings-1</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/route-b-substantial-modification-pilot-4</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/route-b-substantial-modification-pilot-2</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/route-b-substantial-modification-pilot-3</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/route-b-substantial-modification-pilot</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/route-b-substantial-modification-pilot-1</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=4ec7383f-155a-44d3-9f91-e3372ee02aba&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-new-guideline-on-overall-survival</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-32</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-33</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-34</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-28</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-29</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-30</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-31</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-27</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-26</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-24</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-25</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-23</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-21</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-22</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia2026-patient-impact</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MessageKey=d3351fca-23c7-48ba-bb15-7931e6ede884&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-19</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-16</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-17</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-14</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-15</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-12</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-13</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-10</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-11</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-8</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-9</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-6</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-7</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-4</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-5</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-2</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-3</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MessageKey=9769b279-5448-46d6-aa37-b8558857f4ca&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-dia-2026-global-annual-meeting-philadelphia-pa-1</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-policy-00700043foia-working-group-mtg-is-aug-21</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-policy-00700043foia-working-group-mtg-is-aug-21-1</loc><lastmod>2025-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pfdd-workshop-coming-in-september</loc><lastmod>2025-08-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-pec-august-14-mini-crowdsourcing-event-for-your-insights-for-iqvia</loc><lastmod>2025-08-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia2026-patient-impact-1</loc><lastmod>2025-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-about-dia-pec-august-14-mini-crowdsourcing-event-for-your-insights-for-iqvia</loc><lastmod>2025-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-august-meeting-minutes-and-meeting-presentations</loc><lastmod>2025-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-august-meeting-minutes-and-meeting-presentations-2</loc><lastmod>2025-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-august-meeting-minutes-and-meeting-presentations-3</loc><lastmod>2025-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-august-meeting-minutes-and-meeting-presentations-1</loc><lastmod>2025-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-930-at-2pm-cst-from-randomization-to-real-time-the-past-present-and-future-of-innovation-in-biopharmaceutical-statistics</loc><lastmod>2025-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-930-at-2pm-cst-from-randomization-to-real-time-the-past-present-and-future-of-innovation-in-biopharmaceutical-statistics-1</loc><lastmod>2025-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-gold-standard-science</loc><lastmod>2025-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rwe-conference-discounted-early-bird-rates-expiring-1</loc><lastmod>2025-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=db445f3e-023c-47f8-9c24-5853452c66bb&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-19-aug-2025</loc><lastmod>2025-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-19-aug-2025-1</loc><lastmod>2025-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/3-steps-to-stay-up-to-date-with-whats-happening-in-the-community</loc><lastmod>2025-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/3-steps-to-stay-up-to-date-with-whats-happening-in-the-community-1</loc><lastmod>2025-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-sponsor-registration-in-the-combine-pilot-program-2</loc><lastmod>2025-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-sponsor-registration-in-the-combine-pilot-program-3</loc><lastmod>2025-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-sponsor-registration-in-the-combine-pilot-program-1</loc><lastmod>2025-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=815b4cb3-6a98-44af-9880-742d01dcac83&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-aug-20-11am-et-rim-ai-automation-team-ai-for-submissions-authoring-automation</loc><lastmod>2025-08-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-aug-20-11am-et-rim-ai-automation-team-ai-for-submissions-authoring-automation-1</loc><lastmod>2025-08-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MessageKey=b5026122-6257-4c88-bfc1-51f42b504153&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2025-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-12-august-2025</loc><lastmod>2025-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-12-august-2025-1</loc><lastmod>2025-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-12-august-2025-2</loc><lastmod>2025-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-12-august-2025-3</loc><lastmod>2025-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-adpromo-call-for-abstracts-deadline-approaching</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-call-for-abstracts-we-want-to-hear-from-you-6</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-call-for-abstracts-we-want-to-hear-from-you-7</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-call-for-abstracts-we-want-to-hear-from-you-5</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-29-jul-2025-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-4</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-29-jul-2025-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-2</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-29-jul-2025-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-3</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-29-jul-2025-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-29-jul-2025-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-1</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29jul2025-4</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29jul2025-3</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29jul2025</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29jul2025-1</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29jul2025-2</loc><lastmod>2025-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-august-27th-shared-learning-session-ai-immersion-for-regulatory-medical-writers</loc><lastmod>2025-08-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nlm-bulletin-on-screen-scraping-clinicaltrialsgov</loc><lastmod>2025-08-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nlm-bulletin-on-screen-scraping-clinicaltrialsgov-1</loc><lastmod>2025-08-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=b5bdd1bf-1aed-468f-b9db-f11c90662a8e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-no-august-meeting-hold-the-date-for-september-16-guest-presenter-helen-sullivan-1</loc><lastmod>2025-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-july-2025-transparency-initiatives-and-feedback-opportunity-on-clinical-trials-guidance-4</loc><lastmod>2025-08-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-july-2025-transparency-initiatives-and-feedback-opportunity-on-clinical-trials-guidance</loc><lastmod>2025-08-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-july-2025-transparency-initiatives-and-feedback-opportunity-on-clinical-trials-guidance-1</loc><lastmod>2025-08-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-july-2025-transparency-initiatives-and-feedback-opportunity-on-clinical-trials-guidance-2</loc><lastmod>2025-08-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-july-2025-transparency-initiatives-and-feedback-opportunity-on-clinical-trials-guidance-3</loc><lastmod>2025-08-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-release-notes</loc><lastmod>2025-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-release-notes-1</loc><lastmod>2025-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-csv-for-ai-automation-toolsplatforms</loc><lastmod>2025-07-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-csv-for-ai-automation-toolsplatforms-1</loc><lastmod>2025-07-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-clinical-data-publication-qa-document-4</loc><lastmod>2025-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-clinical-data-publication-qa-document</loc><lastmod>2025-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-clinical-data-publication-qa-document-1</loc><lastmod>2025-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-clinical-data-publication-qa-document-2</loc><lastmod>2025-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-clinical-data-publication-qa-document-3</loc><lastmod>2025-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-july-2025-2</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-july-2025</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-july-2025-1</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-july-2025</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-july-2025-1</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-4</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-5</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-2</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-3</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-1</loc><lastmod>2025-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=43404520-a379-4847-a25f-bf233140abce&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-07-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/crc-webinar-the-use-of-ai-in-clinical-trials-26-jun-2025-recording-link-error-1</loc><lastmod>2025-07-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=852cfcda-d0ac-42b5-b2bb-5fcdf5210962&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/presentation-slides-from-bite-size-talk-on-the-updated-training-material-now-available-3</loc><lastmod>2025-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/presentation-slides-from-bite-size-talk-on-the-updated-training-material-now-available-2</loc><lastmod>2025-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/presentation-slides-from-bite-size-talk-on-the-updated-training-material-now-available</loc><lastmod>2025-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/presentation-slides-from-bite-size-talk-on-the-updated-training-material-now-available-1</loc><lastmod>2025-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-unavailable-25-july-2025-due-to-data-center-maintenance-1</loc><lastmod>2025-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-unavailable-25-july-2025-due-to-data-center-maintenance</loc><lastmod>2025-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=0fd12db7-9cce-47ac-b87c-475e246d0315&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-3</loc><lastmod>2025-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-rim-wg-all-hands-july-17-11am-et-annual-meeting-recap</loc><lastmod>2025-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/crc-webinar-the-use-of-ai-in-clinical-trials-26-jun-2025-recording-available</loc><lastmod>2025-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/crc-webinar-the-use-of-ai-in-clinical-trials-26-jun-2025-recording-available-1</loc><lastmod>2025-07-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=dac6f51e-09b1-4b46-b7ad-d357aad1e442&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/learn-more-about-indnda-submissions-join-us-august-18-22-for-the-dia-live-virtual-course-regulatory-affairs-the-ind-nda-and-post-marketing-register-by-july-21-for-extra-savings-1</loc><lastmod>2025-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/learn-more-about-indnda-submissions-join-us-august-18-22-for-the-dia-live-virtual-course-regulatory-affairs-the-ind-nda-and-post-marketing-register-by-july-21-for-extra-savings</loc><lastmod>2025-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ai-neural-network</loc><lastmod>2025-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=f33911ad-c310-41e9-b342-a11e7bfab6f6&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2025-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ai-in-patient-safety-from-pilot-to-practice-1</loc><lastmod>2025-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meeting-notes-from-july-8th-2025-meeting</loc><lastmod>2025-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-annual-report-2024-is-now-available</loc><lastmod>2025-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-annual-report-2024-is-now-available-1</loc><lastmod>2025-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=e5e50c7b-4e90-4ccf-a3e1-00e93357878a&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-ai-regulations-ethics-governance-course-highlights-16-jul-rim-intelligent-automation-team-meeting-1</loc><lastmod>2025-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guide-to-ctis-training-materials-5</loc><lastmod>2025-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guide-to-ctis-training-materials-4</loc><lastmod>2025-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guide-to-ctis-training-materials-1</loc><lastmod>2025-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guide-to-ctis-training-materials-2</loc><lastmod>2025-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guide-to-ctis-training-materials-3</loc><lastmod>2025-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-sponsor-handbook-and-guide-to-ctis-training-materials</loc><lastmod>2025-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-qa-document-on-clinical-study-data-proof-of-concept-pilot</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-qa-document-on-clinical-study-data-proof-of-concept-pilot-2</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-qa-document-on-clinical-study-data-proof-of-concept-pilot-3</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updated-qa-document-on-clinical-study-data-proof-of-concept-pilot-1</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-opdp-wl-sprout-in-the-news-for-uk-and-us</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-opdp-wl-sprout-in-the-news-for-uk-and-us-1</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-3</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-4</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-2</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-1</loc><lastmod>2025-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-national-academies-workshop-1</loc><lastmod>2025-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MessageKey=52a5cd09-d90f-4edd-ba5d-354b57c7012d&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2025-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-00700043foias-2025-06-20-mtg-info-posted</loc><lastmod>2025-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-july-8-12-pm-et-opdp-wl-issued-to-sprout-in-the-news-and-more</loc><lastmod>2025-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-july-8-12-pm-et-opdp-wl-issued-to-sprout-in-the-news-and-more-1</loc><lastmod>2025-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d61679b6-c1f5-4ed5-96f1-63bf028a5bf0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-07-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-to-modernized-prs-system-1</loc><lastmod>2025-07-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/allcommunities</loc><lastmod>2025-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=59d9cd12-98f3-44d4-9f9a-be07b14cb3af&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/central-committee-on-research-involving-human-subjects-ccmo-recent-updates-8</loc><lastmod>2025-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/central-committee-on-research-involving-human-subjects-ccmo-recent-updates-9</loc><lastmod>2025-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/central-committee-on-research-involving-human-subjects-ccmo-recent-updates-7</loc><lastmod>2025-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-july-8-sprout-opdp-wl-uks-pmcpa-in-the-news</loc><lastmod>2025-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-july-8-sprout-opdp-wl-uks-pmcpa-in-the-news-1</loc><lastmod>2025-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-july-8-opdp-wl-issued-to-sprout-in-the-news-and-more</loc><lastmod>2025-06-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-july-8-opdp-wl-issued-to-sprout-in-the-news-and-more-1</loc><lastmod>2025-06-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-build-a-biomarker-how-to-construct-digital-biomarkers-that-matter-24th-june-2025-at-11am-cst-1</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-clinical-trials-guidance-published-25-jun-2025-4</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-clinical-trials-guidance-published-25-jun-2025-5</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-clinical-trials-guidance-published-25-jun-2025-2</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-clinical-trials-guidance-published-25-jun-2025-3</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-clinical-trials-guidance-published-25-jun-2025</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-clinical-trials-guidance-published-25-jun-2025-1</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MessageKey=956c91ef-d8ff-4701-b1cd-c1b39c527ec9&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-25-june-2025-shared-learning-practical-ai-for-regulatory-writers-3</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-25-june-2025-shared-learning-practical-ai-for-regulatory-writers-1</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=abc4a585-5b30-4c70-bbc4-feaa9deb2d9d&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-june-2025-7</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=0f8acfc2-d2e4-4942-8089-981b21548fbb&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-june-2025-5</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-june-2025-6</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-jun-25-11am-et-rim-intelligent-automation-team-ai-survey-results</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-jun-25-11am-et-rim-intelligent-automation-team-ai-survey-results-1</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=bbf04234-182e-4253-ab83-15bcd37fe675&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-17-jun-2025-meeting-key-notes-and-recordings-1</loc><lastmod>2025-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whos-2025-guidance-reporting-summary-results-in-clinical-trial-registries</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MessageKey=dec756b3-7da3-4401-8e25-87840219f147&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-community-important-news-4</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-bayesian-hybrid-design-in-early-phase-oncology-clinical-trials-for-combination-therapy-development</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-bayesian-hybrid-design-in-early-phase-oncology-clinical-trials-for-combination-therapy-development-1</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-4</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-2</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-3</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-1</loc><lastmod>2025-06-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-community-meeting-thursday-612-the-institute-at-one-cancer-place</loc><lastmod>2025-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/innovation-with-gen-ai-in-pharmacovigilance</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/innovation-with-gen-ai-in-pharmacovigilance-1</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/central-committee-on-research-involving-human-subjects-ccmo-recent-updates-4</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/central-committee-on-research-involving-human-subjects-ccmo-recent-updates-5</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=bfa645d1-bacd-4592-97a9-c980b61d8fa8&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/central-committee-on-research-involving-human-subjects-ccmo-recent-updates-3</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-4</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-3</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-1</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-csrs-to-clinical-summaries-the-backbone-of-evidence-to-unlock-regulatory-approvals-29-jul-2025-2</loc><lastmod>2025-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-management-board-meeting-highlights-1</loc><lastmod>2025-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-management-board-meeting-highlights</loc><lastmod>2025-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-management-board-meeting-highlights-june-2025</loc><lastmod>2025-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-management-board-meeting-highlights-june-2025-1</loc><lastmod>2025-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2025-ctd-conference-dia-needs-your-feedback</loc><lastmod>2025-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-12-jun-2025</loc><lastmod>2025-06-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-12-jun-2025-1</loc><lastmod>2025-06-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=5f34f378-fa99-4b9a-aab3-9ad34580142c&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/oncology-dose-optimization-survey-2</loc><lastmod>2025-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/oncology-dose-optimization-survey</loc><lastmod>2025-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MessageKey=a93ccf6d-3d77-40fc-b003-e7a1bacd6d13&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2025-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents-6</loc><lastmod>2025-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents-7</loc><lastmod>2025-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents-4</loc><lastmod>2025-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents-5</loc><lastmod>2025-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whos-2025-guidance-reporting-summary-results-in-clinical-trial-registries-1</loc><lastmod>2025-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-17-jun-2025</loc><lastmod>2025-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-working-group-meeting-agenda-17-jun-2025-1</loc><lastmod>2025-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-june-2025-monthly-meeting-meeting-recording-and-minutes-2</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-june-2025-monthly-meeting-meeting-recording-and-minutes-3</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-june-2025-monthly-meeting-meeting-recording-and-minutes</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-june-2025-monthly-meeting-meeting-recording-and-minutes-1</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=fcb9b8c0-192f-4e3e-aec8-019730e49989&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-00700043foia-wg-mtg-moved-to-friday-june-20</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-00700043foia-wg-mtg-moved-to-friday-june-20-1</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-and-medical-communications-conference-india-1112-july-2025-1</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-conference-india-1112-july-2025-2</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-conference-india-1112-july-2025-3</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-conference-india-1112-july-2025</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-conference-india-1112-july-2025-1</loc><lastmod>2025-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-21</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-20</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-19</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-18</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MessageKey=275f863d-b065-4c66-9717-9cf19fed47ca&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-16</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-15</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-14</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-12</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-11</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-10</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-9</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-8</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-7</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-6</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=243263d1-75df-4829-93c7-8deaaa63d52e&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-4</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-3</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-2</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/share-your-dia-membership-story-at-dia-2025-1</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=adc18fba-fd1b-4190-8baa-3b5dbff7c216&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dias-rsidm-call-for-abstracts-now-open</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dias-rsidm-call-for-abstracts-now-open-1</loc><lastmod>2025-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=7fbafd49-b2bb-47d7-b961-e8963477f77e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-june-10-sarfez-wl-trends-in-opdp-research-and-recent-enforcement-actions-in-the-news-1</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-june-2025-2</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-june-2025-3</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-june-2025</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-june-2025-1</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/brazilian-clinical-trial-registry-new-fast-track-approval-for-priority-studies</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/brazilian-clinical-trial-registry-new-fast-track-approval-for-priority-studies-1</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-community-meeting-thursday-612-the-institute-at-one-cancer-place-1</loc><lastmod>2025-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-10-june-2025-2</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-10-june-2025-3</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=e70e5da0-2195-4f3c-90b7-867856c94aa0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-10-june-2025-1</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=2b7dd415-d18b-4e59-a340-01974687e865</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=5aae23a4-0a11-4b03-9d40-9c482d60691d&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-modernized-prs-updates-1</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=bd0800c3-b574-4026-83a0-0197454ec866&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-dia-direct-event-advanced-therapy-medicinal-product-development-in-europe-on-july-23</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-dia-direct-event-advanced-therapy-medicinal-product-development-in-europe-on-july-23-1</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-june-10-12-pm-et-opdp-wl-guest-presenter-on-opdp-research-enforcement-and-in-the-news-1</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-june-10-12-pm-et-opdp-wl-guest-presenter-on-opdp-research-enforcement-and-in-the-news</loc><lastmod>2025-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-the-dia-cell-and-gene-therapy-summit-june-15th</loc><lastmod>2025-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-may-round-up</loc><lastmod>2025-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-25-june-2025-practical-ai-for-regulatory-writers-2</loc><lastmod>2025-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-25-june-2025-practical-ai-for-regulatory-writers-3</loc><lastmod>2025-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-25-june-2025-practical-ai-for-regulatory-writers</loc><lastmod>2025-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-25-june-2025-practical-ai-for-regulatory-writers-1</loc><lastmod>2025-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=df125bc5-4f89-4738-a9a0-21d056caedfd&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2025-06-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=d86e0fd6-8ef7-48f2-b33a-ba9433fd1606&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-may-2025-updates-on-transparency-initiatives-3</loc><lastmod>2025-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-may-2025-updates-on-transparency-initiatives</loc><lastmod>2025-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-may-2025-updates-on-transparency-initiatives-1</loc><lastmod>2025-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b1985f83-33fd-4932-809c-a99a1c859c95&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/central-committee-on-research-involving-human-subjects-ccmo-recent-updates-1</loc><lastmod>2025-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-upcoming-login-changes-to-access-isrctn-account</loc><lastmod>2025-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-upcoming-login-changes-to-access-isrctn-account-1</loc><lastmod>2025-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=75973f2e-62a5-4c95-b20e-182f2a33e22f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-api-user-update-1</loc><lastmod>2025-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-june-10-opdp-wl-opdp-research-recent-enforcement-actions-guest-presenter</loc><lastmod>2025-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-june-10-opdp-wl-opdp-research-recent-enforcement-actions-guest-presenter-1</loc><lastmod>2025-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-8</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-9</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-6</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-7</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-updates-on-the-hma-ema-rwd-catalogue-2</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-updates-on-the-hma-ema-rwd-catalogue-3</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-updates-on-the-hma-ema-rwd-catalogue</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-updates-on-the-hma-ema-rwd-catalogue-1</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=c06d4067-add0-4f45-b984-7471083efa5e&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-report-benefit-risk-balance-for-medicinal-products-1</loc><lastmod>2025-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-using-artificial-intelligence-in-clinical-trials-on-june-26-at-12pm-est-daylight</loc><lastmod>2025-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-using-artificial-intelligence-in-clinical-trials-on-june-26-at-12pm-est-daylight-1</loc><lastmod>2025-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mw-mentorship-program-submission-dated-extended-to-1st-june-2025-2</loc><lastmod>2025-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mw-mentorship-program-submission-dated-extended-to-1st-june-2025-3</loc><lastmod>2025-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mw-mentorship-program-submission-dated-extended-to-1st-june-2025</loc><lastmod>2025-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mw-mentorship-program-submission-dated-extended-to-1st-june-2025-1</loc><lastmod>2025-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ongoing-efforts-by-france-to-support-clinical-trial-transparency-1</loc><lastmod>2025-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ongoing-efforts-by-france-to-support-clinical-trial-transparency</loc><lastmod>2025-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogues-sop-on-validation-and-maintenance-2</loc><lastmod>2025-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogues-sop-on-validation-and-maintenance-3</loc><lastmod>2025-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-rwd-catalogues-sop-on-validation-and-maintenance-1</loc><lastmod>2025-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=3ad2f92b-a08c-4554-9977-06eb091df615&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/german-clinical-trials-register-drks-webinar-and-maintenance-notice-2</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/german-clinical-trials-register-drks-webinar-and-maintenance-notice-1</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=5d3269d9-1205-4087-b3e7-de518464fec7&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-4</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-5</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-3</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-2</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-may-2025-1</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-16-may-2025-journey-of-regulatory-documentation-from-indcta-to-ndamaa-4</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-16-may-2025-journey-of-regulatory-documentation-from-indcta-to-ndamaa</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-16-may-2025-journey-of-regulatory-documentation-from-indcta-to-ndamaa-1</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-16-may-2025-journey-of-regulatory-documentation-from-indcta-to-ndamaa-2</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-16-may-2025-journey-of-regulatory-documentation-from-indcta-to-ndamaa-3</loc><lastmod>2025-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16may2025-4</loc><lastmod>2025-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16may2025-3</loc><lastmod>2025-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16may2025-2</loc><lastmod>2025-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16may2025-1</loc><lastmod>2025-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16may2025</loc><lastmod>2025-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-few-days-for-submitting-the-interest-form-for-mentees-23-may-2025-eob-2</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-few-days-for-submitting-the-interest-form-for-mentees-23-may-2025-eob-3</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-few-days-for-submitting-the-interest-form-for-mentees-23-may-2025-eob</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-few-days-for-submitting-the-interest-form-for-mentees-23-may-2025-eob-1</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-interested-in-becoming-a-medical-writer-or-improving-your-medical-writing-skills-2</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-interested-in-becoming-a-medical-writer-or-improving-your-medical-writing-skills-3</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-interested-in-becoming-a-medical-writer-or-improving-your-medical-writing-skills-1</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-interested-in-becoming-a-medical-writer-or-improving-your-medical-writing-skills</loc><lastmod>2025-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/bioethics-sessions-at-the-dia-2025-annual-meeting</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=ca39c569-a3c7-4851-8bc5-f8a4f1efb4bc&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/external-guidance-on-the-implementation-of-the-european-medicines-agency-policy-0070-version-15-4</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/external-guidance-on-the-implementation-of-the-european-medicines-agency-policy-0070-version-15-5</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/external-guidance-on-the-implementation-of-the-european-medicines-agency-policy-0070-version-15-2</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/external-guidance-on-the-implementation-of-the-european-medicines-agency-policy-0070-version-15-3</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=2920ca2e-b653-4393-9d37-ca7bcbd6a111&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/external-guidance-on-the-implementation-of-the-european-medicines-agency-policy-0070-version-15-1</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-csp-community-presentation</loc><lastmod>2025-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-annual-meeting-patient-impact-product-development-track</loc><lastmod>2025-05-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/this-friday-dia-pm-community-capability-cafe-2025-global-annual-meeting-preview-05092025-1200pm-est</loc><lastmod>2025-05-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recordings-and-slides-from-may-meeting-scheduling-question-for-the-summer</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-3rd-opdp-letter-of-2025-fda-in-the-news-compounding-communication-more</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-3rd-opdp-letter-of-2025-fda-in-the-news-compounding-communication-more-1</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-may-21-11am-et-rim-intelligent-automation-team-novo-nordisk-genai-use-case-2</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-may-21-11am-et-rim-intelligent-automation-team-novo-nordisk-genai-use-case-3</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=c8652a9a-e3e5-4960-9166-b4c17838fb69&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-may-21-11am-et-rim-intelligent-automation-team-novo-nordisk-genai-use-case-1</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-may-13-12-pm-et-hot-topics-plus-the-latest-opdp-ul</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-may-13-12-pm-et-hot-topics-plus-the-latest-opdp-ul-1</loc><lastmod>2025-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-2</loc><lastmod>2025-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-3</loc><lastmod>2025-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-4</loc><lastmod>2025-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025</loc><lastmod>2025-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-1</loc><lastmod>2025-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-feb-19-11am-et-rim-intelligent-automation-team-guest-speaker</loc><lastmod>2025-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-apr-16-11am-et-rim-intelligent-automation-team-authoring-automation</loc><lastmod>2025-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=f3dcc2c1-3ff5-4b04-8369-c4e71f110298&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-announces-successful-ai-scientific-review-pilot-deployment-1</loc><lastmod>2025-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-notes-may-rim-working-group-workshop-on-instantaneous-approvals-1</loc><lastmod>2025-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-notes-may-rim-working-group-workshop-on-instantaneous-approvals</loc><lastmod>2025-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-00700043foias-2025-04-17-mtg-info-posted</loc><lastmod>2025-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates</loc><lastmod>2025-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-modernized-prs-updates-1</loc><lastmod>2025-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-may-13-12-pm-et-the-latest-info</loc><lastmod>2025-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-may-13-12-pm-et-the-latest-info-1</loc><lastmod>2025-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/this-friday-dia-pm-community-capability-cafe-2025-global-annual-meeting-preview-05092025-1200pm-est-1</loc><lastmod>2025-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=abf4b670-c549-43ff-a5f1-f58630243a2a&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2025-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-centricity-in-biopharmaceutical-industry-new-book-shares-company-insights-1</loc><lastmod>2025-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-community-meeting-thursday-58-patient-centricity-in-the-biopharma-industry</loc><lastmod>2025-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-community-meeting-thursday-58-patient-centricity-in-the-biopharma-industry-1</loc><lastmod>2025-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-report-ai-in-pharmacovigilance-released-for-public-consultation</loc><lastmod>2025-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-report-ai-in-pharmacovigilance-released-for-public-consultation-1</loc><lastmod>2025-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-dia-global-medical-writing-community-as-a-mentor-2</loc><lastmod>2025-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-dia-global-medical-writing-community-as-a-mentor-3</loc><lastmod>2025-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-dia-global-medical-writing-community-as-a-mentor</loc><lastmod>2025-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-dia-global-medical-writing-community-as-a-mentor-1</loc><lastmod>2025-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c8f985ed-08de-49a4-83c3-48bf7e6fba24&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ina-crr-transition-to-new-website-effective-from-1-may-2025-1</loc><lastmod>2025-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-may-8-12pm-et-rim-wg-workshop-on-reducing-approval-timelines</loc><lastmod>2025-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-may-8-12pm-et-rim-wg-workshop-on-reducing-approval-timelines-1</loc><lastmod>2025-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025-6</loc><lastmod>2025-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025-7</loc><lastmod>2025-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025-4</loc><lastmod>2025-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025-5</loc><lastmod>2025-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-april-2025-updates-on-transparency-initiatives-2</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-april-2025-updates-on-transparency-initiatives-3</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-april-2025-updates-on-transparency-initiatives</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-april-2025-updates-on-transparency-initiatives-1</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ethics-guidance-for-ai-research-involving-humans-3</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ethics-guidance-for-ai-research-involving-humans</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ethics-guidance-for-ai-research-involving-humans-1</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ethics-guidance-for-ai-research-involving-humans-2</loc><lastmod>2025-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/april-2025-ema-clinical-trials-highlights-2</loc><lastmod>2025-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/april-2025-ema-clinical-trials-highlights-3</loc><lastmod>2025-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/april-2025-ema-clinical-trials-highlights-1</loc><lastmod>2025-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=bd6906ab-02b2-47ed-9573-2b2832a34365&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-15-apr-2025</loc><lastmod>2025-04-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-15-apr-2025-1</loc><lastmod>2025-04-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-15-apr-2025-meeting-key-notes-and-recordings-1</loc><lastmod>2025-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-15-apr-2025-meeting-key-notes-and-recordings</loc><lastmod>2025-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updates-on-high-risk-medical-devices-and-companion-diagnostics</loc><lastmod>2025-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-updates-on-high-risk-medical-devices-and-companion-diagnostics-1</loc><lastmod>2025-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-apr-16-11am-et-rim-intelligent-automation-team-authoring-automation-2</loc><lastmod>2025-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-apr-16-11am-et-rim-intelligent-automation-team-authoring-automation-3</loc><lastmod>2025-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-apr-16-11am-et-rim-intelligent-automation-team-authoring-automation-1</loc><lastmod>2025-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-medicines-for-human-use-clinical-trials</loc><lastmod>2025-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-6th-dia-advance-therapies-mtg-fda-guest-speaker</loc><lastmod>2025-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-csp-community-meeting-on-april-17th-2025</loc><lastmod>2025-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=36a00159-4122-4e59-b524-eddc0193d76b&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2025-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-clinical-trials-regulation-signed-into-law-2</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-clinical-trials-regulation-signed-into-law-3</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-clinical-trials-regulation-signed-into-law</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-clinical-trials-regulation-signed-into-law-1</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-410-patient-engagement-in-digital-health-based-study-endpoints</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-april-2025-community-meeting-call-recording-minutes-and-chat-transcript-4</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-april-2025-community-meeting-call-recording-minutes-and-chat-transcript-2</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-april-2025-community-meeting-call-recording-minutes-and-chat-transcript-3</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=16426820-8acc-402f-b59d-081583ac4e18&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-april-2025-community-meeting-call-recording-minutes-and-chat-transcript-1</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/support-to-us-site-to-build-research-capacity</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/support-to-us-site-to-build-research-capacity-1</loc><lastmod>2025-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-policy-0043foia-working-group-meeting-is-april-17</loc><lastmod>2025-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-policy-0043foia-working-group-meeting-is-april-17-1</loc><lastmod>2025-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=26b5f27d-d6ab-4f7a-b149-cba6c3786dcf&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2025-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents-3</loc><lastmod>2025-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents</loc><lastmod>2025-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents-1</loc><lastmod>2025-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-catalogues-of-real-world-data-sources-and-studies-updated-documents-2</loc><lastmod>2025-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-webinar-ich-guidelines-in-clinical-trials-on-29-apr-2025-at-12pm-est-1</loc><lastmod>2025-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=ddab3b2e-7008-4abd-b387-276f32e68180&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-4</loc><lastmod>2025-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-3</loc><lastmod>2025-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-2</loc><lastmod>2025-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MessageKey=4d9700ca-309f-4d7f-ab42-6b54fd8bf8d6&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2025-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-1</loc><lastmod>2025-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-2025-04-adpromo-wg-lytgobi-ul-meet-cute-compliant-and-more</loc><lastmod>2025-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-2025-04-adpromo-wg-lytgobi-ul-meet-cute-compliant-and-more-1</loc><lastmod>2025-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025-2</loc><lastmod>2025-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025-3</loc><lastmod>2025-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025</loc><lastmod>2025-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-april-2025-1</loc><lastmod>2025-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-april-8-12-pm-guest-presenter-compliant-meet-cute-and-more</loc><lastmod>2025-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-april-8-12-pm-guest-presenter-compliant-meet-cute-and-more-1</loc><lastmod>2025-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-2</loc><lastmod>2025-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-3</loc><lastmod>2025-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-4</loc><lastmod>2025-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025</loc><lastmod>2025-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-journey-of-regulatory-documentation-from-indcta-to-ndamaa-16-may-2025-1</loc><lastmod>2025-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2025-02-20-meeting-minutes-available</loc><lastmod>2025-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-clinical-trial-disclosure-community-call-agenda-apr-08-2025-4</loc><lastmod>2025-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-clinical-trial-disclosure-community-call-agenda-apr-08-2025-5</loc><lastmod>2025-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-clinical-trial-disclosure-community-call-agenda-apr-08-2025-2</loc><lastmod>2025-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=96546f0f-9ac7-4769-a331-b300cc758d69&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-clinical-trial-disclosure-community-call-agenda-apr-08-2025-1</loc><lastmod>2025-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-apr-03-2025-1</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=878b9a85-557f-46b7-8c77-e4e8f8a8c578&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-information-system-ctis-designated-as-who-primary-registry-2</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-information-system-ctis-designated-as-who-primary-registry-3</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-information-system-ctis-designated-as-who-primary-registry</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-information-system-ctis-designated-as-who-primary-registry-1</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/discontinuation-of-the-encepp-seal-2</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/discontinuation-of-the-encepp-seal-3</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/discontinuation-of-the-encepp-seal</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/discontinuation-of-the-encepp-seal-1</loc><lastmod>2025-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-march-round-up</loc><lastmod>2025-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-community-discussion-about-digital-health-based-study-endpoints-1</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-revised-gdpr-transparency-wording-template-live-2</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-revised-gdpr-transparency-wording-template-live-3</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=6b21c9c7-62ca-474f-8712-be758c92dfce&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-revised-gdpr-transparency-wording-template-live-1</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-71-4</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-71</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-71-1</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-71-2</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-71-3</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-community-discussion-about-digital-health-based-study-endpoints</loc><lastmod>2025-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-march-2025-updates-on-the-hra-strategy-and-clinical-trial-amendment-process-2</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-march-2025-updates-on-the-hra-strategy-and-clinical-trial-amendment-process</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-latest-bulletin-for-march-2025-updates-on-the-hra-strategy-and-clinical-trial-amendment-process-1</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-information-day-5</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=00f9c5cd-6fee-4d91-adfa-7e3511b90fc1&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-information-day-4</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-information-day-3</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-april-8-latest-ul-guest-presenter-on-meet-cutes-on-social-and-so-much-more</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-april-8-latest-ul-guest-presenter-on-meet-cutes-on-social-and-so-much-more-1</loc><lastmod>2025-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=bba5a408-2d6e-430d-9662-cf35fdbdfff1&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-updates-march-26-2025-1</loc><lastmod>2025-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-website-resumes-operation</loc><lastmod>2025-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-website-resumes-operation-1</loc><lastmod>2025-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-inquiry-response-delays-due-to-email-issues</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025-6</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025-7</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025-4</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025-5</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-25-march-2025</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-25-march-2025-1</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diausp-evolution-of-biosimilars-development-workshop</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-medical-writing-community-sessions-journey-of-regulatory-documentation-2</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-medical-writing-community-sessions-journey-of-regulatory-documentation-3</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-medical-writing-community-sessions-journey-of-regulatory-documentation-4</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-medical-writing-community-sessions-journey-of-regulatory-documentation</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-medical-writing-community-sessions-journey-of-regulatory-documentation-1</loc><lastmod>2025-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-mar-2025-rim-intelligent-automation-team-docuvera-1</loc><lastmod>2025-03-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-mar-2025-rim-intelligent-automation-team-docuvera</loc><lastmod>2025-03-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-community-important-news</loc><lastmod>2025-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-community-important-news-1</loc><lastmod>2025-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-community-important-news-2</loc><lastmod>2025-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/attend-dias-new-course-driving-business-performance-with-rim</loc><lastmod>2025-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-from-anywhere-virtual-clinical-innovation-and-biostatistics-summit-1</loc><lastmod>2025-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-from-anywhere-virtual-clinical-innovation-and-biostatistics-summit</loc><lastmod>2025-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dias-new-course-driving-business-performance-with-rim</loc><lastmod>2025-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dias-new-course-driving-business-performance-with-rim-1</loc><lastmod>2025-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-213-calculating-the-participant-burden-for-clinical-trials</loc><lastmod>2025-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-registry-india-ctri-update</loc><lastmod>2025-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-registry-india-ctri-update-1</loc><lastmod>2025-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-6th-dia-advance-therapies-mtg-fda-guest-speaker-1</loc><lastmod>2025-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-document-and-presentation-slides-from-the-act-eu-trial-map-event-3</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-document-and-presentation-slides-from-the-act-eu-trial-map-event-2</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-document-and-presentation-slides-from-the-act-eu-trial-map-event</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-document-and-presentation-slides-from-the-act-eu-trial-map-event-1</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/japan-clinical-research-systems-url-changes-and-service-disruption</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-07-mar-2025-clinical-study-reports-for-ectd-submissions-4</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-07-mar-2025-clinical-study-reports-for-ectd-submissions-3</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-07-mar-2025-clinical-study-reports-for-ectd-submissions</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-07-mar-2025-clinical-study-reports-for-ectd-submissions-1</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-the-session-held-on-07-mar-2025-clinical-study-reports-for-ectd-submissions-2</loc><lastmod>2025-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-313-patient-engagement-for-clinical-trial-recruitment</loc><lastmod>2025-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pre-approval-medical-information</loc><lastmod>2025-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-discussion-on-clinical-trial-participation-burden-1</loc><lastmod>2025-03-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=187&amp;MessageKey=8742f0ec-568c-4cc8-9a0d-6dfbaad0bf2a&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=01cefec3-a093-4f44-9180-6b22cc196d04&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-recording-11-march-2025-1</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-meeting-recording-11-march-2025-3</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-19-mar-rim-intelligent-automation-team-guest-speaker-2</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-19-mar-rim-intelligent-automation-team-guest-speaker-3</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-19-mar-rim-intelligent-automation-team-guest-speaker-1</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-19-mar-rim-intelligent-automation-team-guest-speaker</loc><lastmod>2025-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-clinical-study-reports-for-ectd-submissions-07mar2025-4</loc><lastmod>2025-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=343&amp;MessageKey=41fd9025-d272-4a85-9a72-2c6d3f70488d&amp;CommunityKey=8519a7c0-e085-4520-be03-0186a8b321be</loc><lastmod>2025-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-clinical-study-reports-for-ectd-submissions-07mar2025-3</loc><lastmod>2025-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=ed1ddcb6-2c7e-4339-aa28-fd83c4d4d09c&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-clinical-study-reports-for-ectd-submissions-07mar2025-1</loc><lastmod>2025-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=de20f224-307c-46bc-a47f-8294d54aa5e9&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-hemady-ul-the-trump-administration-new-congress-and-impact-on-adpromo</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-hemady-ul-the-trump-administration-new-congress-and-impact-on-adpromo-1</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025-3</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025-2</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-march-2025-1</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-clinical-trial-landscape-in-denmark-1</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=8255d61b-f62f-4163-baf9-de8e7b2ba0ad&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=e6fa5e46-6348-4ece-adca-019584a2f3ef</loc><lastmod>2025-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-11-2025-10-am-edt-meeting-agenda</loc><lastmod>2025-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-due-mar-15-on-us-ai-action-plan-eo14179-1</loc><lastmod>2025-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-due-mar-15-on-us-ai-action-plan-eo14179</loc><lastmod>2025-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-march-11-12-pm-latest-ul-and-impact-of-the-new-administration-on-adpromo</loc><lastmod>2025-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-march-11-12-pm-latest-ul-and-impact-of-the-new-administration-on-adpromo-1</loc><lastmod>2025-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-community-discussion-on-clinical-trial-recruitment</loc><lastmod>2025-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/humres-human-research-in-switzerland-is-now-live-2</loc><lastmod>2025-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/humres-human-research-in-switzerland-is-now-live-1</loc><lastmod>2025-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/humres-human-research-in-switzerland-is-now-live</loc><lastmod>2025-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-public-portal-updated-training-documents-2</loc><lastmod>2025-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-public-portal-updated-training-documents-3</loc><lastmod>2025-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=25893dc3-6517-47b2-8973-9ff6078949d9&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-public-portal-updated-training-documents-1</loc><lastmod>2025-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-300-with-global-labeling-advance-rate-ends-march-10</loc><lastmod>2025-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-website-temporarily-deactivated-due-to-cybersecurity-incident-2</loc><lastmod>2025-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-website-temporarily-deactivated-due-to-cybersecurity-incident-1</loc><lastmod>2025-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-website-temporarily-deactivated-due-to-cybersecurity-incident</loc><lastmod>2025-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-march-11-12-pm-et-adpromo-wg-impactpotential-impact-of-new-administration-on-adpromo-in-the-us-1</loc><lastmod>2025-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=960fa8e5-4eeb-4be7-a2b8-848b50230432&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-health-research-authority-update-on-progress-of-new-clinical-trials-regulations</loc><lastmod>2025-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-health-research-authority-update-on-progress-of-new-clinical-trials-regulations-1</loc><lastmod>2025-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dec-2024-community-presentation-clinicaltrialsgov-results-submission-updates-3</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dec-2024-community-presentation-clinicaltrialsgov-results-submission-updates-2</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dec-2024-community-presentation-clinicaltrialsgov-results-submission-updates-1</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-2</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-3</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=84203d31-6f3c-47b6-8957-b0848c4d551e&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-1</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=a52807ee-b512-4bc8-ae69-5b8d603c27d4&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/mentoring/mentor-faq</loc><lastmod>2025-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-known-issue-for-results-data-entry-feb-25-2025</loc><lastmod>2025-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-known-issue-for-results-data-entry-feb-25-2025-1</loc><lastmod>2025-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-february-2025-2</loc><lastmod>2025-02-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-february-2025-3</loc><lastmod>2025-02-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=0672489b-bfd8-4cd9-aa7b-4a49c4078ebf&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-02-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-february-2025-1</loc><lastmod>2025-02-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/finding-clinical-trials-with-the-act-eu-trial-map-2</loc><lastmod>2025-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/finding-clinical-trials-with-the-act-eu-trial-map-3</loc><lastmod>2025-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/finding-clinical-trials-with-the-act-eu-trial-map</loc><lastmod>2025-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/finding-clinical-trials-with-the-act-eu-trial-map-1</loc><lastmod>2025-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-18-feb-2025-meeting-recording-key-discussions</loc><lastmod>2025-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctr-working-group-18-feb-2025-meeting-recording-key-discussions-1</loc><lastmod>2025-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=dab48da3-97bc-489e-a61f-d30b43ab5912&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-3</loc><lastmod>2025-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-1</loc><lastmod>2025-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=529cc679-4156-4df2-9ee3-ba516c5fea8b&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-training-modules-for-eu-ctis-3</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-training-modules-for-eu-ctis-2</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-training-modules-for-eu-ctis-1</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=0b449c60-2d7b-4755-8e1f-a6ee3fd9b3e0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-february-2025-2</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-february-2025-3</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-february-2025</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-february-2025-1</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-website-user-interface-updates-5</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-website-user-interface-updates-4</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-website-user-interface-updates-3</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=210422ad-46fd-49ac-8559-2404a235aec4&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/joint-notification-portal-for-bfarm-and-pei-1</loc><lastmod>2025-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/joint-notification-portal-for-bfarm-and-pei</loc><lastmod>2025-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctrctis-wg-meeting-agenda-18-feb-2025-use-new-dial-in-info</loc><lastmod>2025-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctrctis-wg-meeting-agenda-18-feb-2025-use-new-dial-in-info-1</loc><lastmod>2025-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-4th-dia-advance-therapies-mtg-guest-speaker</loc><lastmod>2025-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=febb1bd8-e882-473c-ba64-0195060b0b98&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2025-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=57c2d07b-2a7c-4bdf-80a0-6bd6bbdcf313&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=e8705932-5f61-4007-a410-fb560f0a9249&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-dia-csp-meeting-march-2025</loc><lastmod>2025-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=501c15c7-420f-4397-abe5-dcd9145f3724&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-health-canadas-draft-guidance-for-expanded-access-clinical-trials</loc><lastmod>2025-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-health-canadas-draft-guidance-for-expanded-access-clinical-trials-1</loc><lastmod>2025-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-health-canadas-draft-guidance-for-expanded-access-clinical-trials-2</loc><lastmod>2025-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-feb-19-11am-et-rim-intelligent-automation-team-guest-speaker-1</loc><lastmod>2025-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=b6d2f584-05b5-48a2-be6b-da8dfc86248e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-feb-19-11am-et-rim-intelligent-automation-team-1</loc><lastmod>2025-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=049eb30b-15ec-46d4-932c-31c349d70f28&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-feb-11-anti-kickback-updates-more-on-the-siuu-final-guidance-and-other-happenings-1</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-11-feb-2025-key-notes-and-ema-presentation-3</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-11-feb-2025-key-notes-and-ema-presentation</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-11-feb-2025-key-notes-and-ema-presentation-2</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-call-11-feb-2025-key-notes-and-ema-presentation-1</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b393b017-6606-450c-a8b4-b15e1494e774&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-11-feb-2025-2</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-11-feb-2025-3</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-11-feb-2025</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-11-feb-2025-1</loc><lastmod>2025-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monthly-ctd-community-call-11-feb-2025</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monthly-ctd-community-call-11-feb-2025-1</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monthly-ctd-community-call-11-feb-2025-2</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monthly-ctd-community-call-11-feb-2025-3</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agreements-with-pharmacies-in-the-us</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-2</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-3</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=dc55d64a-cf24-47e8-9ada-352fd7610f91&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-1</loc><lastmod>2025-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=97&amp;MessageKey=87aaf13e-33be-4f59-a286-a482c334fa63&amp;CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-advance-rate-deadline-3</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-advance-rate-deadline-1</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-feb-11-12-pm-et-anti-kickback-update-and-more</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-feb-11-12-pm-et-anti-kickback-update-and-more-1</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-pm-community-capability-cafe-the-future-of-pm-in-pharma-03212025-1130am-est</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-pm-community-capability-cafe-the-future-of-pm-in-pharma-03212025-1130am-est-1</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-q-a-document-version-of-regulations-eu-2017745-and-eu-2017746-for-medical-devices-3</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-q-a-document-version-of-regulations-eu-2017745-and-eu-2017746-for-medical-devices-2</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-q-a-document-version-of-regulations-eu-2017745-and-eu-2017746-for-medical-devices</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-q-a-document-version-of-regulations-eu-2017745-and-eu-2017746-for-medical-devices-1</loc><lastmod>2025-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-engagement-discussion-on-clinical-trial-participation-burden</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=91ac3e70-3db5-4ae8-93b2-a4cf40d690fa&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/two-investigational-agents-given-in-combination-1</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MessageKey=434aba45-af1a-491a-bc06-dc2bdfcc14c4&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-by-february-10-to-save-on-dias-global-labeling-conference</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-patient-partner-program-scholarship-is-open</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-bitesize-talk-5-march-2025-1530-cet-to-1700-cet</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-bitesize-talk-5-march-2025-1530-cet-to-1700-cet-1</loc><lastmod>2025-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/study-raises-transparency-concerns-about-clinical-trials-involving-ai</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/study-raises-transparency-concerns-about-clinical-trials-involving-ai-1</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-20</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-19</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-18</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-17</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-16</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=1367e397-2ca9-4e55-8d0d-80c6cc970952&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-14</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-13</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-11</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-10</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-9</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-8</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=5e012054-c1d9-47d4-b652-a4f320f8fdec&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-3</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MessageKey=611684b6-3cc6-4584-abf1-d65d35560582&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025-1</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/make-your-voice-heard-at-dia-2025</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-pm-community-capability-cafe-harnessing-the-potential-of-chatgpt-02212025-1100am-est</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-pm-community-capability-cafe-harnessing-the-potential-of-chatgpt-02212025-1100am-est-1</loc><lastmod>2025-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-to-faqs-and-details-of-submissions-2</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-to-faqs-and-details-of-submissions-3</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-to-faqs-and-details-of-submissions-1</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=981edbb7-bbea-4e11-abb6-11bebb71e81f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-launches-new-research-portal-4</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=25d0329f-d4d1-4505-ab12-325563f9d4eb&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-launches-new-research-portal</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-launches-new-research-portal-1</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-launches-new-research-portal-3</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=420dbd87-4f01-46f5-94dc-0194ccad919e</loc><lastmod>2025-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=8ed76048-2384-4ba4-8256-e0ad3fce33b2&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-feb-11-12-pm-et-guest-presenter-on-ant-kickback-updates-and-more-1</loc><lastmod>2025-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=2b61cbed-74a8-4871-911c-5f3de19aa261&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-updates-on-the-clinical-trials-regulations-and-other-research-transparency-initiatives</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-updates-on-the-clinical-trials-regulations-and-other-research-transparency-initiatives-1</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-updates-on-the-clinical-trials-regulations-and-other-research-transparency-initiatives-3</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-becomes-fully-applicable-2</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-becomes-fully-applicable-3</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-becomes-fully-applicable-1</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-becomes-fully-applicable</loc><lastmod>2025-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-public-portal-updates-to-sections-of-full-trial-information-and-trial-documents-2</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-public-portal-updates-to-sections-of-full-trial-information-and-trial-documents-3</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=1f3bf36e-f79e-4879-9803-68992f182b04&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-public-portal-updates-to-sections-of-full-trial-information-and-trial-documents-1</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-3</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-2</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-clinical-study-reports-for-ectd-submissions-07-mar-2025-1</loc><lastmod>2025-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=b5221f72-b2df-4bbc-8fce-8c0045974ae2&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2025-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=56140420-9b72-4fe6-97cf-e9c018e6217d&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-28-january-2025-3</loc><lastmod>2025-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-28-january-2025-1</loc><lastmod>2025-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-28-january-2025</loc><lastmod>2025-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-webinar-demystifying-deep-learning-for-statisticians-a-practical-path-from-linear-models-to-computational-graphs-webinar-on-21st-feb-2025-at-1200-est</loc><lastmod>2025-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-webinar-demystifying-deep-learning-for-statisticians-a-practical-path-from-linear-models-to-computational-graphs-webinar-on-21st-feb-2025-at-1200-est-1</loc><lastmod>2025-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-data-protection-board-edpb-issues-draft-guidelines-012025-on-pseudonymisation-for-public-consultation</loc><lastmod>2025-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-5362014-qa-version-7-15-jan-2025-4</loc><lastmod>2025-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-5362014-qa-version-7-15-jan-2025-2</loc><lastmod>2025-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-5362014-qa-version-7-15-jan-2025-3</loc><lastmod>2025-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-5362014-qa-version-7-15-jan-2025</loc><lastmod>2025-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-regulation-5362014-qa-version-7-15-jan-2025-1</loc><lastmod>2025-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=45b79746-bd29-437f-8cc3-c6a21d928503&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/human-research-switzerland-a-new-information-platform-2</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/human-research-switzerland-a-new-information-platform-3</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/human-research-switzerland-a-new-information-platform-1</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-brings-temporary-stop-on-new-requests-for-scientific-advice</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-brings-temporary-stop-on-new-requests-for-scientific-advice-1</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-brings-temporary-stop-on-new-requests-for-scientific-advice-2</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-release-notes-15-jan-2025</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-15-jan-2025-1</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=cc2a3ec6-4f3f-40e4-a2f6-1009f3aa1d88&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/open-call-for-comments-using-ai-to-develop-plain-language-summaries-of-clinical-trial-results-1</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-clinical-study-reports-for-ectd-submissions-26-feb-2025-2</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-clinical-study-reports-for-ectd-submissions-26-feb-2025</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-clinical-study-reports-for-ectd-submissions-26-feb-2025-3</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-clinical-study-reports-for-ectd-submissions-26-feb-2025-1</loc><lastmod>2025-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-workplan-for-2025-2026-3</loc><lastmod>2025-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=0e75acde-759d-4053-9215-fc7e52b0d9c1&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/todays-dia-rpi-mtg-on-trump-administration-impact-for-fda-at-12-noon-est</loc><lastmod>2025-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-workplan-for-2025-2026-1</loc><lastmod>2025-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-workplan-for-2025-2026</loc><lastmod>2025-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-needed-medical-affairs-executive-forum-3</loc><lastmod>2025-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=60314eb4-49c8-4e98-9432-019474919a91&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2025-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-reg-policy-and-intell-jan-21-at-12-est-fda-forecast-2025-with-alec-gaffney</loc><lastmod>2025-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rethinking-clinical-trial-design</loc><lastmod>2025-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-19-pcoris-science-of-engagement-program</loc><lastmod>2025-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-needed-medical-affairs-executive-forum-2</loc><lastmod>2025-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-needed-medical-affairs-executive-forum-1</loc><lastmod>2025-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-adpromo-conference-feb-24-25-1</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-adpromo-conference-feb-24-25</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-final-guidance-siuu-globaluk-opdp-metrics</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-final-guidance-siuu-globaluk-opdp-metrics-1</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-e6r3-reached-step-4-2</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-e6r3-reached-step-4-3</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=18b75f12-a60a-4913-bfc5-f1b4010acf3b&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-e6r3-reached-step-4-1</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/interested-in-learning-more-about-core-datasheets</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-14-january-2025-2</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-14-january-2025-3</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-14-january-2025-1</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-newsflash-14-january-2025</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=283&amp;MessageKey=8070cfdb-88ac-46de-a8ce-c5df732f13f8&amp;CommunityKey=fc80e507-13cd-4967-9d9c-9cd2b13faed8</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-policy-0043foia-working-group-meeting-schedule-for-2025</loc><lastmod>2025-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=349&amp;MessageKey=5c2e7728-d872-4996-af24-255e18ff0c52&amp;CommunityKey=761a544b-eee9-494f-b450-01894b896649</loc><lastmod>2025-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-jan-15-11am-et-hackathon-for-reg-intelligence-rim-intelligent-automation-team-1</loc><lastmod>2025-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-january-14-12-pm-et-various-topics-including-final-guidance-on-unapproved-uses-of-approvedcleared-productseview</loc><lastmod>2025-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-january-14-12-pm-et-various-topics-including-final-guidance-on-unapproved-uses-of-approvedcleared-productseview-1</loc><lastmod>2025-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-june-14-many-topics-including-final-guidance-1</loc><lastmod>2025-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=7251fe2c-f956-4ad6-8682-edf3eab49306&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=3f90d552-25ea-4b2f-a7c8-01945a3c0a06</loc><lastmod>2025-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-wg-new-meetings-scheduled-moved-to-bi-monthly</loc><lastmod>2025-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-wg-new-meetings-scheduled-moved-to-bi-monthly-1</loc><lastmod>2025-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-discounted-early-bird-pricing-deadline-2</loc><lastmod>2025-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-discounted-early-bird-pricing-deadline-3</loc><lastmod>2025-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-discounted-early-bird-pricing-deadline-1</loc><lastmod>2025-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ai-act-are-you-prepared-for-the-ai-literacy-principle-1</loc><lastmod>2025-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-january-14-12-pm-et-fda-guidance-and-more</loc><lastmod>2025-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-january-14-12-pm-et-fda-guidance-and-more-1</loc><lastmod>2025-01-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-by-january-8-to-save-on-dias-regulatory-submissions-information-and-document-management-forum-1</loc><lastmod>2025-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-by-january-8-to-save-on-dias-regulatory-submissions-information-and-document-management-forum</loc><lastmod>2025-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-17-dec-2024-3</loc><lastmod>2025-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-rim-wg-all-hands-jan-2-noon-et-rim-ref-model</loc><lastmod>2025-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/jan-7-fireside-chat-with-drverdun-registration-1</loc><lastmod>2025-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/jan-7-fireside-chat-with-drverdun-registration</loc><lastmod>2025-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=29b63399-6f66-4701-bb69-1314024b9c85&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2025-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-posted-rim-wg-all-hands-nov-2024-ctis-web-portals-1</loc><lastmod>2025-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/blessed-year-2025</loc><lastmod>2025-01-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/blessed-year-2025-1</loc><lastmod>2025-01-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-from-our-global-pv-2025-co-chair-2</loc><lastmod>2024-12-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-from-our-global-pv-2025-co-chair-1</loc><lastmod>2024-12-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-from-our-global-pv-2025-co-chair</loc><lastmod>2024-12-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ai-generated-plain-language-summaries-of-trial-results-can-save-time-but-need-a-human-touch</loc><lastmod>2024-12-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ai-generated-plain-language-summaries-of-trial-results-can-save-time-but-need-a-human-touch-1</loc><lastmod>2024-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participate-in-a-research-project-comparing-ai-and-human-written-medical-summaries</loc><lastmod>2024-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/season-wishes</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/season-wishes-1</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c5edd28c-96d0-44be-90e5-18b2c2b91134&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/indonesia-clinical-research-registry-ina-crr-transitioning-to-new-website-1</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/indonesia-clinical-research-registry-ina-crr-transitioning-to-new-website-2</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-ai-session-held-on-12-dec-2024-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-2</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-ai-session-held-on-12-dec-2024-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-3</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-ai-session-held-on-12-dec-2024-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-ai-session-held-on-12-dec-2024-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-1</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12dec2024-2</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12dec2024-3</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=094394fd-b489-4569-a5eb-235103da767f&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-presentation-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12dec2024-1</loc><lastmod>2024-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-dia-adpromo-wg-merz-opdp-ul-guardant-lanham-act-2024-trends-and-more</loc><lastmod>2024-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-dia-adpromo-wg-merz-opdp-ul-guardant-lanham-act-2024-trends-and-more-1</loc><lastmod>2024-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/chatgpt-like-ai-tool-promises-to-speed-treatment-advances-and-free-doctors-time-by-matching-patients-with-clinical-trials</loc><lastmod>2024-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/chatgpt-like-ai-tool-promises-to-speed-treatment-advances-and-free-doctors-time-by-matching-patients-with-clinical-trials-1</loc><lastmod>2024-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-updated-guidance-document-on-identification-of-cci-and-personal-data-4</loc><lastmod>2024-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-updated-guidance-document-on-identification-of-cci-and-personal-data-5</loc><lastmod>2024-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-updated-guidance-document-on-identification-of-cci-and-personal-data-2</loc><lastmod>2024-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-updated-guidance-document-on-identification-of-cci-and-personal-data-3</loc><lastmod>2024-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-updated-guidance-document-on-identification-of-cci-and-personal-data</loc><lastmod>2024-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-updated-guidance-document-on-identification-of-cci-and-personal-data-1</loc><lastmod>2024-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-relaunch-step-2-may-2025-4</loc><lastmod>2024-12-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=bb412cd6-a873-40be-b12f-e3a073b27331&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-12-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anzctr-processing-of-submissions-and-updates-paused-for-the-holiday-season</loc><lastmod>2024-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-17-dec-2024-2</loc><lastmod>2024-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=cfb7d915-23b5-4f82-90a3-b5cb5eb98c65&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-17-dec-2024-1</loc><lastmod>2024-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=ff1b5cf9-a8af-48ef-95d9-c1c4b44c5521&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-on-draft-considerations-for-using-ai-to-create-pls-7</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-on-draft-considerations-for-using-ai-to-create-pls-4</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-on-draft-considerations-for-using-ai-to-create-pls-5</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-on-draft-considerations-for-using-ai-to-create-pls-2</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-on-draft-considerations-for-using-ai-to-create-pls-3</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-on-draft-considerations-for-using-ai-to-create-pls</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/feedback-on-draft-considerations-for-using-ai-to-create-pls-1</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faqs-how-to-create-submit-and-withdraw-a-clinical-trial-application-ctis-training-programme-module-10-3</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faqs-how-to-create-submit-and-withdraw-a-clinical-trial-application-ctis-training-programme-module-10-2</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faqs-how-to-create-submit-and-withdraw-a-clinical-trial-application-ctis-training-programme-module-10</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faqs-how-to-create-submit-and-withdraw-a-clinical-trial-application-ctis-training-programme-module-10-1</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-relaunch-step-2-may-2025-5</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-relaunch-step-2-may-2025-2</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-relaunch-step-2-may-2025-3</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-relaunch-step-2-may-2025-1</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-relaunch-step-2-may-2025</loc><lastmod>2024-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=a0bd799e-ce9e-43c8-a1b8-8c00944f9fc9&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-january-2025</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-january-2025-3</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-january-2025-1</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-4</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-5</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-3</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-2</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-1</loc><lastmod>2024-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-rim-wg-all-hands-jan-2-noon-et-rim-ref-model-1</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=af794794-8e35-4fea-b674-dbb38d62e760&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=bf3c3a96-e7c6-4e1b-b7ff-77ccb71f5422&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=e61bc0a8-1359-4fa8-81cd-a437bf846baf&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=ff2bcc31-8fa9-4a61-94c4-2a57caaedb7d&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-1212-our-annual-jolabokaflod-gathering</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctrctis-wg-meeting-agenda-17-dec-2024</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-uk-clinical-trials-regulations-laid-in-parliament-1</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-uk-clinical-trials-regulations-laid-in-parliament</loc><lastmod>2024-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=aa78b3b5-b3da-46ff-9f69-4355a8097c0f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-application-programming-interface-temporarily-disabled-1</loc><lastmod>2024-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-updates-on-public-portal-and-structured-data-form-2</loc><lastmod>2024-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-updates-on-public-portal-and-structured-data-form-3</loc><lastmod>2024-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-updates-on-public-portal-and-structured-data-form-1</loc><lastmod>2024-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-updates-on-public-portal-and-structured-data-form</loc><lastmod>2024-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-2</loc><lastmod>2024-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=d3c8f553-9282-493d-b88c-2726246a55a4&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-1</loc><lastmod>2024-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-3</loc><lastmod>2024-12-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MessageKey=61afa36e-14f9-401c-8479-5517299deedf&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-regulatory-submissions-information-and-document-management-forum-1</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-dec-18-11am-et-rim-intelligent-automation-mock-hackathon-1</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-dec-18-11am-et-rim-intelligent-automation-mock-hackathon</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-dec-2024-2</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-dec-2024-3</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-dec-2024</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-dec-2024-1</loc><lastmod>2024-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-dec-12-12-pm-et-many-topics-including-the-latest-ul-and-2024-enforcement-trends</loc><lastmod>2024-12-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-dec-12-12-pm-et-many-topics-including-the-latest-ul-and-2024-enforcement-trends-1</loc><lastmod>2024-12-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ebook-on-rim</loc><lastmod>2024-12-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-2</loc><lastmod>2024-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-3</loc><lastmod>2024-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024</loc><lastmod>2024-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-1</loc><lastmod>2024-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-call-for-posters-deadline-2</loc><lastmod>2024-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-call-for-posters-deadline-3</loc><lastmod>2024-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-call-for-posters-deadline-1</loc><lastmod>2024-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-and-clinicaltrialsgov-modernized-prs-dec-04-2024-2</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-and-clinicaltrialsgov-modernized-prs-dec-04-2024-3</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-and-clinicaltrialsgov-modernized-prs-dec-04-2024-1</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=3de8a513-09fe-4e14-bf5d-42bbef18ff02&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=a1ba106a-9272-4054-aa2d-019392e5d5bf</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=3384a40b-9475-4f9f-9a72-019392e1bc6b&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-december-03-2024-2</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-december-03-2024-3</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-december-03-2024</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-december-03-2024-1</loc><lastmod>2024-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/national-observatory-on-clinical-trials-of-medicinal-products-ossc-provisions-from-january-31-2025</loc><lastmod>2024-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/national-observatory-on-clinical-trials-of-medicinal-products-ossc-provisions-from-january-31-2025-2</loc><lastmod>2024-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/national-observatory-on-clinical-trials-of-medicinal-products-ossc-provisions-from-january-31-2025-3</loc><lastmod>2024-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/national-observatory-on-clinical-trials-of-medicinal-products-ossc-provisions-from-january-31-2025-1</loc><lastmod>2024-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-dia-inspire-awards-americas</loc><lastmod>2024-12-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-real-world-data-rwd-catalogues-feedback-survey-2</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-real-world-data-rwd-catalogues-feedback-survey-3</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-real-world-data-rwd-catalogues-feedback-survey</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hma-ema-real-world-data-rwd-catalogues-feedback-survey-1</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cyber-week-announcement-discounted-early-bird-registration-rates-for-dias-global-pharmacovigilance-and-risk-management-strategies-conference-extended-until-thursday-december-5-2</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cyber-week-announcement-discounted-early-bird-registration-rates-for-dias-global-pharmacovigilance-and-risk-management-strategies-conference-extended-until-thursday-december-5-1</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cyber-week-announcement-discounted-early-bird-registration-rates-for-dias-global-pharmacovigilance-and-risk-management-strategies-conference-extended-until-thursday-december-5</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cyber-week-announcement-early-bird-registration-rates-for-dias-global-pharmacovigilance-and-risk-management-strategies-conference-extended-until-thursday-december-5</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-dec-12-thursday-12-pm-et-untitled-letter-and-more</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-dec-12-thursday-12-pm-et-untitled-letter-and-more-1</loc><lastmod>2024-12-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-november-round-up-1</loc><lastmod>2024-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=62a782a6-5e19-4628-b235-34923bf4e394&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-3</loc><lastmod>2024-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-2</loc><lastmod>2024-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=eb0cfbf8-33e3-4360-a8a1-29fce1c08c37&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-1</loc><lastmod>2024-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-and-cdp-p0070-webinar-step-2-4</loc><lastmod>2024-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-and-cdp-p0070-webinar-step-2-2</loc><lastmod>2024-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-and-cdp-p0070-webinar-step-2-3</loc><lastmod>2024-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-and-cdp-p0070-webinar-step-2-1</loc><lastmod>2024-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-and-cdp-p0070-webinar-step-2</loc><lastmod>2024-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-test-environment-26-nov-2024-1</loc><lastmod>2024-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-test-environment-26-nov-2024</loc><lastmod>2024-11-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/december-policy-0070prcifoia-meeting-will-be-dec-12</loc><lastmod>2024-11-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-kober-presentation-understanding-the-ind-process-19nov2024-2</loc><lastmod>2024-11-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-kober-presentation-understanding-the-ind-process-19nov2024-3</loc><lastmod>2024-11-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-kober-presentation-understanding-the-ind-process-19nov2024-4</loc><lastmod>2024-11-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-kober-presentation-understanding-the-ind-process-19nov2024-5</loc><lastmod>2024-11-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-kober-presentation-understanding-the-ind-process-19nov2024</loc><lastmod>2024-11-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-kober-presentation-understanding-the-ind-process-19nov2024-1</loc><lastmod>2024-11-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-2</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-understanding-the-ind-process-19-nov-2024</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-understanding-the-ind-process-19-nov-2024-1</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-19-nov-2024-understanding-the-ind-process-2</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-19-nov-2024-understanding-the-ind-process-3</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-19-nov-2024-understanding-the-ind-process</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-19-nov-2024-understanding-the-ind-process-1</loc><lastmod>2024-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-understanding-the-ind-process-2</loc><lastmod>2024-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-2</loc><lastmod>2024-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-3</loc><lastmod>2024-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-revolutionizing-ctd-document-authoring-with-aigc-from-ai-assisted-systems-to-ai-native-generation-in-csr-and-protocol-writing-12-dec-2024-1</loc><lastmod>2024-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meeting-nov-14-impact-of-act-eu-on-clinical-trial-innovation</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-understanding-the-ind-process-3</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-fda-guidance-faq-developing-potential-cellular-and-gene-therapy-products</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=721a9563-0cba-4b74-8f28-f6101a1c5883&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-understanding-the-ind-process</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-understanding-the-ind-process-1</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-understanding-the-ind-process-4</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b2ff57d0-2258-4386-84fc-019fb1d8325b&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-november-2024-1</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-november-2024-2</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-november-2024-3</loc><lastmod>2024-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070-working-group-clinical-data-publication-policy-0070-webinar-step-2-presentations-2</loc><lastmod>2024-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070-working-group-clinical-data-publication-policy-0070-webinar-step-2-presentations-3</loc><lastmod>2024-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070-working-group-clinical-data-publication-policy-0070-webinar-step-2-presentations</loc><lastmod>2024-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070-working-group-clinical-data-publication-policy-0070-webinar-step-2-presentations-1</loc><lastmod>2024-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-policy-0070-webinar-step-2-presentations-1</loc><lastmod>2024-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=98126cf1-7ad4-4c58-8215-864fdfc3cd22&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-nov-20-11am-et-rim-intelligent-automation-team-michelle-wu-guest-speaker-2</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-nov-20-11am-et-rim-intelligent-automation-team-michelle-wu-guest-speaker-3</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-nov-20-11am-et-rim-intelligent-automation-team-michelle-wu-guest-speaker</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-nov-20-11am-et-rim-intelligent-automation-team-michelle-wu-guest-speaker-1</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/key-points-from-ema-webinar-on-clinical-data-publication-policy-0070-step-2-2</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/key-points-from-ema-webinar-on-clinical-data-publication-policy-0070-step-2-4</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/key-points-from-ema-webinar-on-clinical-data-publication-policy-0070-step-2-5</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/key-points-from-ema-webinar-on-clinical-data-publication-policy-0070-step-2-3</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/key-points-from-ema-webinar-on-clinical-data-publication-policy-0070-step-2</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/key-points-from-ema-webinar-on-clinical-data-publication-policy-0070-step-2-1</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-mhra-clinical-trials-regulations-webinar-recording-published-2</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-mhra-clinical-trials-regulations-webinar-recording-published</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-mhra-clinical-trials-regulations-webinar-recording-published-1</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=9e5b7550-7cdb-41f4-9daa-51491d5ebc25&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-updates-introduced-to-the-study-registration-form-1</loc><lastmod>2024-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=e029de83-48ff-4f6a-898e-7025155b4422&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/roundup-mhra-webinar-on-implementing-the-new-uk-clinical-trial-regulations-15-oct-2024-1</loc><lastmod>2024-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-website-user-interface-updates-2</loc><lastmod>2024-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-website-user-interface-updates</loc><lastmod>2024-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-website-user-interface-updates-1</loc><lastmod>2024-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-2024-11-adpromo-wg-mhra-guidance-opdp-research-in-the-know-with-patient-experiencedatadiversity</loc><lastmod>2024-11-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-2024-11-adpromo-wg-mhra-guidance-opdp-research-in-the-know-with-patient-experiencedatadiversity-1</loc><lastmod>2024-11-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-our-best-savings-on-canada-annual-meeting-registration-2</loc><lastmod>2024-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-our-best-savings-on-canada-annual-meeting-registration-3</loc><lastmod>2024-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-our-best-savings-on-canada-annual-meeting-registration-1</loc><lastmod>2024-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-our-best-savings-on-canada-annual-meeting-registration</loc><lastmod>2024-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-dia-direct-webinar-driving-adoption-and-value-across-the-rim-ecosystem</loc><lastmod>2024-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-dia-direct-webinar-driving-adoption-and-value-across-the-rim-ecosystem-1</loc><lastmod>2024-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-nov-12-12-1-pm-et-staying-in-the-know-with-the-latest-happenings</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-nov-12-12-1-pm-et-staying-in-the-know-with-the-latest-happenings-1</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-update-on-human-research-act-hra-ordinances-2</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-update-on-human-research-act-hra-ordinances-3</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-update-on-human-research-act-hra-ordinances</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-update-on-human-research-act-hra-ordinances-1</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-ai-session-held-on-23-oct-2024-leveraging-ai-to-transform-regulatory-medical-writing-2</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-ai-session-held-on-23-oct-2024-leveraging-ai-to-transform-regulatory-medical-writing-1</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-ai-session-held-on-23-oct-2024-leveraging-ai-to-transform-regulatory-medical-writing</loc><lastmod>2024-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-for-shared-learning-understanding-the-ind-process-2</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-for-shared-learning-understanding-the-ind-process-1</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-available-for-shared-learning-understanding-the-ind-process</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-avaiable-for-shared-learning-understanding-the-ind-process-4</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-avaiable-for-shared-learning-understanding-the-ind-process-5</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-avaiable-for-shared-learning-understanding-the-ind-process-2</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-avaiable-for-shared-learning-understanding-the-ind-process-3</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-avaiable-for-shared-learning-understanding-the-ind-process</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-avaiable-for-shared-learning-understanding-the-ind-process-1</loc><lastmod>2024-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=ec22f3c3-89dd-433a-9f29-4c2903b2e1a9&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-workshop-strategic-solutions-to-enhance-the-functionality-of-pactr-registry-1</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-nov-07-2024-1</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=2955ed50-e82f-41f4-a00d-e103f0ebe33f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-understanding-the-ind-process-4</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-understanding-the-ind-process-2</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-understanding-the-ind-process-3</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-understanding-the-ind-process</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-understanding-the-ind-process-1</loc><lastmod>2024-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-november-05-2024-2</loc><lastmod>2024-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-november-05-2024-3</loc><lastmod>2024-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-november-05-2024</loc><lastmod>2024-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-november-05-2024-1</loc><lastmod>2024-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-07-november-cmc-ra-working-group-all-hands-call-3</loc><lastmod>2024-11-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-07-november-cmc-ra-working-group-all-hands-call-2</loc><lastmod>2024-11-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/november-8-2024-capabilities-cafe-complex-planning-1</loc><lastmod>2024-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-nov-12-12-pm-et-in-the-know-topics-with-the-potential-to-shape-adpromo</loc><lastmod>2024-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-nov-12-12-pm-et-in-the-know-topics-with-the-potential-to-shape-adpromo-1</loc><lastmod>2024-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-07-november-cmc-ra-working-group-all-hands-call-1</loc><lastmod>2024-11-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-07-november-cmc-ra-working-group-all-hands-call</loc><lastmod>2024-11-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-october-round-up-1</loc><lastmod>2024-10-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=23d8b27b-0a86-4829-8419-cbb8d70fd14f&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2024-10-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b924de0e-269a-4e4f-acf8-d50b2534488b&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-release-notes-oct-30-2024-1</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-release-notes-oct-30-2024</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=3a45ba35-dbf9-4f10-981d-bd307b229d69&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-fdas-in-vitro-diagnostics-ivd-roundtable-fall-meeting-nov-12-2024-1</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-webinar-agenda-released-6</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=b2e45b2f-fbc1-47d4-b8d4-a56a4eed8f63&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-webinar-agenda-released-5</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-webinar-agenda-released-3</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=283&amp;MessageKey=95bbc28b-3541-4989-95e7-af68480eb89d&amp;CommunityKey=fc80e507-13cd-4967-9d9c-9cd2b13faed8</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-webinar-agenda-released</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-webinar-agenda-released-1</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/november-8-2024-capabilities-cafe-complex-planning</loc><lastmod>2024-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-fda-initiative-device-trial-participant-snapshots</loc><lastmod>2024-10-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=897e1d74-cb98-46db-96ad-926b11aa6d5e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-fdas-tamy-kim-will-discuss-the-latest-from-oce-12-noon-pm-est-1</loc><lastmod>2024-10-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/re-clinical-data-publication-policy-0070-webinar-step-2-14-nov-2024-2</loc><lastmod>2024-10-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=cd294bd2-f859-400a-a0f0-373153039c6a&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/re-clinical-data-publication-policy-0070-webinar-step-2-14-nov-2024-1</loc><lastmod>2024-10-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-policy-0070-webinar-step-2-14-nov-2024-2</loc><lastmod>2024-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=96788806-4ab5-49c8-9e0d-0192d2d9a346&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-mtg-with-fda-oces-tamy-kim-1029-12-pm-est</loc><lastmod>2024-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-mtg-with-fda-oces-tamy-kim-1029-12-pm-est-1</loc><lastmod>2024-10-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/november-advance-therapies-kick-off-meeting-poll</loc><lastmod>2024-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-multi-stakeholder-platform-annual-meeting-2</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-multi-stakeholder-platform-annual-meeting-3</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-multi-stakeholder-platform-annual-meeting</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-multi-stakeholder-platform-annual-meeting-1</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/australian-new-zealand-clinical-trials-registry-website-technical-issue</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/australian-new-zealand-clinical-trials-registry-website-technical-issue-1</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=79973e4a-ddf5-4675-8061-535ef63872e8&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-policy-0070-webinar-step-2-14-nov-2024-1</loc><lastmod>2024-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-22-october-2024-1</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-22-october-2024-2</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-22-october-2024-3</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-22-october-2024-4</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-22-october-2024</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=6c43431d-7c7f-40ea-8588-e76beff0d794&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/savethe-date-rim-webinar-nov-13-1130-et-1</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-now-updated-gdpr-transparency-wording-template-for-all-sponsors-4</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-now-updated-gdpr-transparency-wording-template-for-all-sponsors-2</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-now-updated-gdpr-transparency-wording-template-for-all-sponsors-3</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=0b50a988-f105-4188-81e2-8c20f2ff0bc6&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-now-updated-gdpr-transparency-wording-template-for-all-sponsors-1</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/commercially-sponsored-clinical-trials-run-in-europe-almost-halved-over-the-last-10-years</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/release-notes-for-clinicaltrialsgov-oct-22-2024</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/release-notes-for-clinicaltrialsgov-oct-22-2024-2</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/release-notes-for-clinicaltrialsgov-oct-22-2024-1</loc><lastmod>2024-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/commercially-sponsored-clinical-trials-run-in-europe-almost-halved-over-the-last-10-years-1</loc><lastmod>2024-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-24-october-cmc-ra-working-group-all-hands-call-3</loc><lastmod>2024-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-24-october-cmc-ra-working-group-all-hands-call-2</loc><lastmod>2024-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-leveraging-ai-to-transform-regulatory-medical-writing-23-oct-2024-2</loc><lastmod>2024-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-leveraging-ai-to-transform-regulatory-medical-writing-23-oct-2024</loc><lastmod>2024-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-call-session-on-leveraging-ai-to-transform-regulatory-medical-writing-23-oct-2024-1</loc><lastmod>2024-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/roundtable-discuss-on-qualitative-meaningful-change-with-loads-of-experts</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=0002e9c5-b799-4470-8ef3-018c26735bad</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=010b5db6-8dd6-4238-abea-aba3530a51d5</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=0c69c80d-cbda-44b8-a0cb-8ac296687a90</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=167351bf-9b9e-4b85-a40e-0186a8b321c2</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=3aaf957b-eb04-460f-b481-7f77b4999646</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=551fbffc-d754-46ea-9846-989704b74e43</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=8519a7c0-e085-4520-be03-0186a8b321be</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=96f41e04-3fb8-4f1f-9aad-bd7d831298d9</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=a88c328c-6fdc-4734-9694-653df40cbb6b</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=ad750faa-ad65-4321-a7d3-132d1c579f24</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=bfd10c91-1da6-4e45-9ecb-0da2a47b9c8f</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=c70a1db4-f59f-47ee-93c8-70d8cfae57fd</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=d62aa613-a392-4a61-8d4b-5556f648a88b</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=e33a91ff-b513-4d83-9413-7a1fae545034</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=e43b5d06-90cc-4480-a082-fe9b95422cf8</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=f6147642-c57d-45e7-8cbe-209795825a55</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home?CommunityKey=fc80e507-13cd-4967-9d9c-9cd2b13faed8</loc><lastmod>2024-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-participants-2</loc><lastmod>2024-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-participants-4</loc><lastmod>2024-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-participants-3</loc><lastmod>2024-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-participants</loc><lastmod>2024-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-participants-1</loc><lastmod>2024-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/how-to-be-a-peer-reviewr</loc><lastmod>2024-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-24-october-cmc-ra-working-group-all-hands-call-1</loc><lastmod>2024-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-24-october-cmc-ra-working-group-all-hands-call</loc><lastmod>2024-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-webinar-on-informed-consent-for-clinical-trials-1</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-oct-rim-intelligent-automation-team-sponsor-fhir-and-other-use-cases</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-oct-rim-intelligent-automation-team-sponsor-fhir-and-other-use-cases-1</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=5b8f57a0-3ae1-4295-a93b-2183694d2387&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;tab=digestviewer</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-webinar-on-informed-consent-for-clinical-trials-5</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=5297c915-b97a-4a9f-8902-8d31b5b382f3&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-webinar-on-informed-consent-for-clinical-trials-3</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=afd8a8ee-91cc-4143-8c23-93b14127b9d0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=303cb25e-a482-4181-9a73-ee4c6ec2bdb6&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-leveraging-ai-to-transform-regulatory-medical-writing-23-oct-2024-2</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-leveraging-ai-to-transform-regulatory-medical-writing-23-oct-2024</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-session-on-leveraging-ai-to-transform-regulatory-medical-writing-23-oct-2024-1</loc><lastmod>2024-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=7e0d267e-d2d2-4031-bdf1-46757d0609ec&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-oct-14-opdp-talk-show-research-theres-a-new-audience-and-its-ai-guest-presenter-1</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-16-oct-rim-intelligent-automation-team-sponsor-use-cases-2</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-16-oct-rim-intelligent-automation-team-sponsor-use-cases-3</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-16-oct-rim-intelligent-automation-team-sponsor-use-cases</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-16-oct-rim-intelligent-automation-team-sponsor-use-cases-1</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/focus-on-safety-and-pharmacovigilance-canada-annual-meeting</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/focus-on-clinical-canada-annual-meeting-2</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/focus-on-clinical-canada-annual-meeting-3</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/focus-on-regulatory-canada-annual-meeting-1</loc><lastmod>2024-10-15</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=c0b64883-cf70-4c77-aeef-01928c658fb2</loc><lastmod>2024-10-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/crc-webinar-03-oct-2024-clinical-evaluation-mdr-recording-posted-in-the-library</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/crc-webinar-03-oct-2024-clinical-evaluation-mdr-recording-posted-in-the-library-1</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/crc-webinar-03-oct-2024-clinical-evaluation-mdr</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/crc-webinar-03-oct-2024-clinical-evaluation-mdr-1</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-rwe-conference-1</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=89f6bdb7-1fd1-4b76-a933-0d91c088f784&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/interested-in-clinical-trial-applications-ctas-in-canada-2</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/interested-in-clinical-trial-applications-ctas-in-canada</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/interested-in-clinical-trial-applications-ctas-in-canada-1</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/have-your-voice-heard-submit-a-topic-during-our-global-labeling-conference-call-for-topics</loc><lastmod>2024-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-oct-15-12-pm-et-opdp-research-theres-a-new-audience-in-pharmabiotech-guest-presenter</loc><lastmod>2024-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-oct-15-12-pm-et-opdp-research-theres-a-new-audience-in-pharmabiotech-guest-presenter-1</loc><lastmod>2024-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-free-fdaacs-workshop-benchmarks-for-diversity-in-oncology-clinical-trials</loc><lastmod>2024-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/publication-of-interest-impact-measurement-of-patient-engagement</loc><lastmod>2024-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MessageKey=96cd0d9a-33c6-4fcb-aead-338bf71e415e&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2024-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-october-2024-2</loc><lastmod>2024-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-october-2024-3</loc><lastmod>2024-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-october-2024</loc><lastmod>2024-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-october-2024-1</loc><lastmod>2024-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=1ad319da-4a20-46c1-9d34-019194507b98</loc><lastmod>2024-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/emwa-medical-writing-journal-september-issue</loc><lastmod>2024-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-10-october-ra-cmc-working-group-1</loc><lastmod>2024-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-10-october-ra-cmc-working-group</loc><lastmod>2024-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/october-11-capabilities-cafe-change-management</loc><lastmod>2024-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/october-11-capabilities-cafe-change-management-1</loc><lastmod>2024-10-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=bbaedc59-461d-472e-b753-441001fb1e77&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2024-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nanosphere-newsletter-nanomedicine</loc><lastmod>2024-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nanosphere-newsletter-nanomedicine-1</loc><lastmod>2024-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-poll-to-help-shape-the-rim-ai-and-automation-survey-2</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-poll-to-help-shape-the-rim-ai-and-automation-survey-3</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-poll-to-help-shape-the-rim-ai-and-automation-survey</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-poll-to-help-shape-the-rim-ai-and-automation-survey-1</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementing-the-new-uk-clinical-trials-regulations-webinar-2</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementing-the-new-uk-clinical-trials-regulations-webinar-3</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementing-the-new-uk-clinical-trials-regulations-webinar-1</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=cb71c0ea-dd62-4c33-bec6-78445eb6b4b1&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-features-rolled-out-on-the-anzctr-website-2</loc><lastmod>2024-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f69a3c48-2f91-44ba-8fa9-7d66a1389b0f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-features-rolled-out-on-the-anzctr-website-1</loc><lastmod>2024-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=2f004eed-900a-4764-a7f8-7eb62cc2f84a&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2024-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-postpones-go-live-of-the-new-research-portal-october-3-2024-3</loc><lastmod>2024-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-postpones-go-live-of-the-new-research-portal-october-3-2024</loc><lastmod>2024-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-postpones-go-live-of-the-new-research-portal-october-3-2024-1</loc><lastmod>2024-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-oct-2-2024</loc><lastmod>2024-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-oct-2-2024-1</loc><lastmod>2024-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-10-october-cmc-ra-working-group-all-hands-call-1</loc><lastmod>2024-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-10-october-cmc-ra-working-group-all-hands-call</loc><lastmod>2024-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/electronic-systems-electronic-records-and-electronic-signatures-in-clinical-investigations-questions-and-answers</loc><lastmod>2024-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/electronic-systems-electronic-records-and-electronic-signatures-in-clinical-investigations-questions-and-answers-1</loc><lastmod>2024-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=16d36340-e5c1-4e27-a082-097154fbfca6&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-oct-15-12-pm-et-opdp-research-theres-a-new-audience-in-pharmabiotech-guest-presenter-1</loc><lastmod>2024-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-sep-2024-3</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-sep-2024-2</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-sep-2024</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-sep-2024-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-newsletter-sep-2024-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-newsletter-sep-2024-2</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-newsletter-sep-2024</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reflection-paper-on-the-use-of-ai-in-the-medicinal-product-lifecycle-2</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reflection-paper-on-the-use-of-ai-in-the-medicinal-product-lifecycle</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reflection-paper-on-the-use-of-ai-in-the-medicinal-product-lifecycle-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-bitesize-talk-end-of-transition-period-and-notifications-including-serious-breach-3</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-bitesize-talk-end-of-transition-period-and-notifications-including-serious-breach-2</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=89f03764-4154-4d87-abce-603a78472d6f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-bitesize-talk-end-of-transition-period-and-notifications-including-serious-breach-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f77745f9-3a57-4cfa-839e-86d42c8432d4&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=digestviewer</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-leveraging-ai-to-transform-regulatory-medical-writing</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-session-on-leveraging-ai-to-transform-regulatory-medical-writing-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=4abe33c9-7584-4344-89ce-019242e1190d</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-issue-21-september-2024-2</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-issue-21-september-2024-3</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-issue-21-september-2024-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-issue-21-september-2024</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-september-round-up</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-september-round-up-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-center-health-literacy-month-webinar-series-1</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-center-health-literacy-month-webinar-series</loc><lastmod>2024-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-introducing-the-first-calculator-of-participants-financial-burden-in-clinical-trials</loc><lastmod>2024-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-introducing-the-first-calculator-of-participants-financial-burden-in-clinical-trials-1</loc><lastmod>2024-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-guidance-for-best-practices-for-clinical-trials-4</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-guidance-for-best-practices-for-clinical-trials-2</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-guidance-for-best-practices-for-clinical-trials-3</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-guidance-for-best-practices-for-clinical-trials</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/who-guidance-for-best-practices-for-clinical-trials-1</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-september-2024-2</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=8a701df2-ecac-4b77-ab25-a204c1622974&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-september-2024-1</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-september-2024-3</loc><lastmod>2024-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thusrd-26-september-dia-ra-cmc-working-group-all-hands-call</loc><lastmod>2024-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-26-september-cmc-working-group-all-hands-call</loc><lastmod>2024-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-enhanced-search-and-updated-evaluation-timeline-v21-2</loc><lastmod>2024-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-enhanced-search-and-updated-evaluation-timeline-v21-3</loc><lastmod>2024-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-enhanced-search-and-updated-evaluation-timeline-v21</loc><lastmod>2024-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-enhanced-search-and-updated-evaluation-timeline-v21-1</loc><lastmod>2024-09-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=2ca47d44-ce17-45aa-ace7-618d68487fbe&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-09-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-updates-september-19-2024-1</loc><lastmod>2024-09-20</lastmod></url><url><loc>https://communities.diaglobal.org/mentoring/mentoring-program-dashboard</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/mentoring/mentoringrelationships</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-test-update-enhanced-features-and-bug-fixes-sep-16-2024-1</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-sep-2024-3</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-sep-2024-2</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-sep-2024-1</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-sep-2024</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcement-of-upcoming-initiatives-for-the-dia-india-medical-writing-community</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcement-of-upcoming-initiatives-for-the-dia-india-medical-writing-community-1</loc><lastmod>2024-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-test-update-enhanced-features-and-bug-fixes-sep-16-2024</loc><lastmod>2024-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cmc-ra-working-group-all-hands-call-thursd-26-september-1</loc><lastmod>2024-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cmc-ra-working-group-all-hands-call-thursd-26-september</loc><lastmod>2024-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/callout-for-use-case-prototype-collaboration</loc><lastmod>2024-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-sep-12-2024</loc><lastmod>2024-09-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-sep-12-2024-1</loc><lastmod>2024-09-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-sep-17-opdp-uls-ukmhra-and-linkedin-dhts-in-adpromo-clinical-research</loc><lastmod>2024-09-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-sep-17-opdp-uls-ukmhra-and-linkedin-dhts-in-adpromo-clinical-research-1</loc><lastmod>2024-09-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meeting-thursday-sept-12-company-wide-commitment-to-full-patient-engagement</loc><lastmod>2024-09-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-sep-18-11am-et-rim-intelligent-automation-team-ai-survey-planning-2</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-sep-18-11am-et-rim-intelligent-automation-team-ai-survey-planning-3</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-sep-18-11am-et-rim-intelligent-automation-team-ai-survey-planning</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-sep-18-11am-et-rim-intelligent-automation-team-ai-survey-planning-1</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/flash-sale-will-we-see-you-next-week-at-the-ctd-conference-2</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/flash-sale-will-we-see-you-next-week-at-the-ctd-conference-3</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/flash-sale-will-we-see-you-next-week-at-the-ctd-conference-1</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/flash-sale-will-we-see-you-next-week-at-the-ctd-conference</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-canada-annual-meeting-2</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-canada-annual-meeting-3</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-canada-annual-meeting</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-canada-annual-meeting-1</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=10b78d2e-7d61-4ecc-9f93-c2d47a810ed8&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-sep-17-12-pm-et-opdp-ul-dht-in-adpromo-in-clinical-research-more-1</loc><lastmod>2024-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-the-looming-industry-challenge-compliance-with-the-new-eu-mdr-to-deliver-clinical-evaluation</loc><lastmod>2024-09-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-the-looming-industry-challenge-compliance-with-the-new-eu-mdr-to-deliver-clinical-evaluation-1</loc><lastmod>2024-09-15</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=502c5f47-adc9-4179-af24-0191ea683c71</loc><lastmod>2024-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-summer-round-up-1</loc><lastmod>2024-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-disclosure-updates-summer-round-up</loc><lastmod>2024-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=e622cbea-be5d-454a-9f93-73f2cf961765&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2024-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-innovative-statistical-methods-for-external-data-borrowing-in-clinical-trials-23-oct-2024-1100am-1230om-est-1</loc><lastmod>2024-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=b7e885fa-66c3-460a-8030-0fb5cca3368e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursd-12-september-cmc-ra-working-group-all-hands-call</loc><lastmod>2024-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=34f8e6ce-6556-45d8-8b53-0191e23fdf90</loc><lastmod>2024-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-medical-writing-support</loc><lastmod>2024-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-eu-hta-simultaneous-with-dossier-review-starting-january-2025</loc><lastmod>2024-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wha-resolution-on-social-participation-reporting-requirements</loc><lastmod>2024-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/wha-resolution-on-social-participation-reporting-requirements-1</loc><lastmod>2024-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursday-september-12-1100-am-est-webinar-on-eu-hta-simultaneous-with-dossier-review-starting-in-january-2025</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thursday-september-12-1100-am-est-webinar-on-eu-hta-simultaneous-with-dossier-review-starting-in-january-2025-1</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=22e4bf43-277b-4aef-9731-e9f151257cc1&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=7b1daa09-bba7-4000-9ef4-f00653c6a293&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=887cd473-e950-4464-bb31-0de0993b4d76&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-17</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-16</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-14</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-15</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-12</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-11</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-9</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-8</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-7</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-6</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-5</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-4</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-3</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-2</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MessageKey=ad6c14ad-e533-4f5a-ae75-30d1b9aa90ee&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-closes-on-sept-12-submit-today-1</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/redaction-mtg-moved-from-oct-17-to-oct-24-1</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-10-sep-2024-3</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-10-sep-2024-2</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-10-sep-2024-1</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-10-sep-2024</loc><lastmod>2024-09-10</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=aede91aa-0647-4ca2-b4de-018ede9b39fe</loc><lastmod>2024-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/redaction-mtg-moved-from-oct-17-to-oct-24</loc><lastmod>2024-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-sep-17-12-pm-et-opdp-ul-deep-dive-digitial-health-tech-guest-presenters</loc><lastmod>2024-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-sep-17-12-pm-et-opdp-ul-deep-dive-digitial-health-tech-guest-presenters-1</loc><lastmod>2024-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=3173d0ed-9845-4145-b5fe-66c5f2fde1eb&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-09-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-to-check-whether-older-studies-recorded-on-iras-are-still-active-1</loc><lastmod>2024-09-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cmc-ra-working-group-all-hands-call-thursd-12-september-pqcmc-idmp-and-ich-m4q</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=a9672073-91d8-4329-b48c-6f8d1b9b20b2&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/complimentary-webinar-real-world-data-quality-1</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-transition-to-the-new-research-portal-for-medical-research-september-3-2024-2</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-transition-to-the-new-research-portal-for-medical-research-september-3-2024-3</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-transition-to-the-new-research-portal-for-medical-research-september-3-2024-1</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-transition-to-the-new-research-portal-for-medical-research-september-3-2024</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=58f30923-c2e5-41b8-be31-8f453d713475&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-posted-rim-wg-all-hands-july-11-ectd-40-discussion-1</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-5-sep-rim-wg-all-hands-meeting-fhir</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-jul-aug-rim-intelligent-automation-team-gens-briefing-survey-workshops-3</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-jul-aug-rim-intelligent-automation-team-gens-briefing-survey-workshops-2</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-jul-aug-rim-intelligent-automation-team-gens-briefing-survey-workshops</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-jul-aug-rim-intelligent-automation-team-gens-briefing-survey-workshops-1</loc><lastmod>2024-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024</loc><lastmod>2024-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-2</loc><lastmod>2024-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-3</loc><lastmod>2024-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-november-2024-1</loc><lastmod>2024-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-information-day-17-october-2024</loc><lastmod>2024-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-information-day-17-october-2024-1</loc><lastmod>2024-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-5-sep-rim-wg-all-hands-meeting-fhir-1</loc><lastmod>2024-09-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-cumulative-glossary-75th-anniversary-edition</loc><lastmod>2024-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-cumulative-glossary-75th-anniversary-edition-1</loc><lastmod>2024-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-eu-hta-simultaneous-with-dossier-review-starting-january-2025-1</loc><lastmod>2024-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=cf8b9665-dbe2-4a81-8a68-0191b78f1569</loc><lastmod>2024-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-2</loc><lastmod>2024-08-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-3</loc><lastmod>2024-08-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants</loc><lastmod>2024-08-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-1</loc><lastmod>2024-08-30</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=2cec30d3-c08f-429b-a2cb-01912c1b2071</loc><lastmod>2024-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rwe-conference-early-bird-deadline-1</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-call-for-mentees</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=6b65042b-6313-4139-b3e7-1122b85947b1&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-aug-28-2024-1</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/browse/career-center</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-tomorrow-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-2</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-tomorrow-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-3</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-tomorrow-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-tomorrow-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-1</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-pooja-phogat-new-dia-india-mw-community-chairperson-2</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-pooja-phogat-new-dia-india-mw-community-chairperson-3</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-pooja-phogat-new-dia-india-mw-community-chairperson</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-pooja-phogat-new-dia-india-mw-community-chairperson-1</loc><lastmod>2024-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-optimizing-clinical-trial-designs-incorporating-estimand-thinking-1</loc><lastmod>2024-08-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-optimizing-clinical-trial-designs-incorporating-estimand-thinking</loc><lastmod>2024-08-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=7338d4db-618f-4415-9a67-e6b456ac8d40&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2024-08-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-ai-redefining-medical-and-safety-review-a-paradigm-shift</loc><lastmod>2024-08-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=fe3781a9-5ba9-4aa7-b082-70113e08aa36&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-08-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/isrctn-registry-transparency-tracker-1</loc><lastmod>2024-08-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/swiss-authorities-amended-ordinances-transparency-updates-1</loc><lastmod>2024-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/swiss-authorities-amended-ordinances-transparency-updates</loc><lastmod>2024-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-latin-america-annual-meeting-1</loc><lastmod>2024-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-latin-america-annual-meeting-2</loc><lastmod>2024-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-latin-america-annual-meeting</loc><lastmod>2024-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-call-for-abstracts-we-want-to-hear-from-you-3</loc><lastmod>2024-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-call-for-abstracts-we-want-to-hear-from-you</loc><lastmod>2024-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-call-for-abstracts-we-want-to-hear-from-you-1</loc><lastmod>2024-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants</loc><lastmod>2024-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-1</loc><lastmod>2024-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-linked-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants</loc><lastmod>2024-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-linked-for-shared-learning-28-aug-2024-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-1</loc><lastmod>2024-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-ticking-global-clinical-trial-disclosure-and-data-transparency-conference</loc><lastmod>2024-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-ticking-global-clinical-trial-disclosure-and-data-transparency-conference-1</loc><lastmod>2024-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-2</loc><lastmod>2024-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-3</loc><lastmod>2024-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants</loc><lastmod>2024-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-session-writing-for-trans-inclusivity-an-introduction-to-writing-clinical-trials-to-include-transgender-participants-1</loc><lastmod>2024-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-dia-rpi-mtg-12-est-with-fdas-kevin-bugin-about-c3ti</loc><lastmod>2024-08-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MessageKey=4174887f-ad7c-4fe0-b768-0d6d226e2f8f&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2024-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/gcp-vendor-qualification-survey-1</loc><lastmod>2024-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/gcp-vendor-qualification-survey</loc><lastmod>2024-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-mtg-aug-20th-12-noon-et-with-fdas-kevin-bugin</loc><lastmod>2024-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-documentation-14-aug-2024-2</loc><lastmod>2024-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-documentation-14-aug-2024-3</loc><lastmod>2024-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-documentation-14-aug-2024</loc><lastmod>2024-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-eu-ctis-documentation-14-aug-2024-1</loc><lastmod>2024-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-aug-2024-oig-advisory-opinions-free-drug-program-opdp-uls-revised-draft-guidance-on-correcting-misinfo-and-more</loc><lastmod>2024-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-aug-2024-oig-advisory-opinions-free-drug-program-opdp-uls-revised-draft-guidance-on-correcting-misinfo-and-more-1</loc><lastmod>2024-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/iriss-meeting-of-interest-aug-20-10am-et-rim-wg-update-ai-use-discussion-1</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=bf20481d-56b7-4781-82f9-14b87e08fcc4&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=cdb6555e-e3fe-488e-9fdf-0e9bd2f4cd24&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-eudract-and-updated-faqs-aug-09-2024-1</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-aug-21-11am-et-rim-intelligent-automation-team-gens-survey-insights</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-aug-21-11am-et-rim-intelligent-automation-team-gens-survey-insights-1</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-aug-14-12-pm-et-oig-and-free-drug-programs-opdp-uls-and-more</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-aug-14-12-pm-et-oig-and-free-drug-programs-opdp-uls-and-more-1</loc><lastmod>2024-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-28</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-29</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-26</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-27</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-25</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-24</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-23</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-22</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-20</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-21</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-18</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-19</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=91&amp;MessageKey=edbe8db2-c283-43a8-a568-f09477a54e73&amp;CommunityKey=c70a1db4-f59f-47ee-93c8-70d8cfae57fd</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-14</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-15</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=73&amp;MessageKey=0795ab7f-5045-4c50-b260-9cba1a3d67a1&amp;CommunityKey=0c69c80d-cbda-44b8-a0cb-8ac296687a90</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-13</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-10</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-11</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-8</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-9</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-6</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-7</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-4</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-5</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-3</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-2</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstracts-now-open-1</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=349&amp;MessageKey=485b1fa0-a477-401b-bdf4-9aaca66d3048&amp;CommunityKey=761a544b-eee9-494f-b450-01894b896649</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstract-is-now-open-3</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstract-is-now-open</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2025-call-for-abstract-is-now-open-1</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-new-chairperson-for-dia-india-medical-writing-community-2</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-new-chairperson-for-dia-india-medical-writing-community-3</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-new-chairperson-for-dia-india-medical-writing-community-1</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=bb68eb93-6212-40a6-9ecd-c48812994ac4&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=30e98602-fef6-46bf-84b9-3e47028e51fa&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-aug-07-2024-1</loc><lastmod>2024-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-ai-redefining-medical-and-safety-review-a-paradigm-shift-1</loc><lastmod>2024-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=b2f098d8-404a-4be1-9e7c-19ff5ad7c600&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2024-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-digital-health-technologies-and-novel-data-modality-in-clinical-development-1</loc><lastmod>2024-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=030b2ebc-146b-4d15-a26c-8540d2852674&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2024-08-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-open-source-software-for-clinical-trial-reporting-and-regulatory-submissions-1</loc><lastmod>2024-08-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-understanding-estimand-framework-applications-in-multiple-therapeutic-areas</loc><lastmod>2024-08-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-understanding-estimand-framework-applications-in-multiple-therapeutic-areas-1</loc><lastmod>2024-08-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=7c43c620-21da-4b86-928a-ee5dc4126bf7&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-aug-14-12-1-pm-et-opdp-ul-oig-advisory-opinions-free-drug-programs-guest-speaker-more-1</loc><lastmod>2024-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-quick-guide-for-users</loc><lastmod>2024-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ebook-achieving-excellence-in-regulatory-information-management</loc><lastmod>2024-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meeting-thursday-august-8-annual-meeting-review-and-ideas-for-2025</loc><lastmod>2024-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=42b948e8-27e5-4f21-b743-b83bcacd47d7&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ind-and-nda-submissions-1</loc><lastmod>2024-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-posted-jun-26-rim-intelligent-automation-team-ai-adoption-discussion</loc><lastmod>2024-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-posted-jun-26-rim-intelligent-automation-team-ai-adoption-discussion-1</loc><lastmod>2024-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=f62e9514-4c85-474f-9b03-89414f409091&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/date-change-rim-wg-all-hands-moved-to-sep-5-at-noon-et-1</loc><lastmod>2024-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-jul-17-rim-intelligent-automation-team-survey-planning-workshop</loc><lastmod>2024-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-jul-17-rim-intelligent-automation-team-survey-planning-workshop-1</loc><lastmod>2024-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-multi-factor-authentication-mfa-2</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-multi-factor-authentication-mfa-3</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-multi-factor-authentication-mfa</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-multi-factor-authentication-mfa-1</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/u-ctis-newsflash-july-26-2024</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/u-ctis-newsflash-july-26-2024-1</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-july-26-2024</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-july-26-2024-1</loc><lastmod>2024-07-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/template-cover-letters-and-rfi-response-ctcg-documents-2</loc><lastmod>2024-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/template-cover-letters-and-rfi-response-ctcg-documents-3</loc><lastmod>2024-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c6de3259-5b38-45f2-b718-701c505b25ef&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/template-cover-letters-and-rfi-response-ctcg-documents-1</loc><lastmod>2024-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/july-2024-improvements-in-clinicaltrialsgov-prs-beta-1</loc><lastmod>2024-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/july-2024-improvements-in-clinicaltrialsgov-prs-beta</loc><lastmod>2024-07-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-regulation-ctr-collaborate-stakeholder-meeting-11-sep-2024</loc><lastmod>2024-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-regulation-ctr-collaborate-stakeholder-meeting-11-sep-2024-1</loc><lastmod>2024-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-ctd-conference-early-bird-savings-end-tomorrow-july-25</loc><lastmod>2024-07-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/global-ctd-conference-early-bird-savings-end-tomorrow-july-25-1</loc><lastmod>2024-07-23</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=0ee76900-d745-441d-83ac-0190dea6b0cd</loc><lastmod>2024-07-23</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=e4c43f93-f47f-4a34-8741-0190de9f7c1e</loc><lastmod>2024-07-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-22-july-2024</loc><lastmod>2024-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-22-july-2024-1</loc><lastmod>2024-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c0388d2d-6382-4f23-a1ba-516d70c8cdab&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-2</loc><lastmod>2024-07-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-3</loc><lastmod>2024-07-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-quick-guide-for-users-1</loc><lastmod>2024-07-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-jul-17-11am-et-rim-intelligent-automation-team-ai-survey-planning-1</loc><lastmod>2024-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=e08a07c0-c4f9-43d4-98b1-1a487cad7a2d&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-for-aug-sep-and-oct-hold-the-dates-guest-presenters-and-more</loc><lastmod>2024-07-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-for-aug-sep-and-oct-hold-the-dates-guest-presenters-and-more-1</loc><lastmod>2024-07-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-library-of-science-plos-open-science-indicators-osi-2</loc><lastmod>2024-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-library-of-science-plos-open-science-indicators-osi-3</loc><lastmod>2024-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-library-of-science-plos-open-science-indicators-osi</loc><lastmod>2024-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-unions-eu-artificial-intelligence-act-ai-act-regulation-eu-20241689-2</loc><lastmod>2024-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-unions-eu-artificial-intelligence-act-ai-act-regulation-eu-20241689</loc><lastmod>2024-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-unions-eu-artificial-intelligence-act-ai-act-regulation-eu-20241689-1</loc><lastmod>2024-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-july-2024-4</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-july-2024-5</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-july-2024-2</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-july-2024-3</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-july-2024-1</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-july-2024</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d6c4bee9-ad34-48dd-916f-b0de1deadead&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-survey-5</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-survey-4</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-survey-2</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-survey-3</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-survey-1</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-survey</loc><lastmod>2024-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-new-version-of-the-public-portal-joint-pcwp-hcpwp-meeting-2</loc><lastmod>2024-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-new-version-of-the-public-portal-joint-pcwp-hcpwp-meeting</loc><lastmod>2024-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-new-version-of-the-public-portal-joint-pcwp-hcpwp-meeting-1</loc><lastmod>2024-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-wg-meeting-scheduled-for-16-july-2024</loc><lastmod>2024-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-wg-meeting-scheduled-for-16-july-2024-1</loc><lastmod>2024-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=76ef07d4-ef62-4fa4-ae3c-0190a13a54ca</loc><lastmod>2024-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/decentralized-and-hybrid-clinical-trials-what-are-your-pain-points</loc><lastmod>2024-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/kamila-novak-wins-dia-award</loc><lastmod>2024-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/decentralized-and-hybrid-clinical-trials-what-are-your-pain-points-1</loc><lastmod>2024-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-complimentary-webinar-on-unlocking-opportunities-in-latin-america-2</loc><lastmod>2024-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-complimentary-webinar-on-unlocking-opportunities-in-latin-america-3</loc><lastmod>2024-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-complimentary-webinar-on-unlocking-opportunities-in-latin-america-1</loc><lastmod>2024-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-meeting-on-july-18</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=a906fd54-7401-478a-a9dc-01909459bb0d&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-rim-wg-all-hands-july-11-noon-et-ectd-40-discussion</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-rim-wg-all-hands-july-11-noon-et-ectd-40-discussion-1</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MessageKey=7abc9a00-7b2c-4813-9e85-95737bba7276&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-on-the-revised-transparency-rules-materials-3</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-on-the-revised-transparency-rules-materials</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-on-the-revised-transparency-rules-materials-1</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-documentation-from-act-eu-on-eu-ctis-3</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=47983b5a-ef11-4ede-8ecc-640bc2cd6149&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-documentation-from-act-eu-on-eu-ctis</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-documentation-from-act-eu-on-eu-ctis-1</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-make-it-public-workshop-summary-2</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-make-it-public-workshop-summary-3</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d2c1f893-6a30-4c20-ad12-625e6c8fcf0d&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-make-it-public-workshop-summary-1</loc><lastmod>2024-07-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=0effb1e2-14fd-40de-804b-23deef8a4e67&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2024-07-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-of-multinational-clinical-trials-version-5-2</loc><lastmod>2024-07-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-of-multinational-clinical-trials-version-5-3</loc><lastmod>2024-07-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-of-multinational-clinical-trials-version-5-1</loc><lastmod>2024-07-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=ddf13467-7cda-4af7-8096-b65678c9fb45&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-07-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-v40</loc><lastmod>2024-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-v40-1</loc><lastmod>2024-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-v40-2</loc><lastmod>2024-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-v40-3</loc><lastmod>2024-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-28-june-2024-2</loc><lastmod>2024-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-28-june-2024</loc><lastmod>2024-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-newsflash-28-june-2024-1</loc><lastmod>2024-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-historical-trials-quick-guide-for-users-5</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-historical-trials-quick-guide-for-users-1</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-historical-trials-quick-guide-for-users-3</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-historical-trials-quick-guide-for-users-4</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-historical-trials-quick-guide-for-users</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-and-historical-trials-quick-guide-for-users-2</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-mtg-next-thurs-june-27</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/no-july-meeting-adpromo-wg-see-you-aug-14-1</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=cda7c692-56e5-43cf-9e08-f25b4e6092a1&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-jun-26-11am-et-rim-intelligent-automation-team</loc><lastmod>2024-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-june-25-2024</loc><lastmod>2024-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-june-25-2024-1</loc><lastmod>2024-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-2</loc><lastmod>2024-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-3</loc><lastmod>2024-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=ca8758e2-2ac5-4a99-9730-02dcd6903d9c&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trials-highlights-1</loc><lastmod>2024-06-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/behavioural-science-and-risk-management</loc><lastmod>2024-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/behavioural-science-and-risk-management-1</loc><lastmod>2024-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-amendment-today-at-3pm-gmt10-am-est-lindsey-murray-from-c-path-presenting-on-the-rare-disease-coa-tool-2</loc><lastmod>2024-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=04759c31-4571-43b3-9003-355521bb707c&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2024-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-amendment-today-at-3pm-gmt10-am-est-lindsey-murray-from-c-path-presenting-on-the-rare-disease-coa-tool-1</loc><lastmod>2024-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MessageKey=c37d7f1e-3025-41a8-8f22-83febc7125ce&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2024-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=ce1f4ac7-0c75-48c7-9f38-019034cb3dfb&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f&amp;Home=%2fevents%2fevent-description</loc><lastmod>2024-06-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-prs-test-updates-june-20-2024</loc><lastmod>2024-06-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-and-prs-test-updates-june-20-2024-1</loc><lastmod>2024-06-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/two-new-advice-pilots-to-improve-clinical-trials-in-europe</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/two-new-advice-pilots-to-improve-clinical-trials-in-europe-1</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/two-new-advice-pilots-to-improve-clinical-trials-in-europe-2</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/two-new-advice-pilots-to-improve-clinical-trials-in-europe-3</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-new-ctis-and-revised-transparency-rules-18-june-2024-1</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-new-ctis-and-revised-transparency-rules-18-june-2024</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/congratulations-to-our-mw-community-chairperson-nimita-limaye-global-dia-inspire-award-winner-2</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/congratulations-to-our-mw-community-chairperson-nimita-limaye-global-dia-inspire-award-winner-3</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=adbc33f8-d043-48b7-8435-dd2917d12aaf&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/congratulations-to-our-mw-community-chairperson-nimita-limaye-global-dia-inspire-award-winner-1</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-intelligence-working-group</loc><lastmod>2024-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-mtg-next-thurs-june-27-1</loc><lastmod>2024-06-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-about-24th-june-webinar-on-c-paths-rare-disease-coa-resource-with-calendar-invite</loc><lastmod>2024-06-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-mtg-this-thurs-10am-est</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-mtg-topic</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-modules-2</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-modules-3</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-modules</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-training-modules-1</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-version-20-3</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-version-20-2</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-version-20</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-version-20-1</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-the-encepp-conduct-your-study-podcast-series-3</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faster-access-to-clinical-trial-information-in-europe-4</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faster-access-to-clinical-trial-information-in-europe-5</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faster-access-to-clinical-trial-information-in-europe-2</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faster-access-to-clinical-trial-information-in-europe-3</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=560113a7-0d8f-41e4-805c-67ce35acc854&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faster-access-to-clinical-trial-information-in-europe-1</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-to-structured-data-forms-and-appendix-on-disclosure-rules-18-june-2024-2</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-to-structured-data-forms-and-appendix-on-disclosure-rules-18-june-2024-3</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-to-structured-data-forms-and-appendix-on-disclosure-rules-18-june-2024-1</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-to-structured-data-forms-and-appendix-on-disclosure-rules-18-june-2024</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trial-information-system-ctis-revised-transparency-rules-18-june-2024-2</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trial-information-system-ctis-revised-transparency-rules-18-june-2024-3</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-clinical-trial-information-system-ctis-revised-transparency-rules-18-june-2024-1</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=2a38f48d-473b-41f3-ab11-0fef02ad4dab&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-document-on-how-to-approach-the-ppd-and-cci-while-using-the-ctis-version-2-2</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-document-on-how-to-approach-the-ppd-and-cci-while-using-the-ctis-version-2-3</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=4d46488d-7bd7-4486-94b4-7107ab311b82&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-document-on-how-to-approach-the-ppd-and-cci-while-using-the-ctis-version-2-1</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meeting-thursday-june-13-annual-meeting-preview-and-member-roundtable</loc><lastmod>2024-06-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-the-encepp-conduct-your-study-podcast-series-2</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-the-encepp-conduct-your-study-podcast-series</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-the-encepp-conduct-your-study-podcast-series-1</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-new-implementing-regulations-apply-as-of-1-november-2024-4</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-new-implementing-regulations-apply-as-of-1-november-2024-2</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-new-implementing-regulations-apply-as-of-1-november-2024-3</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-new-implementing-regulations-apply-as-of-1-november-2024</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/switzerland-new-implementing-regulations-apply-as-of-1-november-2024-1</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-ctis-information-day-oct-17-2024-1</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updates-from-eu-ctis-newsflash-june-14-2024</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updates-from-eu-ctis-newsflash-june-14-2024-1</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/introduction-1</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/introduction-2</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/highlights-of-ema-management-boards-june-2024-meeting-2</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/highlights-of-ema-management-boards-june-2024-meeting-3</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/highlights-of-ema-management-boards-june-2024-meeting</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/highlights-of-ema-management-boards-june-2024-meeting-1</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-trends-and-charts</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-trends-and-charts-1</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=4f8f9a9b-7261-4013-8608-d3719b55ca2b&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=904d7e6d-769c-467f-924c-019017e15b10</loc><lastmod>2024-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updates-from-eu-ctis-newsflash-june-14-2024-2</loc><lastmod>2024-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transparency-for-machine-learning-enabled-medical-devices-guiding-principles-2</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transparency-for-machine-learning-enabled-medical-devices-guiding-principles-3</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=70f9c90e-3124-43da-98d1-b5085efd1414&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transparency-for-machine-learning-enabled-medical-devices-guiding-principles-1</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-june-13-2024-2</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-june-13-2024</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-june-13-2024-1</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/raps-sf-networking-during-dia-annual-meeting-in-san-diego</loc><lastmod>2024-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/attending-the-global-annual-meeting-join-dia-communities-for-lunch-on-tuesday</loc><lastmod>2024-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-jun-26-11am-et-rim-intelligent-automation-team-1</loc><lastmod>2024-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-now-available-for-shared-learning-challenges-and-complexities-for-cros-managing-outsourced-medical-writing-partnerships-2</loc><lastmod>2024-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-now-available-for-shared-learning-challenges-and-complexities-for-cros-managing-outsourced-medical-writing-partnerships-3</loc><lastmod>2024-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-now-available-for-shared-learning-challenges-and-complexities-for-cros-managing-outsourced-medical-writing-partnerships</loc><lastmod>2024-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-now-available-for-shared-learning-challenges-and-complexities-for-cros-managing-outsourced-medical-writing-partnerships-1</loc><lastmod>2024-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/gcp-qa-at-dia-annual-meeting</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-2</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-3</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-1</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-june-11-ai-in-adpromo-ccn-webinar-uk-medical-site-violation</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-june-11-ai-in-adpromo-ccn-webinar-uk-medical-site-violation-1</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/kpis-to-monitor-the-european-clinical-trials-environment-1-30-april-2024-2</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/kpis-to-monitor-the-european-clinical-trials-environment-1-30-april-2024</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/kpis-to-monitor-the-european-clinical-trials-environment-1-30-april-2024-1</loc><lastmod>2024-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/date-change-dia-eu-ctrctis-working-group-meeting-moved-to-25-june</loc><lastmod>2024-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-study-endpoints-community-presents-c-paths-rare-disease-coa-resource-webinar-on-24-june</loc><lastmod>2024-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-study-endpoints-community-presents-c-paths-rare-disease-coa-resource-webinar-on-24-june-1</loc><lastmod>2024-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-scheduled-downtime-on-june-17-2024-monday</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-scheduled-downtime-on-june-17-2024-monday-1</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-scheduled-downtime-on-june-17-2024-monday-2</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-scheduled-downtime-on-june-17-2024-monday-3</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/declaration-of-helsinki-public-comment-period-two-2</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/declaration-of-helsinki-public-comment-period-two-3</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/declaration-of-helsinki-public-comment-period-two</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/declaration-of-helsinki-public-comment-period-two-1</loc><lastmod>2024-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-next-rim-wg-meeting-moved-to-july-11th-at-noon-et</loc><lastmod>2024-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=59b4ea8a-d729-4bf5-bb5c-9954cad9fb79&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2024-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=16c7686b-9052-44b9-85ee-55c76cb84257&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-june-11-12-pm-et-ai-ready-for-adpromo-1</loc><lastmod>2024-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-release-notes-june-5-2024-2</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-release-notes-june-5-2024</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-release-notes-june-5-2024-1</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-june-5-2024-2</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-june-5-2024-1</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-update-june-5-2024</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-a-mw-community-networking-lunch-at-dia-annual-meeting-in-san-diego-3</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-a-mw-community-networking-lunch-at-dia-annual-meeting-in-san-diego-2</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-a-mw-community-networking-lunch-at-dia-annual-meeting-in-san-diego</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-a-mw-community-networking-lunch-at-dia-annual-meeting-in-san-diego-1</loc><lastmod>2024-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-anonymization-report-template</loc><lastmod>2024-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-medical-writing-partnerships-7-june-2024-10-11-am-us-et-3</loc><lastmod>2024-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-medical-writing-partnerships-7-june-2024-10-11-am-us-et-2</loc><lastmod>2024-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-medical-writing-partnerships-7-june-2024-10-11-am-us-et</loc><lastmod>2024-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-medical-writing-partnerships-7-june-2024-10-11-am-us-et-1</loc><lastmod>2024-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MessageKey=a254fe11-4359-4f69-86a7-237320fd99e8&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2024-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-c-paths-rare-disease-coa-resource-later-this-month-1</loc><lastmod>2024-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/interested-in-protocol-development</loc><lastmod>2024-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/060624-1200-pm-edt-dia-pm-community-all-hands-call-preview-of-2024-dia-global-annual-meeting</loc><lastmod>2024-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reschedule-embracing-digital-health-technologies-and-novel-data-modality-in-clinical-development</loc><lastmod>2024-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reschedule-embracing-digital-health-technologies-and-novel-data-modality-in-clinical-development-1</loc><lastmod>2024-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-embracing-digital-health-technologies-and-novel-data-modality-in-clinical-development</loc><lastmod>2024-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-june-11-12-pm-et-ai-ready-for-adpromo</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-june-11-12-pm-et-ai-ready-for-adpromo-1</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-coordination-and-advisory-group-meeting-minutes-april-2024-2</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-coordination-and-advisory-group-meeting-minutes-april-2024-3</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-coordination-and-advisory-group-meeting-minutes-april-2024-1</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-coordination-and-advisory-group-meeting-minutes-april-2024</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-walk-in-clinic-10-july-2024-at-1600-1700-cest</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-walk-in-clinic-10-july-2024-at-1600-1700-cest-1</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-monthly-newsletter-may-2024-2</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-monthly-newsletter-may-2024</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-monthly-newsletter-may-2024-1</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-latest-release-2</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-latest-release-3</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-latest-release</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-hot-off-the-prs-latest-release-1</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-mw-partnerships-7-june-2024-10-11-am-us-et-2</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-mw-partnerships-7-june-2024-10-11-am-us-et-3</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-mw-partnerships-7-june-2024-10-11-am-us-et</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-challenges-and-complexities-for-cros-in-managing-outsourced-mw-partnerships-7-june-2024-10-11-am-us-et-1</loc><lastmod>2024-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=969a7853-5674-47e8-b624-e0c43c546a14&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/gen-ai-the-how-maybe-start-with-low-hanging-fruits</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pharmnetbund-website-redesigned</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pharmnetbund-website-redesigned-1</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/encepp-membership-survey-action-for-encepp-partners-2</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/encepp-membership-survey-action-for-encepp-partners</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/encepp-membership-survey-action-for-encepp-partners-1</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-webinar-07-june-1130-1300-uk-time-4</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-webinar-07-june-1130-1300-uk-time-5</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-webinar-07-june-1130-1300-uk-time-2</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-webinar-07-june-1130-1300-uk-time-3</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-webinar-07-june-1130-1300-uk-time</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-reference-webinar-07-june-1130-1300-uk-time-1</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/merct-webinar-implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-04-june-11-12-et</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/merct-webinar-implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-04-june-11-12-et-1</loc><lastmod>2024-05-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-version-4-may-2024-3</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-anonymization-report-template-1</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-anonymization-report-template-2</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-september-october-and-november-2024-3</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-september-october-and-november-2024-2</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-september-october-and-november-2024</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-september-october-and-november-2024-1</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-harnessing-the-power-of-ai-in-scientific-publications-1</loc><lastmod>2024-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=b2ef286e-7496-4945-9d4a-71aa2169ffd8&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2024-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-login-issue-resolved-and-rfi-timelines-extended</loc><lastmod>2024-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-login-issue-resolved-and-rfi-timelines-extended-1</loc><lastmod>2024-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-login-issue-resolved-and-rfi-timelines-extended-2</loc><lastmod>2024-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-anonymization-report-template-3</loc><lastmod>2024-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-may-2024-5</loc><lastmod>2024-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-may-2024-3</loc><lastmod>2024-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-may-2024-4</loc><lastmod>2024-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/famhp-belgium-hosts-a-webinar-for-all-stakeholders-on-the-transition-of-clinical-trials-2</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/famhp-belgium-hosts-a-webinar-for-all-stakeholders-on-the-transition-of-clinical-trials-3</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=2596194d-7bfb-41a2-b1e9-021e46624fa4&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/famhp-belgium-hosts-a-webinar-for-all-stakeholders-on-the-transition-of-clinical-trials-1</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-version-4-may-2024-2</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-version-4-may-2024-1</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=aa867aa5-ec80-4561-9618-46e8af0e4095&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reporting-pk-results-in-plain-language-summaries</loc><lastmod>2024-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=e0e5725d-7afd-40cb-8e1a-a73670a495c1&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-september-2024-2</loc><lastmod>2024-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-september-2024-1</loc><lastmod>2024-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=1f62fa65-bc8e-45fd-901d-81120d10ad8c&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-wg-all-hands-12pm-et-jun-6-ectd-40-discussion-1</loc><lastmod>2024-05-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-wg-all-hands-12pm-et-jun-6-ectd-40-discussion</loc><lastmod>2024-05-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/medical-devices-updated-guidance-for-industry-and-notified-bodies</loc><lastmod>2024-05-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/medical-devices-updated-guidance-for-industry-and-notified-bodies-1</loc><lastmod>2024-05-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-today-dia-rpi-mtg-12-noon-et-with-fdas-dr-peter-stein</loc><lastmod>2024-05-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-beta-available-in-the-prs-test-system-may-20-2024</loc><lastmod>2024-05-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meeting-thursday-may-9-on-patient-advocacy-in-latin-america</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-system-improvements-2</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-system-improvements</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-system-improvements-1</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/report-on-combined-studies-analysis-phase-and-ways-forward</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/report-on-combined-studies-analysis-phase-and-ways-forward-1</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/report-on-combined-studies-analysis-phase-and-ways-forward-2</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/report-on-combined-studies-analysis-phase-and-ways-forward-3</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-revised-transparency-rules-and-the-new-ctis-public-portal-20-june-2024-1530-to-1700-cest</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-revised-transparency-rules-and-the-new-ctis-public-portal-20-june-2024-1530-to-1700-cest-1</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-revised-transparency-rules-and-the-new-ctis-public-portal-on-20-june-2024-1530-to-1700-cest</loc><lastmod>2024-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-july-2024</loc><lastmod>2024-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-july-2024-2</loc><lastmod>2024-05-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-july-2024-1</loc><lastmod>2024-05-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-2024-cdm-monthly-meeting-thursday-may-16th</loc><lastmod>2024-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-2024-cdm-monthly-meeting-thursday-may-16th-1</loc><lastmod>2024-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/network-with-members-of-the-pm-community-aboard-the-uss-midway-1</loc><lastmod>2024-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MessageKey=5f5ed57b-681a-47b9-8f63-9c8efca6c2ee&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2024-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/060624-1200-pm-edt-dia-pm-community-all-hands-call-preview-of-2024-dia-global-annual-meeting-1</loc><lastmod>2024-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-classic-website-retiring-on-june-25-2024-1</loc><lastmod>2024-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=a6511b29-be41-4af4-9dc1-281422ff7eb5&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-embracing-digital-health-technologies-and-novel-data-modality-in-clinical-development-1</loc><lastmod>2024-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=36f9f2b8-180d-4eb1-ab92-9f89625a3a3f&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2024-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-1</loc><lastmod>2024-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-may-8-fda-revised-biologics-guidance-adpromo-geofencing-ai-initial-discussion-1</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=53e7d2f0-87e5-44fc-9569-b4a963614934&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=b6a0970c-b444-4ee7-b6ac-ddbf35374948&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-health-data-space-ehds-news-6</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-health-data-space-ehds-news-7</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=fc423afc-fbb8-437a-af17-b5ddd841b683&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-health-data-space-ehds-news-5</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-clinical-trials-analytics-workshop-report-25-26-jan-2024-2</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-clinical-trials-analytics-workshop-report-25-26-jan-2024</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-clinical-trials-analytics-workshop-report-25-26-jan-2024-1</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=1fd7312b-b0c7-4406-af52-018f5597d6de&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-mtg-may-21st-12-noon-et-with-fdas-dr-peter-stein</loc><lastmod>2024-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-june-short-courses-selected-just-for-you-register-now</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=8cd28bda-db4e-44e5-9696-947a3cd61bf4&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-short-courses-selected-just-for-you-register-today-1</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-short-courses-selected-just-for-you-register-today</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/jump-start-your-summer-learning-with-dia-short-courses-june-3-16-2024</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-to-sponsors-updating-the-application-dossier-part-i-after-ctr-transition-vs-20-2</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-to-sponsors-updating-the-application-dossier-part-i-after-ctr-transition-vs-20-1</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-to-sponsors-updating-the-application-dossier-part-i-after-ctr-transition-vs-20-3</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-to-sponsors-updating-the-application-dossier-part-i-after-ctr-transition-vs-20</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-et-may-15</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-et-may-15-1</loc><lastmod>2024-05-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-nih-resource-for-terminology-for-clinical-research</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-nih-resource-for-terminology-for-clinical-research-1</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=0e87c7ca-a6e8-4fa6-9a1a-e5bb5d67443f&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-list-of-known-issues</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-list-of-known-issues-1</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-structured-data-form-updated-2</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-structured-data-form-updated</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-structured-data-form-updated-1</loc><lastmod>2024-05-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-may-8-12-pm-et-revised-biological-guidance-geofencing-and-more</loc><lastmod>2024-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-may-8-12-pm-et-revised-biological-guidance-geofencing-and-more-1</loc><lastmod>2024-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/research-ethics-book-review</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ctis-feature-updating-sponsor-information-via-a-non-substantial-modification-2</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ctis-feature-updating-sponsor-information-via-a-non-substantial-modification</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ctis-feature-updating-sponsor-information-via-a-non-substantial-modification-1</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ctis-feature-field-on-individual-participant-data-and-system-improvements-3</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ctis-feature-field-on-individual-participant-data-and-system-improvements-2</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=0f4c9698-a74a-48b7-9298-0982b94d1be0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-ctis-feature-field-on-individual-participant-data-and-system-improvements-1</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monitoring-the-european-clinical-trials-environment-kpi-report-2</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monitoring-the-european-clinical-trials-environment-kpi-report</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/monitoring-the-european-clinical-trials-environment-kpi-report-1</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reflection-paper-on-use-of-real-world-data-in-non-interventional-studies-to-generate-real-world-evidence-scientific-guideline-1</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reflection-paper-on-use-of-real-world-data-in-non-interventional-studies-to-generate-real-world-evidence-scientific-guideline</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/sponsors-guide-transition-of-trials-from-eudract-to-ctis-ctis-training-programme-module-23-3</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/sponsors-guide-transition-of-trials-from-eudract-to-ctis-ctis-training-programme-module-23-1</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/sponsors-guide-transition-of-trials-from-eudract-to-ctis-ctis-training-programme-module-23-2</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/sponsors-guide-transition-of-trials-from-eudract-to-ctis-ctis-training-programme-module-23</loc><lastmod>2024-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-meeting-minutes-1</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-public-involvement-newsletter-for-may-2024-3</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-public-involvement-newsletter-for-may-2024-2</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-public-involvement-newsletter-for-may-2024</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-public-involvement-newsletter-for-may-2024-1</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/writing-informed-consent-and-assent-information-for-families-and-children</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/australian-new-zealand-clinical-trials-registry-maintenance-may-8-2024</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/response-to-fda-consultation-on-providing-plain-language-icf-summaries</loc><lastmod>2024-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=e79ea585-1d3d-4ecd-ad3f-018f35edf8e7</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/impact-of-ai-on-the-regulation-of-medical-products</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/impact-of-ai-on-the-regulation-of-medical-products-1</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-policy-paper-impact-of-ai-on-the-regulation-of-medical-products</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-policy-paper-impact-of-ai-on-the-regulation-of-medical-products-1</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-signal-management-pre-marketing-vs-post-marketing</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-webinar-implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-tuesday-june-4-from-11-12-pm-et-2</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-webinar-implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-tuesday-june-4-from-11-12-pm-et</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-webinar-implementing-the-clinical-research-glossary-and-your-critical-role-in-public-review-tuesday-june-4-from-11-12-pm-et-1</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-initiative-lgbtqia-resources</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-walk-in-clinic-15-may-2024-2</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-walk-in-clinic-15-may-2024-3</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-walk-in-clinic-15-may-2024</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-walk-in-clinic-15-may-2024-1</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/medical-devices-update</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/medical-devices-update-1</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=2724b1b3-d47a-4165-ab43-a40c7146ffde&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/phuse-blog-year-2-update-on-eu-ctr-implementtaion</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/phuse-blog-year-2-update-on-eu-ctr-implementtaion-1</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/phuse-blog-year-2-update-on-eu-ctr-implementtaion-3</loc><lastmod>2024-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-and-release-notes-april-30-2024</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/national-academy-of-medicine-calls-for-public-comments-on-ai-code-of-conduct-principles-and-commitments-discussion-draft</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-clinical-research-data-sharing-alliance-crdsa-and-icmje-1</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c8835fb8-3090-4666-ab6f-b9549aab00a0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/efpia-statement-on-the-use-of-ai-in-the-medicinal-product-lifecycle-in-the-context-of-the-ai-act-2</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/efpia-statement-on-the-use-of-ai-in-the-medicinal-product-lifecycle-in-the-context-of-the-ai-act-1</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=aae017bf-b948-43e9-80fc-fca93247fe9d&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudamed-updates-1</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudamed-updates-2</loc><lastmod>2024-04-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=264ef999-8b61-418c-96f3-9f601476c4a6&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-closed-may-01-2024-3</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-closed-may-01-2024-1</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=3616f7c4-d539-4f3c-b6b9-e511dacf1660&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/celebrate-dias-60th-anniversary-on-the-uss-midway-sunday-june-16</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-posted-for-apr-2024-rim-community-all-hands-meeting</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-posted-for-apr-2024-rim-community-all-hands-meeting-1</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=a2f2e5ba-4f0d-480a-80f2-19cf20bfe2a7&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-on-real-world-evidence-provided-by-ema-support-for-regulatory-decision-making-1</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/real-world-data-darwin-eu-data-analysis-and-real-world-interrogation-network-1</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/real-world-data-darwin-eu-data-analysis-and-real-world-interrogation-network</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=13f9883d-81cf-421c-a905-f11b68d9db01&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-mhra-update-1</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=b5dbacf4-d4cb-44cf-9460-c92e81e2af25&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-29</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=7f8b101c-6abc-440c-a46c-018f1b475a97</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anonymisation-of-personal-data-and-assessment-of-commercially-confidential-information-during-the-preparation-and-redaction-of-rmps-body-and-annexes-4-and-6-2</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anonymisation-of-personal-data-and-assessment-of-commercially-confidential-information-during-the-preparation-and-redaction-of-rmps-body-and-annexes-4-and-6-3</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anonymisation-of-personal-data-and-assessment-of-commercially-confidential-information-during-the-preparation-and-redaction-of-rmps-body-and-annexes-4-and-6</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anonymisation-of-personal-data-and-assessment-of-commercially-confidential-information-during-the-preparation-and-redaction-of-rmps-body-and-annexes-4-and-6-1</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-beta-april-25-2024</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/becoming-a-lay-member-of-the-confidentiality-advisory-group-cag-4</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/becoming-a-lay-member-of-the-confidentiality-advisory-group-cag-2</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/becoming-a-lay-member-of-the-confidentiality-advisory-group-cag-3</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/becoming-a-lay-member-of-the-confidentiality-advisory-group-cag</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/becoming-a-lay-member-of-the-confidentiality-advisory-group-cag-1</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/information-commissioners-offices-ico-new-transparency-guidance</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/information-commissioners-offices-ico-new-transparency-guidance-1</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=747fd53e-0d31-47d5-91ed-ea4bbf340ddf&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-article-regulatory-issues-of-platform-trials-learnings-from-eu-pearl-2</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-article-regulatory-issues-of-platform-trials-learnings-from-eu-pearl-3</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-article-regulatory-issues-of-platform-trials-learnings-from-eu-pearl-4</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-article-regulatory-issues-of-platform-trials-learnings-from-eu-pearl</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-article-regulatory-issues-of-platform-trials-learnings-from-eu-pearl-1</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-may-8-12-pm-et-note-the-date-1</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-may-8-12-pm-et-note-the-date</loc><lastmod>2024-04-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-dia-rpi-mtg-today-12-pm-et-on-cloud-based-pharmaceutical-quality-knowledge-mgmt-system-by-accumulus</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=967cc1f5-9008-4b3d-9bd6-b34943237155&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-slides-posted-for-apr-2024-rim-intelligent-automation-meeting-1</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=283&amp;MessageKey=72abf21c-49ee-4a62-ab8f-64ffbedf5782&amp;CommunityKey=fc80e507-13cd-4967-9d9c-9cd2b13faed8</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guide-on-access-to-unpublished-documents-3</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=7c85f120-145f-4574-acc5-4768479ecf68&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guide-on-access-to-unpublished-documents-1</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-call-for-comments-on-new-study-agreement-template-2</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-call-for-comments-on-new-study-agreement-template-3</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c83f08ba-0f07-4fdb-baba-6d84c1ba8a04&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-call-for-comments-on-new-study-agreement-template-1</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-for-sponsor-users-10-13-june-2024-2</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-for-sponsor-users-10-13-june-2024-1</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-for-sponsor-users-10-13-june-2024</loc><lastmod>2024-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-24-apr-2024-alternate-impd-q-and-new-guidance-axmp</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-24-apr-2024-alternate-impd-q-and-new-guidance-axmp-2</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-24-apr-2024-alternate-impd-q-and-new-guidance-axmp-1</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-guidance-for-sponsors-transitioning-trials-to-ctr-2</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-guidance-for-sponsors-transitioning-trials-to-ctr-3</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-guidance-for-sponsors-transitioning-trials-to-ctr-4</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-guidance-for-sponsors-transitioning-trials-to-ctr</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-guidance-for-sponsors-transitioning-trials-to-ctr-1</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=7988679c-7a79-477e-843d-73432171c705&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recent-improvements-in-ctis</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recent-improvements-in-ctis-1</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-consolidated-advice-pilots-2</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-consolidated-advice-pilots</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-consolidated-advice-pilots-1</loc><lastmod>2024-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=8112510a-e051-4457-b54a-018f066e5b62</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=5cc20331-ac3e-4706-93d7-4def1692c242&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-how-to-submit-a-transitional-trial-in-ctis-2</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-how-to-submit-a-transitional-trial-in-ctis-3</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-5</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-6</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-3</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-4</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-revised-transparency-rules-in-ctis-re-confirmed-for-18-june-2024-2</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-revised-transparency-rules-in-ctis-re-confirmed-for-18-june-2024-3</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=922e3559-c383-43bc-913b-e00542095342&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-revised-transparency-rules-in-ctis-re-confirmed-for-18-june-2024-1</loc><lastmod>2024-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-april-17-dia-adpromo-conference-select-highlights</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-april-17-dia-adpromo-conference-select-highlights-1</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recordings-posted-for-feb-mar-2024-rim-intelligent-automation-meetings</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recordings-posted-for-feb-mar-2024-rim-intelligent-automation-meetings-1</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=69511b6c-d348-4f2b-aa75-051b34ec8c0f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=7da187e9-62a2-4c1c-aa4a-e1c2ae690f77&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=1b7e4b09-e7a7-42e9-93a7-f41b7f226398&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=3346f309-4a63-4bf0-880a-e4cd1f7e02c2&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=8e9316ea-867d-49ec-af27-018eebbcce33&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=c15f6bce-6322-4fb4-8c33-a00b2c4a507a&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=dc969808-01b7-4cdd-9b7b-4074ba262f62&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2024-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-may-2024-2</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-may-2024</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-may-2024-1</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-days-left-to-submit-an-abstract-dia-canada-annual-meeting-abstract-submissions-close-april-18-3</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-days-left-to-submit-an-abstract-dia-canada-annual-meeting-abstract-submissions-close-april-18-1</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-days-left-to-submit-an-abstract-dia-canada-annual-meeting-abstract-submissions-close-april-18-2</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-days-left-to-submit-an-abstract-dia-canada-annual-meeting-abstract-submissions-close-april-18</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-and-recordings-of-transcelerates-webinar-on-enabling-individual-participant-data-return-ipdr-an-overview-of-transcelerates-individual-participant-data-return-package-3</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=5297ad0d-c3be-4bbe-b6b3-c8e42463818c&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-and-recordings-of-transcelerates-webinar-on-enabling-individual-participant-data-return-ipdr-an-overview-of-transcelerates-individual-participant-data-return-package-2</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-and-recordings-of-transcelerates-webinar-on-enabling-individual-participant-data-return-ipdr-an-overview-of-transcelerates-individual-participant-data-return-package-1</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-of-the-revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-2</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-of-the-revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-of-the-revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-1</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-webinar-last-year-of-transition-video-recording</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-webinar-last-year-of-transition-video-recording-1</loc><lastmod>2024-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=89db0806-e40d-4c6f-b98c-815f1e6e2ca1&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-apr-17-11am-et-genai-reg-intel-study-results-1</loc><lastmod>2024-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-centricity-engagementtopic-forthe-csp-community-meeting-on-april-18th</loc><lastmod>2024-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=c7a2d9b7-f0df-4939-9f0c-018ee2014fb6</loc><lastmod>2024-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-mtg-april-16th-12-pm-et-on-cloud-based-pharmaceutical-quality-knowledge-mgmt-system-by-accumulus</loc><lastmod>2024-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=a05e27ca-1380-46bb-a41c-018ed7553b67</loc><lastmod>2024-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/follow-up-and-recordings-from-the-april-pec-all-hands-meeting</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f271b590-1d6a-40f0-8cf8-d872792e1e6b&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-question-on-eu-clinical-trial-disclosure-and-data-transparency-conference-1</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hmaema-guidance-document-on-the-identification-of-pd-and-cci-within-the-structure-of-the-maa-dossier-2</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hmaema-guidance-document-on-the-identification-of-pd-and-cci-within-the-structure-of-the-maa-dossier-3</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hmaema-guidance-document-on-the-identification-of-pd-and-cci-within-the-structure-of-the-maa-dossier-1</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hmaema-guidance-document-on-the-identification-of-pd-and-cci-within-the-structure-of-the-maa-dossier</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=c0e31cc9-1198-42b2-b7aa-f3e239d6944a&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-april-17-12-1-pm-et-dia-adpromo-conference-highlights-1</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-revised-transparency-rules-in-ctis-18-jun-2024</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-q-submissions</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-q-submissions-1</loc><lastmod>2024-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-revised-transparency-rules-in-ctis-1</loc><lastmod>2024-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-revised-transparency-rules-in-ctis</loc><lastmod>2024-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-revised-transparency-rules-in-ctis-18-jun-2024-1</loc><lastmod>2024-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-march-2024</loc><lastmod>2024-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-march-2024-1</loc><lastmod>2024-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-updates-in-the-template-research-protocol-wmo</loc><lastmod>2024-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-updates-in-the-template-research-protocol-wmo-2</loc><lastmod>2024-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-updates-in-the-template-research-protocol-wmo-1</loc><lastmod>2024-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rwe-call-for-abstracts-is-open-1</loc><lastmod>2024-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c77868a4-b3e0-42fc-83b8-f1559ccf6536&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-resonse-letter-to-citizens-petition-1</loc><lastmod>2024-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-2</loc><lastmod>2024-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu</loc><lastmod>2024-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-1</loc><lastmod>2024-04-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-systems-disruption-expected-from-11-to-17-april-2</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-systems-disruption-expected-from-11-to-17-april</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-systems-disruption-expected-from-11-to-17-april-1</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/april-meeting-minutes</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hmaema-rwd-catalogues-features-and-bug-fixes-april-2024-1</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hmaema-rwd-catalogues-features-and-bug-fixes-april-2024</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=bf185116-c740-4921-b087-edf903b56a81&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-march-2024-2</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-march-2024-3</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-march-2024</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-clinical-research-glossary-march-2024-1</loc><lastmod>2024-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-2</loc><lastmod>2024-04-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=9d977a7f-c95f-4852-9c7e-4180e411c5a4&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-1</loc><lastmod>2024-04-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-dia-pm-community-2024-capabilities-caf-2</loc><lastmod>2024-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-enabling-individual-participant-data-return-ipdr-an-overview-of-transcelerates-individual-participant-data-return-package</loc><lastmod>2024-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-enabling-individual-participant-data-return-ipdr-an-overview-of-transcelerates-individual-participant-data-return-package-1</loc><lastmod>2024-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meeting-thursday-april-11-featuring-the-paladin-consortium</loc><lastmod>2024-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=25e88a28-604d-4106-b103-018e9fb02dfa</loc><lastmod>2024-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-wg-all-hands-12pm-et-apr-4</loc><lastmod>2024-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/artificial-intelligencemachine-learning-1</loc><lastmod>2024-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-securing-medical-writing-navigating-data-confidentiality-with-ai-innovations-2</loc><lastmod>2024-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-securing-medical-writing-navigating-data-confidentiality-with-ai-innovations-1</loc><lastmod>2024-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-securing-medical-writing-navigating-data-confidentiality-with-ai-innovations</loc><lastmod>2024-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-in-person-at-the-dia-global-clinical-trial-disclosure-and-data-transparency-conference-4</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-in-person-at-the-dia-global-clinical-trial-disclosure-and-data-transparency-conference-5</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-in-person-at-the-dia-global-clinical-trial-disclosure-and-data-transparency-conference-3</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-in-person-at-the-dia-global-clinical-trial-disclosure-and-data-transparency-conference-2</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-in-person-at-the-dia-global-clinical-trial-disclosure-and-data-transparency-conference</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-in-person-at-the-dia-global-clinical-trial-disclosure-and-data-transparency-conference-1</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-feb-apr-and-jun-2024-1</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-feb-apr-and-jun-2024</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-health-data-space-ehds-news-3</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d54ef7a9-23e3-48d3-8596-d48a1c0fe081&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-health-data-space-ehds-news-1</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-health-data-space-ehds-news-2</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=d41b946c-0580-48a2-a4eb-85ca0c072fd0&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-video-recording-how-to-submit-a-transition-trial-2</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=4cfc9e3c-91c3-465c-aa5e-722b0f9c4b38&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-video-recording-how-to-submit-a-transition-trial-1</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=85c6b853-5e9f-421c-aec6-a2c4dcc2f02b&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-april-17-dia-adpromo-conference-select-highlights-1</loc><lastmod>2024-04-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-clinical-trial-disclosure-and-data-transparency-think-tank</loc><lastmod>2024-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-clinical-trial-disclosure-and-data-transparency-think-tank-1</loc><lastmod>2024-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-becomes-first-country-to-release-detailed-data-on-sponsors-that-fail-to-register-clinical-trials</loc><lastmod>2024-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/information-commissioners-office-consultation-on-transparency-uk-hra</loc><lastmod>2024-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-first-substantial-modification-part-i</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-first-substantial-modification-part-i-1</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d3380412-28fc-47bc-a4ef-efdf77a71a2e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-first-substantial-modification-part-i-after-ctr-transition-1</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-now-open-for-dia-canada-annual-meeting-2</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstracts-now-open-for-dia-canada-annual-meeting-1</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=1f90b669-036d-4bdb-a0f3-fc1a1bd0d540&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=510d2fb6-73da-4526-9de0-e485b7ff799a&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2024-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cmc-ra-working-group-all-hands-call-wed-27-march-2</loc><lastmod>2024-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=1207e469-71d3-4f3b-893c-336aade03374&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2024-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/article-on-clinical-trial-results-on-clinical-trialsgov-limited-value-and-utility-to-patients-and-professionals</loc><lastmod>2024-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-to-provide-scientific-advice-prior-to-the-submission-of-an-investigation-file</loc><lastmod>2024-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ccmo-to-provide-scientific-advice-prior-to-the-submission-of-an-investigation-file-1</loc><lastmod>2024-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-2</loc><lastmod>2024-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users</loc><lastmod>2024-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-ctis-transparency-rules-historical-trials-and-interim-period-quick-guide-for-users-1</loc><lastmod>2024-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-management-board-highlights-of-march-2024-meeting-2</loc><lastmod>2024-03-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-management-board-highlights-of-march-2024-meeting</loc><lastmod>2024-03-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-management-board-highlights-of-march-2024-meeting-1</loc><lastmod>2024-03-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-wg-all-hands-12pm-et-apr-4-1</loc><lastmod>2024-03-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/follow-up-and-recordings-from-the-march-pec-all-hands-meeting</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/peru-guidance-document-for-reporting-clinical-trial-results-and-conclusions</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcgs-recommendation-paper</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcgs-recommendation-paper-1</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-9-day-left-to-submit-an-abstract-dia-latin-american-annual-meeting-4</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-9-day-left-to-submit-an-abstract-dia-latin-american-annual-meeting-2</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-9-day-left-to-submit-an-abstract-dia-latin-american-annual-meeting-1</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/just-9-day-left-to-submit-an-abstract-dia-latin-american-annual-meeting</loc><lastmod>2024-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cmc-ra-working-group-all-hands-call-wed-27-march</loc><lastmod>2024-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-is-live-dia-biostatistics-industry-and-regulator-forum</loc><lastmod>2024-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-on-content-of-clinical-investigation-plan</loc><lastmod>2024-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/artificial-intelligencemachine-learning</loc><lastmod>2024-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=6b7053df-3596-4b65-9092-018e606e5ea6</loc><lastmod>2024-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=3921368d-08be-44ee-a2dc-3f75addfb4a7&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2024-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-open-source-software-for-clinical-trial-reporting-and-regulatory-submissions-1</loc><lastmod>2024-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-march-20-will-x-mark-the-spot-opdp-research-and-more</loc><lastmod>2024-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-march-20-will-x-mark-the-spot-opdp-research-and-more-1</loc><lastmod>2024-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-plain-language-summaries-recording-slides-now-available-3</loc><lastmod>2024-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-plain-language-summaries-recording-slides-now-available-2</loc><lastmod>2024-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-plain-language-summaries-recording-slides-now-available</loc><lastmod>2024-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-plain-language-summaries-recording-slides-now-available-1</loc><lastmod>2024-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=d9f8770d-3e05-4331-a457-482cc7387647&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-clinical-trial-registration-report-2022</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-release-notes-march-19-2024</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-march-19-2024</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-compensation-research-1</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-compensation-research-2</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-which-parts-of-the-csr-are-made-public</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/article-on-clinical-trial-results-on-clinical-trialsgov-limited-value-and-utility-to-patients-and-professionals-1</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-12-dia-rpi-mtg-with-fdas-theresa-mullin</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/today-12-dia-rpi-mtg-with-fdas-theresa-mullin-1</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-compensation-research</loc><lastmod>2024-03-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ready-for-january-2025roadmap-to-ctis-compliance-webinar-on-32724</loc><lastmod>2024-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-monthly-meeting-thursday-march-21-6-pm-et</loc><lastmod>2024-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-monthly-meeting-thursday-march-21-6-pm-et-1</loc><lastmod>2024-03-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-regulatory-policy-and-intelligence-march-19th-at-12-est-with-theresa-mullin-fda</loc><lastmod>2024-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-march-20-12-pm-et-will-x-mark-the-spot-and-more-to-discuss-1</loc><lastmod>2024-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=9d1fe8e1-d8a6-4941-9cd4-674294805d39&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-make-it-public-week-18-22-march-2024-3</loc><lastmod>2024-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-make-it-public-week-18-22-march-2024</loc><lastmod>2024-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-make-it-public-week-18-22-march-2024-1</loc><lastmod>2024-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-make-it-public-week-18-22-march-2024-2</loc><lastmod>2024-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-pharma-legislation-reform</loc><lastmod>2024-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=33e94def-9038-4482-87b0-a4ff92862bf9&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/encepp-steering-group-sg-kick-off-meeting-for-the-2024-2026-term-minutes-1</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/m11-implementation-working-group-1</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-seats-left-quality-management-ethics-meets-compliance-07-apr-2024-aurora-co-3</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-seats-left-quality-management-ethics-meets-compliance-07-apr-2024-aurora-co-2</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-seats-left-quality-management-ethics-meets-compliance-07-apr-2024-aurora-co</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-seats-left-quality-management-ethics-meets-compliance-07-apr-2024-aurora-co-1</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-on-transition-trials-version-4-march-2024-2</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-on-transition-trials-version-4-march-2024</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-on-transition-trials-version-4-march-2024-1</loc><lastmod>2024-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-13-march-plain-language-documents-how-to-streamline-your-process-2</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-13-march-plain-language-documents-how-to-streamline-your-process-3</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-13-march-plain-language-documents-how-to-streamline-your-process</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/final-reminder-shared-learning-13-march-plain-language-documents-how-to-streamline-your-process-1</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-latin-america-annual-meeting-call-for-abstracts-open-4</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-latin-america-annual-meeting-call-for-abstracts-open-2</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-latin-america-annual-meeting-call-for-abstracts-open-1</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-latin-america-annual-meeting-call-for-abstracts-open</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-how-to-submit-a-transitional-trial-in-ctis-29-february-2024-2</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-how-to-submit-a-transitional-trial-in-ctis-29-february-2024</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-how-to-submit-a-transitional-trial-in-ctis-29-february-2024-1</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/question-on-results-for-transition-trials</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-call-is-one-hour-earlier-for-non-us-participants</loc><lastmod>2024-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thai-clinical-trials-registry-tctr-resumes-operations-march-11-2024</loc><lastmod>2024-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-opportunity-on-participant-data-return-in-clinical-trials-7</loc><lastmod>2024-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-opportunity-on-participant-data-return-in-clinical-trials-6</loc><lastmod>2024-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=187&amp;MessageKey=755fe1f9-1c9b-4506-ae3a-a229abbeec44&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f</loc><lastmod>2024-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-opportunity-on-participant-data-return-in-clinical-trials-5</loc><lastmod>2024-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=bbe94356-b5b3-4224-8a53-57216529f3b3&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-opportunity-on-participant-data-return-in-clinical-trials-3</loc><lastmod>2024-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-opportunity-on-participant-data-return-in-clinical-trials</loc><lastmod>2024-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-opportunity-on-participant-data-return-in-clinical-trials-1</loc><lastmod>2024-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-next-thursday-featuring-the-tigerlily-foundation-raise-platform</loc><lastmod>2024-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=355&amp;MessageKey=3166da0b-f01b-4a0d-a647-9b177c22bf77&amp;CommunityKey=0002e9c5-b799-4470-8ef3-018c26735bad</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/what-is-your-perspective-for-conducting-decentralized-clinical-trials-brief-survey-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/multi-stakeholder-webinar-on-the-hma-ema-catalogues-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/multi-stakeholder-webinar-on-the-hma-ema-catalogues</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-center-clinical-research-glossary-new-words-new-opportunities-2</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MessageKey=dd91ac70-3dbd-4f60-938d-f627f8c7b07e&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-pm-community-capabilities-cafe-technology-and-tools-for-pm-professionals-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-your-ai-experience-tell-us-in-2-minute-survey</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-your-ai-experience-tell-us-in-2-minute-survey-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=abf7032d-15a9-4660-893d-06307bd25278&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-meeting-minutes</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f198b54c-bc74-4acf-8e0f-ca42e4e9efbb&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dutch-trial-register-ltr-becomes-overview-of-medical-scientific-research-in-the-netherlands-omon-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-march-20-12pm-et-will-x-mark-the-spot-in-pharma-advertising</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-march-20-12pm-et-will-x-mark-the-spot-in-pharma-advertising-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-availabe-estimand-framework-in-multiple-tas</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-availabe-estimand-framework-in-multiple-tas-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-registration-link-for-shared-learning-plain-language-documents-how-to-streamline-your-process-2</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-registration-link-for-shared-learning-plain-language-documents-how-to-streamline-your-process-3</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-registration-link-for-shared-learning-plain-language-documents-how-to-streamline-your-process-1</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=07fd0499-aabe-4415-aefe-586c5297f5c4&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2024-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=8c19a6ad-67a5-44e9-8f2a-d30c82daca5a&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-recommends-participants-receive-key-trial-information-early-concisely-2</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-recommends-participants-receive-key-trial-information-early-concisely-3</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-recommends-participants-receive-key-trial-information-early-concisely</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-recommends-participants-receive-key-trial-information-early-concisely-1</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-improved-dia-biostatistics-industry-and-regulator-forum</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-improved-dia-biostatistics-industry-and-regulator-forum-1</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-improved-dia-biostatistics-industry-and-regulator-forum-in-2024</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/proposed-regulation-on-european-health-data-space-ehds-1</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/proposed-regulation-on-european-health-data-space-ehds</loc><lastmod>2024-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-regulation-5362014-in-practice-2</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-regulation-5362014-in-practice-1</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-regulation-5362014-in-practice</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=1415398d-4d37-4eda-b2d0-54a376865ea7&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recommendations-on-the-use-of-auxiliary-medicinal-products-in-clinical-trials-1</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-5</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-6</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-68-2</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-68-3</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-68-1</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-5362014-qa-version-68</loc><lastmod>2024-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MessageKey=04bd7084-861e-45f9-85a9-470512a01ae9&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-plain-language-documents-how-to-streamline-your-process-3</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-plain-language-documents-how-to-streamline-your-process</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-plain-language-documents-how-to-streamline-your-process-1</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-resource-databases</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-resource-databases-1</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=4c7a8c1f-773d-4d05-bf28-1a78b2506619&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mrct-center-clinical-research-glossary-new-words-new-opportunities-1</loc><lastmod>2024-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f8af15ff-b2cb-4a65-9655-a0d827553eaf&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-training-for-non-commercial-sponsors-transitioning-trials-to-the-ctr-ctis-4</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-training-for-non-commercial-sponsors-transitioning-trials-to-the-ctr-ctis-5</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=f81292fe-59be-444c-90d1-6ea8e80583ee&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-missing-nordic-trials-how-can-we-avoid-research-waste-and-meet-ethical-standards</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-new-templates-for-substantial-modifications-sm-2</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-new-templates-for-substantial-modifications-sm-1</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-new-templates-for-substantial-modifications-sm</loc><lastmod>2024-02-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/multi-stakeholder-webinar-on-the-hma-ema-catalogues-2</loc><lastmod>2024-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pharma-data-science-conference-march-18-19-2024-1</loc><lastmod>2024-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-committee-meeting-minutes-feb-2024</loc><lastmod>2024-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/open-call-for-volunteers-to-join-the-gcp-qa-decentralized-clinical-trial-working-group-1</loc><lastmod>2024-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-march-2024-2</loc><lastmod>2024-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-gives-mixed-response-to-greater-clinical-trial-transparency</loc><lastmod>2024-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-gives-mixed-response-to-greater-clinical-trial-transparency-1</loc><lastmod>2024-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-evaluation-timelines-version-20-feb-2024-3</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-evaluation-timelines-version-20-feb-2024-2</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-evaluation-timelines-version-20-feb-2024-1</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=72ca5a61-9669-49de-b103-d725c31745cb&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;tab=digestviewer</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=599eede0-3501-42c3-87d2-bfacdf4f8407&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;tab=digestviewer</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-materials-latest-updates</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-materials-latest-updates-1</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-information-forums-health-literacy-checklist-2</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-information-forums-health-literacy-checklist</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-information-forums-health-literacy-checklist-1</loc><lastmod>2024-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/testing-the-new-dia-marketplace</loc><lastmod>2024-02-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/testing-the-new-dia-marketplace-1</loc><lastmod>2024-02-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-22-feb-2024</loc><lastmod>2024-02-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/presentation-on-transition-trials</loc><lastmod>2024-02-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=38c23fea-9ac4-477b-9355-c41d2d1716da&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-feb-21-kisqali-ul-deep-dive-senators-to-fda-on-social-media-and-more-1</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-feb-20-2024</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-clinical-trials-update-feb-20-2024-1</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-feb-21-2024</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-short-course-next-week-join-us</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=211b310e-2cd3-4083-8a63-905130bc065f&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-gene-therapy-essentials-for-clinical-research-professionals-presentation-1</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-feb-21-weavebio-genai-guest-speaker</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-webinar-last-year-of-transition-25-march-2024-2</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=fb0554a4-5bba-4530-b194-776b5da6641e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-webinar-last-year-of-transition-25-march-2024-1</loc><lastmod>2024-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-pec-all-meeting-next-thursday-on-ai-in-patient-engagement</loc><lastmod>2024-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=45ac2160-195c-42a1-a695-69e37148a114&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-issue-18-february-2024-1</loc><lastmod>2024-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-issue-18-february-2024</loc><lastmod>2024-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-issue-18-february-2024-2</loc><lastmod>2024-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/calling-all-global-labeling-professionals</loc><lastmod>2024-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-community-survey-organizational-affiliation-scope-assessemet-1</loc><lastmod>2024-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=378c24b2-39cb-4ce6-8009-53f1989a87a1&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-feb-21-12-pm-updated-agenda-guest-presenter-opdp-ul-discussion-1</loc><lastmod>2024-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-version-5-07-feb-24</loc><lastmod>2024-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-modernization-transition-top-questions</loc><lastmod>2024-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-eu-ctr-frequently-asked-questions-2</loc><lastmod>2024-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-eu-ctr-frequently-asked-questions</loc><lastmod>2024-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-eu-ctr-frequently-asked-questions-1</loc><lastmod>2024-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-new-hma-ema-catalogues-of-real-world-data-sources-and-studies-feb-15-2024-2</loc><lastmod>2024-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-new-hma-ema-catalogues-of-real-world-data-sources-and-studies-feb-15-2024</loc><lastmod>2024-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/launch-of-new-hma-ema-catalogues-of-real-world-data-sources-and-studies-feb-15-2024-1</loc><lastmod>2024-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-february-2024-monthly-meeting-feb-15-6-pm-et-2</loc><lastmod>2024-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2024-february-meeting</loc><lastmod>2024-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-join-us-on-tuesday-february-13th-for-our-monthly-conference-call</loc><lastmod>2024-02-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-february-2024-monthly-meeting-feb-15-6-pm-et-3</loc><lastmod>2024-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-february-2024-monthly-meeting-feb-15-6-pm-et-1</loc><lastmod>2024-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-february-2024-monthly-meeting-feb-15-6-pm-et</loc><lastmod>2024-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-clinical-trials-analytics-workshop-january-2024-2</loc><lastmod>2024-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-clinical-trials-analytics-workshop-january-2024-1</loc><lastmod>2024-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-clinical-trials-analytics-workshop-january-2024</loc><lastmod>2024-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/open-call-for-volunteers-to-join-the-gcp-qa-decentralized-clinical-trial-working-group</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-policy-and-intelligence-march-19th-theresa-mullins-fda</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=89569931-2095-48ef-aa1f-018d8f746854</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=d7d8e342-9cb1-4e11-9b66-018d8a57c8fc&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4&amp;Home=%2fevents%2fevent-description</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-how-to-get-started-and-how-to-transition-a-trial</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-how-to-get-started-and-how-to-transition-a-trial-2</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-how-to-get-started-and-how-to-transition-a-trial-1</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-disclosure-community-survey-organizational-affiliation-scope-assessemet</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/user-guide-for-sme-enterprises-2</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=441663f2-3793-429b-b36b-456a9f0e508d&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/user-guide-for-sme-enterprises-1</loc><lastmod>2024-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-feb-21-weavebio-genai-guest-speaker-1</loc><lastmod>2024-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/uk-hra-updates-disclosure-policy-note-ctis-not-accepted-as-only-registry-for-ukeu-trials</loc><lastmod>2024-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-dia-pm-community-2024-capabilities-caf-3</loc><lastmod>2024-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-updated-glossary-of-terms-and-definitions-2</loc><lastmod>2024-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-dia-regulatory-policy-and-intelligence-mtg-with-theresa-mullin-319</loc><lastmod>2024-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-feb-06-2024</loc><lastmod>2024-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=8b0e0aed-9149-475e-a7ef-731ddea9e8cd&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-draft-guidance-on-collection-of-race-and-ethnicity-data</loc><lastmod>2024-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-1</loc><lastmod>2024-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-2</loc><lastmod>2024-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme</loc><lastmod>2024-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rsidm-dont-miss-it</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rsidm-dont-miss-it-1</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-dont-miss-this-2</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-dont-miss-this-3</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-dont-miss-this-1</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-beta-feb-06-2024</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/all-hands-meeting-11-jan-2024-recording-slides-now-available-2</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/all-hands-meeting-11-jan-2024-recording-slides-now-available-3</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/all-hands-meeting-11-jan-2024-recording-slides-now-available</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/all-hands-meeting-11-jan-2024-recording-slides-now-available-1</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/accord-guidelines-1</loc><lastmod>2024-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-feb-21-12-1-pm-et-opdp-untitled-letter-and-more</loc><lastmod>2024-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-feb-21-12-1-pm-et-opdp-untitled-letter-and-more-1</loc><lastmod>2024-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-gene-therapy-essentials-for-clinical-research-professionals-1</loc><lastmod>2024-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-shared-learning-gene-therapy-essentials-for-clinical-research-professionals</loc><lastmod>2024-02-04</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=f1e457d5-7063-459e-ae03-018d6edcdfa2</loc><lastmod>2024-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2024-call-for-roundtables-and-content-hubs-are-open-submit-today</loc><lastmod>2024-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-training-for-non-commercial-sponsors-transitioning-trials-to-the-ctr-ctis</loc><lastmod>2024-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-training-for-non-commercial-sponsors-transitioning-trials-to-the-ctr-ctis-1</loc><lastmod>2024-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=3209c41d-e89b-4cf6-a514-043622afa927&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-31-jan-2024-1</loc><lastmod>2024-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-31-jan-2024</loc><lastmod>2024-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-ctis-transparency-rules-ctis-newsflash-jan-26-2024</loc><lastmod>2024-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-ctis-transparency-rules-ctis-newsflash-jan-26-2024-1</loc><lastmod>2024-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctti-and-fda-share-strategies-for-improving-timely-accurate-and-complete-disclosure-of-applicable-clinical-trials-on-clinicaltrialsgov</loc><lastmod>2024-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/availability-of-results-of-clinical-trials-registered-on-eu-clinical-trials-register-cross-sectional-audit-study</loc><lastmod>2024-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=2cf014cc-be2f-433c-9b25-6d823b4fea01&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-transition-to-new-eu-system-one-year-left-1</loc><lastmod>2024-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=c34bf4ee-ebf0-47a4-b058-6046c2fb3a59&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2024-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transparency-in-research-our-focus-for-2024-hras-blog-post</loc><lastmod>2024-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2024-meetings</loc><lastmod>2024-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=1a3e67e8-789c-4227-b23b-650fd59a4916&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-fda-draft-guidance-documents</loc><lastmod>2024-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-fda-draft-guidance-documents-1</loc><lastmod>2024-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/getting-started-with-ctis-sponsor-quick-guide-jan-29-2024-2</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/getting-started-with-ctis-sponsor-quick-guide-jan-29-2024</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/getting-started-with-ctis-sponsor-quick-guide-jan-29-2024-1</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-meeting-schedule-details-released-2</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-meeting-schedule-details-released</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-0070prcifoia-subgroup-meeting-schedule-details-released-1</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hra-policy-on-registration-of-ctimps-taking-place-in-the-uk-and-eu</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-of-the-icmje-recommendations-22-jan-2024</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/december-2023-report-on-the-implementation-of-the-clinical-trials-regulation-ctr-2</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/december-2023-report-on-the-implementation-of-the-clinical-trials-regulation-ctr-1</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/december-2023-report-on-the-implementation-of-the-clinical-trials-regulation-ctr</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=a8dc2ca6-0c95-4fce-90cb-13ca4134ade7&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/access-to-the-ctis-training-environment</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/access-to-the-ctis-training-environment-1</loc><lastmod>2024-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=5d412358-095a-447c-b0e8-bb9343640220&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fdas-joint-public-meeting-on-improving-the-quality-of-clinical-studies-1</loc><lastmod>2024-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rn-with-gen-ai-experience-open-to-work</loc><lastmod>2024-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rn-with-gen-ai-experience-open-to-work-1</loc><lastmod>2024-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-update-jan-26-2024-2</loc><lastmod>2024-01-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-update-jan-26-2024-1</loc><lastmod>2024-01-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-update-jan-26-2024</loc><lastmod>2024-01-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-training-for-non-commercial-sponsors-transitioning-trials-to-the-ctr-ctis-2</loc><lastmod>2024-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-understanding-estimand-framework-applications-in-multiple-therapeutic-areas-28-feb-2024-10am-est-2</loc><lastmod>2024-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-understanding-estimand-framework-applications-in-multiple-therapeutic-areas-28-feb-2024-10am-est-1</loc><lastmod>2024-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-understanding-estimand-framework-applications-in-multiple-therapeutic-areas-28-feb-2024-10am-est</loc><lastmod>2024-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/amendment-to-harmonize-part-i-documents-of-a-multinational-trial-1</loc><lastmod>2024-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=a5d44385-fdf2-4919-9d81-b360085a487e&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2024-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/what-say-you-call-for-topics-is-now-open-1</loc><lastmod>2024-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/what-say-you-call-for-topics-is-now-open</loc><lastmod>2024-01-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-round-table-plus-invitation-to-in-person-events-hartford-and-private</loc><lastmod>2024-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-round-table-plus-invitation-to-in-person-events-hartford-and-private-1</loc><lastmod>2024-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/national-medical-research-register-nmrr-malaysia-updates-16-january-2024</loc><lastmod>2024-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-sponsor-end-user-training-programme-feb-apr-and-jun-2024-2</loc><lastmod>2024-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-jan-17</loc><lastmod>2024-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-jan-17-1</loc><lastmod>2024-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=6157adcc-486b-4895-942e-934555251269&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/notices-of-noncompliance-and-civil-money-penalty-actions</loc><lastmod>2024-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/outcome-of-the-second-survey-on-ctr-and-ctis-nov-2023</loc><lastmod>2024-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/outcome-of-the-second-survey-on-ctr-and-ctis-nov-2023-1</loc><lastmod>2024-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-january-18-2024-6pm-et</loc><lastmod>2024-01-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-january-18-2024-6pm-et-1</loc><lastmod>2024-01-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-jan-17-12-pm-et-hot-topics-including-lets-chat</loc><lastmod>2024-01-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-jan-17-12-pm-et-hot-topics-including-lets-chat-1</loc><lastmod>2024-01-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-meeting-17-jan-11am-et-guest-speaker-2</loc><lastmod>2024-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-meeting-17-jan-11am-et-guest-speaker-3</loc><lastmod>2024-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-meeting-17-jan-11am-et-guest-speaker</loc><lastmod>2024-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-meeting-17-jan-11am-et-guest-speaker-1</loc><lastmod>2024-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-hands-meetings-calendar-invitation-and-zoom-info</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/1st-2024-mtg-on-feb-15-for-policy-0070prcifoia-subgroup</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=80a91d41-6dd1-41d9-83d5-018cff84552e</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/list-of-national-contact-points-for-eu-eu-ctiseu-ctr-5362014-2</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=1f60036e-bff5-4123-8d5e-ff7206309b21&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/list-of-national-contact-points-for-eu-eu-ctiseu-ctr-5362014-1</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-4</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=0f763fbe-47c4-4769-a17f-1d25f0c19bbf&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-3</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/january-regulatory-intelligence-and-policy-meeting</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/how-long-to-process-amendment-to-harmonize-part-i-documents-of-a-multinational-trial</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-training-environment-new-version</loc><lastmod>2024-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rsidm-advance-rates-expiring-friday-1</loc><lastmod>2024-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rsidm-advance-rates-expiring-friday</loc><lastmod>2024-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-csp-community-meeting-on-january-18th-2024</loc><lastmod>2024-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/february-8-from-11-12-est-artificial-intelligence-in-patient-engagement</loc><lastmod>2024-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/february-8-from-11-12-est-artificial-intelligence-in-patient-engagement-1</loc><lastmod>2024-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-experience-spfq-frequently-asked-questions</loc><lastmod>2024-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-experience-spfq-frequently-asked-questions-1</loc><lastmod>2024-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-bitesize-talk-training-materials-ctis-pre-requisites-and-updates-on-transparency-rules-4</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=64575bdf-1ce3-4f7a-9b65-57952fa8bbd0&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/no-january-pec-all-meeting-save-the-date-for-february</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-dr-peter-marks-and-talk-cell-gene-therapy</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-all-hands-mw-community-meeting-thurs-11-jan-2024-4-pm-us-et-3</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-running-out-to-save-on-dias-adpromo-conference</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-all-hands-mw-community-meeting-thurs-11-jan-2024-4-pm-us-et</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-all-hands-mw-community-meeting-thurs-11-jan-2024-4-pm-us-et-2</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-all-hands-mw-community-meeting-thurs-11-jan-2024-4-pm-us-et-1</loc><lastmod>2024-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-jan-09-2024</loc><lastmod>2024-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-join-us-on-tuesday-january-9th-for-our-monthly-conference-call</loc><lastmod>2024-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-jan-17-12-pm-et-hot-topics</loc><lastmod>2024-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-jan-17-12-pm-et-hot-topics-1</loc><lastmod>2024-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-ticking-masc-early-bird-is-expiring-1</loc><lastmod>2024-01-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/time-is-ticking-masc-early-bird-is-expiring-2</loc><lastmod>2024-01-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-gene-therapy-essentials-for-clinical-research-professionals-2</loc><lastmod>2024-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-gene-therapy-essentials-for-clinical-research-professionals-3</loc><lastmod>2024-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-gene-therapy-essentials-for-clinical-research-professionals-1</loc><lastmod>2024-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=5055c82a-896f-4fdf-ba65-3e9be076da0e&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2024-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=27cb94f8-717a-4630-9e6d-018ce00df4b0</loc><lastmod>2024-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/bridging-clinical-trial-innovation-and-biostatistics</loc><lastmod>2024-01-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/bridging-clinical-trial-innovation-and-biostatistics-1</loc><lastmod>2024-01-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=4eafd28e-0d25-4b26-9489-f9b6688535fc&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2024-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/jj-positions-ai-and-patient-engagement</loc><lastmod>2024-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/jj-positions-ai-and-patient-engagement-1</loc><lastmod>2024-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/action-required-new-ctd-monthly-call-info-posted-please-note-the-new-id-and-passcode</loc><lastmod>2024-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=e5917e3b-f3a4-48db-8ba2-018cca6155e0</loc><lastmod>2024-01-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/all-hands-mw-community-meeting-thurs-11-jan-2024-4-pm-us-et</loc><lastmod>2023-12-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=da0b2693-28e8-4eb4-b0b9-fd5d37f7ba6f&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2023-12-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/all-hands-mw-community-meeting-thurs-11-jan-2024-4-pm-us-et-1</loc><lastmod>2023-12-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=761f27e9-5a6a-45e6-88db-ca35274174dc&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-12-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-walk-in-clinic-24-january-2024-1</loc><lastmod>2023-12-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2024-list-of-official-public-holidays-in-the-eu</loc><lastmod>2023-12-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2024-list-of-official-public-holidays-in-the-eu-1</loc><lastmod>2023-12-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/2024-list-of-official-public-holidays-in-the-eu-2</loc><lastmod>2023-12-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulation-eu-5362014-quick-guide-for-sponsors-and-qa-version-67-21-dec-2023-2</loc><lastmod>2023-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulation-eu-5362014-quick-guide-for-sponsors-and-qa-version-67-21-dec-2023-3</loc><lastmod>2023-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulation-eu-5362014-quick-guide-for-sponsors-and-qa-version-67-21-dec-2023</loc><lastmod>2023-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulation-eu-5362014-quick-guide-for-sponsors-and-qa-version-67-21-dec-2023-1</loc><lastmod>2023-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-approves-final-version-of-2-rwe-guidelines</loc><lastmod>2023-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgov-prs-beta-release-notes-dec-14-2023</loc><lastmod>2023-12-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-13-of-act-eu-question-answer-qa-on-the-protection-of-commercially-confidential-information-and-personal-data-published</loc><lastmod>2023-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=e5391ba8-65c0-4f34-ad05-018c83b2b3c5</loc><lastmod>2023-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-results-training-environment</loc><lastmod>2023-12-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-results-training-environment-1</loc><lastmod>2023-12-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/early-bird-rates-expiring-regulatory-submissions-information-and-document-management-rsidm-forum</loc><lastmod>2023-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/early-bird-rates-expiring-regulatory-submissions-information-and-document-management-rsidm-forum-1</loc><lastmod>2023-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-call-for-posters-deadline-today-2</loc><lastmod>2023-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-masc-call-for-posters-deadline-today-1</loc><lastmod>2023-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/jolabokaflod-recommendations</loc><lastmod>2023-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=c495c628-4eb7-4317-98ee-6ebc44ed2083&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-dec-14-2023-ccn-final-rule-rsa-webinar-2023-opdp-trends-and-more-1</loc><lastmod>2023-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=7466ec19-5e80-48a8-a6b1-5b9c7ee958ce&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2023-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/artificial-intelligence-insights-sought-use-in-patient-engagement-clinical-development-1</loc><lastmod>2023-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=224a923a-f2a7-4d73-b3c5-d6df53a9dab3&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-dec-14-note-date-12-pm-1-pm-1</loc><lastmod>2023-12-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=4b99b7bd-fedf-4296-8053-2403e9b9bcc3&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-user-support-service-and-updates-to-oms-2</loc><lastmod>2023-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d489d1ee-4275-43ef-9ef7-083b75d68b5e&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-user-support-service-and-updates-to-oms-1</loc><lastmod>2023-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/winter-clock-stop-ctis</loc><lastmod>2023-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/winter-clock-stop-ctis-1</loc><lastmod>2023-12-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-pas-register-migrating-to-the-new-ema-hma-catalogue-of-studies</loc><lastmod>2023-12-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-thursday-1214-our-annual-jolabokaflod-gathering</loc><lastmod>2023-12-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-pre-notices-of-non-compliance-now-published-on-their-website-1</loc><lastmod>2023-12-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-pre-notices-of-non-compliance-now-published-on-their-website</loc><lastmod>2023-12-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/holiday-savings-expiring-soon-4</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/holiday-savings-expiring-soon-3</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/holiday-savings-expiring-soon-6</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/holiday-savings-expiring-soon</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/holiday-savings-expiring-soon-1</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/holiday-savings-on-specialty-meetings</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/holiday-savings-on-specialty-meetings-1</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/general-guidance-on-anonymisation-of-ppd-andassessment-of-cciduring-the-preparation-of-rmps-mainbody-and-annexes-4-and-6</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/general-guidance-on-anonymisation-of-ppd-andassessment-of-cciduring-the-preparation-of-rmps-mainbody-and-annexes-4-and-6-1</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anonymisation-of-ppd-and-assessment-of-cci-during-the-preparation-of-rmps-main-body-and-annexes-4-and-6</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/anonymisation-of-ppd-and-assessment-of-cci-during-the-preparation-of-rmps-main-body-and-annexes-4-and-6-1</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clarification-question-on-revised-rules-for-historical-trials</loc><lastmod>2023-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-corporate-website-re-launch</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/year-end-savings-on-certification-programs</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-in-person-short-course-short-course-good-pharmacovigilance-practices-gvp-operations-development-from-clinical-trial-to-post-marketing</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-in-person-event-philadelphia-1</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=349&amp;MessageKey=5940ee96-c280-4933-9d54-7ebe69d3e458&amp;CommunityKey=761a544b-eee9-494f-b450-01894b896649</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/end-of-year-savings-on-certificate-programs</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/end-of-year-savings-on-certificate-programs-1</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/the-importance-of-clinical-trial-transparency-and-fda-oversight</loc><lastmod>2023-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-december-2023</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-december-2023-1</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-walk-in-clinic-december-2023-2</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=8be28af2-e671-4331-8877-a1936f77af98&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-review-implementation-of-estimands-ich-e9-r1-using-data-standards-white-paper-1</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-revised-ctis-transparency-rules-2</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-revised-ctis-transparency-rules</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-revised-ctis-transparency-rules-1</loc><lastmod>2023-12-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rbqm</loc><lastmod>2023-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=4b2c4ef5-1589-4c3d-bdd4-018c26d8bd66&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2023-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-meeting-for-2023-december-5-2023-11-am-et</loc><lastmod>2023-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-community-meeting-for-2023-december-5-2023-11-am-et-1</loc><lastmod>2023-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-nov-30-2023</loc><lastmod>2023-11-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-13-of-act-eu-question-answer-qa-on-the-protection-of-commercially-confidential-information-and-personal-data-published-2</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-13-of-act-eu-question-answer-qa-on-the-protection-of-commercially-confidential-information-and-personal-data-published-3</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-version-13-of-act-eu-question-answer-qa-on-the-protection-of-commercially-confidential-information-and-personal-data-published-1</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-dia-inspire-awards-for-2024-americas</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-dia-inspire-awards-for-2024-americas-1</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-for-the-dia-inspire-awards-for-2024-americas-5</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-for-the-dia-inspire-awards-for-2024-americas-6</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-for-the-dia-inspire-awards-for-2024-americas-3</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-for-the-dia-inspire-awards-for-2024-americas-4</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-for-the-dia-inspire-awards-for-2024-americas-1</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-for-the-dia-inspire-awards-for-2024-americas-2</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-nominations-for-the-dia-inspire-awards-for-2024-americas</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/posting-ai-generated-pls</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/posting-ai-generated-pls-1</loc><lastmod>2023-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-transition-trials-november-2023-2</loc><lastmod>2023-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-transition-trials-november-2023</loc><lastmod>2023-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcg-best-practice-guide-for-sponsors-transition-trials-november-2023-1</loc><lastmod>2023-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=439a7690-082d-4b4d-aa38-6eb9066820a2&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-dec-14-12-pm-et-hot-topics-1</loc><lastmod>2023-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-training-environment</loc><lastmod>2023-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-training-environment-1</loc><lastmod>2023-11-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=d4f4dab2-17d0-4c77-87d6-11f78c7e2c45&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2023-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-utilization-of-historical-trial-data-in-drug-development-webinar-17th-nov-2023</loc><lastmod>2023-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-utilization-of-historical-trial-data-in-drug-development-webinar-17th-nov-2023-1</loc><lastmod>2023-11-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-workplan-for-2023-2026-published-updated-timelines-for-new-transparency-rules</loc><lastmod>2023-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=7df10f6e-eaeb-4b2f-8459-e8677a363f85&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/no-health-canada-shutdown-at-eoy-1</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/no-health-canada-shutdown-at-eoy</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-workplan-for-2023-2026-published-updated-timelines-for-new-transparency-rules-2</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/act-eu-workplan-for-2023-2026-published-updated-timelines-for-new-transparency-rules-1</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-available-utilization-of-historical-trial-data-in-drug-development-webinar-17th-nov-2023</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-available-utilization-of-historical-trial-data-in-drug-development-webinar-17th-nov-2023-1</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-committee-meeting-minutes-03-nov-2023</loc><lastmod>2023-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-dia-pm-community-2024-capabilities-caf</loc><lastmod>2023-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-dia-pm-community-2024-capabilities-caf-1</loc><lastmod>2023-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/duke-margolis-fda-workshop-on-qbd-and-rbqm-hybrid-event</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/duke-margolis-fda-workshop-on-qbd-and-rbqm-hybrid-event-1</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrials-prs-beta-16-nov-2023</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-policy-0070-response-to-questions</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-on-training-materials-ctis-pre-requisites-and-updates-on-transparency-rules-1</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-on-training-materials-ctis-pre-requisites-and-updates-on-transparency-rules</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-policy-0070-response-to-questions-2</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-policy-0070-response-to-questions-3</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-policy-0070-response-to-questions-1</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-classic-clinicaltrialsgov-website-1</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-classic-clinicaltrialsgov-website</loc><lastmod>2023-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-nov-15-siuu-draft-guidance-two-opdp-letters-and-more</loc><lastmod>2023-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-nov-15-siuu-draft-guidance-two-opdp-letters-and-more-1</loc><lastmod>2023-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctrctis-wg-meeting-21-nov-2023-cancellation</loc><lastmod>2023-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-shared-learning-webinar-ai-and-med-writing-01-nov-2023-2</loc><lastmod>2023-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-shared-learning-webinar-ai-and-med-writing-01-nov-2023-3</loc><lastmod>2023-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-available-shared-learning-webinar-ai-and-med-writing-01-nov-2023-1</loc><lastmod>2023-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=31b972a2-de30-4515-b64f-db39ca81694e&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2023-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/thai-clinical-trials-registry-tctr-close-down</loc><lastmod>2023-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-nov-15-11am-et-hackathon-solutioning-2</loc><lastmod>2023-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-nov-15-11am-et-hackathon-solutioning-3</loc><lastmod>2023-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-nov-15-11am-et-hackathon-solutioning</loc><lastmod>2023-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-nov-15-11am-et-hackathon-solutioning-1</loc><lastmod>2023-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-system-issues-with-uploading-documents-2</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-system-issues-with-uploading-documents</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-system-issues-with-uploading-documents-1</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-on-fda-user-fees-by-cders-angela-granum-nov-21st-12-noon-est</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/petition-to-increase-diversity-in-clinical-trials</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-csp-community-meeting-on-november-16th</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=403ac40d-6ff9-4a2b-a011-018bc75f770e</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=b57d35f6-4fed-45a5-a432-0af2283e58cf&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-interdisciplinary-safety-evaluation-for-learning-and-decision-making-education-for-executives-16-november-at-1000-et-1</loc><lastmod>2023-11-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-nov-15-12-pm-updated-agenda-added-two-recent-opdp-uls-1</loc><lastmod>2023-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-nov-15-12-pm-updated-agenda-added-two-recent-opdp-uls-2</loc><lastmod>2023-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-expedited-procedure-for-transitioning-trials-to-ctis-and-winter-clock-stop</loc><lastmod>2023-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updates-expedited-procedure-for-transitioning-trials-to-ctis-and-winter-clock-stop-1</loc><lastmod>2023-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-ctis-not-available-from-1800-cet-today-until-0700-cet-on-monday-13-nov-2</loc><lastmod>2023-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-ctis-not-available-from-1800-cet-today-until-0700-cet-on-monday-13-nov</loc><lastmod>2023-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-ctis-not-available-from-1800-cet-today-until-0700-cet-on-monday-13-nov-1</loc><lastmod>2023-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/help-develop-dia-ai-poll</loc><lastmod>2023-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/help-develop-dia-ai-poll-1</loc><lastmod>2023-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=e7c2f4dd-af32-4f17-9ac7-c788449e1fd7&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-11-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-unplanned-system-downtime-2</loc><lastmod>2023-11-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-unplanned-system-downtime-1</loc><lastmod>2023-11-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updates-to-training-modules-10-and-13-for-eu-ctis-nov-2023-2</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=cfcab2fc-bd6e-47fb-91d8-5424eb895f45&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updates-to-training-modules-10-and-13-for-eu-ctis-nov-2023-1</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-v303-nov-06-2023-2</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-v303-nov-06-2023-3</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=9ce1dd89-1bad-47b2-b7f3-895499dd34a8&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trial-information-system-ctis-sponsor-handbook-v303-nov-06-2023-1</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-bitesize-talk-training-materials-ctis-pre-requisites-and-updates-on-transparency-rules-2</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-bitesize-talk-training-materials-ctis-pre-requisites-and-updates-on-transparency-rules</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-bitesize-talk-training-materials-ctis-pre-requisites-and-updates-on-transparency-rules-1</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-this-thursday-november-9</loc><lastmod>2023-11-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudamed-updates</loc><lastmod>2023-11-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-pregnancy-and-lactation-how-are-we-going-to-get-useful-data-5</loc><lastmod>2023-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-pregnancy-and-lactation-how-are-we-going-to-get-useful-data-6</loc><lastmod>2023-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-pregnancy-and-lactation-how-are-we-going-to-get-useful-data-4</loc><lastmod>2023-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-pregnancy-and-lactation-how-are-we-going-to-get-useful-data-2</loc><lastmod>2023-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-pregnancy-and-lactation-how-are-we-going-to-get-useful-data-3</loc><lastmod>2023-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-pregnancy-and-lactation-how-are-we-going-to-get-useful-data-1</loc><lastmod>2023-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-pregnancy-and-lactation-how-are-we-going-to-get-useful-data</loc><lastmod>2023-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-in-person-event-seattle-wa</loc><lastmod>2023-11-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-narratives-for-csr-1</loc><lastmod>2023-10-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-personalized-clinical-trials-framework</loc><lastmod>2023-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-personalized-clinical-trials-framework-1</loc><lastmod>2023-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=5b0d8a6b-d559-49fb-b29c-d3bd34a810ac&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-nov-15-12-1-pm-et-fda-revised-draft-guidance-on-siuu-and-more-1</loc><lastmod>2023-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faqs-on-hras-quality-standards-and-design-and-review-principles</loc><lastmod>2023-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/faqs-on-hras-quality-standards-and-design-and-review-principles-1</loc><lastmod>2023-10-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-i-share-external-webinars-on-complementary-topics</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/missed-todays-cross-dia-pm-legal-communities-capability-cafe</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transition-trials-and-tips-for-eu-ctis-users-2</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transition-trials-and-tips-for-eu-ctis-users-1</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d1c50afd-bf6d-48b9-ace1-300baba1d963&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d52e46e9-b4f7-4d8e-aa00-3e12e4ac1e55&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-transparency-rules-for-the-eu-clinical-trials-information-system-ctis-1</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=057fd4b9-3907-4fda-83b9-28c4f623d6a4&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/documents-related-to-transparency-rules-1</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/documents-related-to-transparency-rules</loc><lastmod>2023-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MessageKey=8eb3d092-e792-4d81-a526-3f8fc7f15095&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2023-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-for-01-nov-2023-shared-learning-ai-in-medical-writing-and-intro-to-the-new-dia-ai-community-3</loc><lastmod>2023-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-for-01-nov-2023-shared-learning-ai-in-medical-writing-and-intro-to-the-new-dia-ai-community-1</loc><lastmod>2023-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-for-01-nov-2023-shared-learning-ai-in-medical-writing-and-intro-to-the-new-dia-ai-community</loc><lastmod>2023-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recordings-from-the-october-2023-meeting</loc><lastmod>2023-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-ai-in-medical-writing-and-intro-to-the-new-dia-ai-community-2</loc><lastmod>2023-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-ai-in-medical-writing-and-intro-to-the-new-dia-ai-community-3</loc><lastmod>2023-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=c340b215-96bc-483c-b5bf-0caa67ddb5e0&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2023-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-shared-learning-ai-in-medical-writing-and-intro-to-the-new-dia-ai-community-1</loc><lastmod>2023-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=8d0ad540-91ea-467f-aee0-cada8e855964&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2023-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MessageKey=fcdca875-56fb-4577-81b8-24bc11188c76&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2023-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-short-course-available-introduction-to-statistics-in-pharmacovigilance-2</loc><lastmod>2023-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-short-course-available-introduction-to-statistics-in-pharmacovigilance-3</loc><lastmod>2023-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=8bc90008-bc07-4428-b838-d73a9d572022&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2023-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-short-course-available-introduction-to-statistics-in-pharmacovigilance-1</loc><lastmod>2023-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/psis-journal-club-presents-bayesian-approaches-in-efficacy-and-safety-thursday-9th-november-2023-4-5pm-gmt-1</loc><lastmod>2023-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=08e747b6-8784-46e0-8a78-cfbf6e7e4873&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2023-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=349&amp;MessageKey=0dd1cc1e-a353-46e6-8a22-10fce433b24d&amp;CommunityKey=761a544b-eee9-494f-b450-01894b896649</loc><lastmod>2023-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/automationscheduling-tool-for-ar</loc><lastmod>2023-10-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-oct-18-2023-fda-draft-guidance-on-pdurs-2253s-and-more-1</loc><lastmod>2023-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-oct-18-2023-fda-draft-guidance-on-pdurs-2253s-and-more</loc><lastmod>2023-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-narratives-for-csr</loc><lastmod>2023-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/submission-of-validated-signalslabel-changes-to-fda</loc><lastmod>2023-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-information-day-notes</loc><lastmod>2023-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/october-19th-csp-call-cancelled</loc><lastmod>2023-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MessageKey=72c65458-f2c1-4ae5-8b5f-997ed055661f&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2023-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-on-amplifying-participant-voices-crafting-respectful-inclusive-and-understandable-patient-materials-1</loc><lastmod>2023-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=42352d81-4e82-40d8-8fe6-018b392e72de</loc><lastmod>2023-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=26238da0-798d-4565-99c6-3334704830ec&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2023-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-utilization-of-historical-trialregistry-data-in-drug-development-17-nov-2023-11am-est-1</loc><lastmod>2023-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-oct-18-11am-et-hackathon-prep-2</loc><lastmod>2023-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-oct-18-11am-et-hackathon-prep-3</loc><lastmod>2023-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-oct-18-11am-et-hackathon-prep-1</loc><lastmod>2023-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=a51a48a4-ba8c-43f0-b372-2679504e983f&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-10-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2023-tchotchke-awards-most-useful-category-1</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=fb9e56a9-8cb6-4da8-96d9-92c43613598f&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-in-person-event-seattle-wa-1</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=40b2fba0-5ff9-4180-b919-d5e492167b64&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-agenda-clinical-trials-information-system-ctis-information-day-1</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=403aac27-be66-438a-8fd1-010e75250ec4&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-shared-learning-platform-trials-cdisc-glossary-11-oct-2023-2</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-shared-learning-platform-trials-cdisc-glossary-11-oct-2023-3</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-shared-learning-platform-trials-cdisc-glossary-11-oct-2023</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-shared-learning-platform-trials-cdisc-glossary-11-oct-2023-1</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-webinar-platorm-trials-11-oct-2023-2</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-webinar-platorm-trials-11-oct-2023-3</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-webinar-platorm-trials-11-oct-2023</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-webinar-platorm-trials-11-oct-2023-1</loc><lastmod>2023-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=20bbb725-4687-4bcd-baa1-018b255e5b2f</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/work-with-responsive-search-ads-join-us-for-a-complimentary-webinar</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-part-i-only-applications-and-part-ii-requirements-in-ctis-1</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-part-i-only-applications-and-part-ii-requirements-in-ctis</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=3f0b3323-4301-4a87-9d9d-018b235f9e57&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb&amp;Home=%2fevents%2fevent-description</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=f6bce469-4b0f-4f57-a39f-018b23611071&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fevents%2fevent-description</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=0808c86d-b3b1-4bd2-bc4b-018b2360e6aa&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860&amp;Home=%2fevents%2fevent-description</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=4858e670-42e3-464f-ba56-018b23601e76&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e&amp;Home=%2fevents%2fevent-description</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=3c1e5f2b-00fc-4739-864e-018b2360d1dc&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2023-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-join-our-medical-writing-shared-learning-session-this-wednesday-11-oct-2023-2</loc><lastmod>2023-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-join-our-medical-writing-shared-learning-session-this-wednesday-11-oct-2023-1</loc><lastmod>2023-10-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-adpromo-wg-on-oct-18-official-start-1215-pm-call-opens-by-1200-pm</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-adpromo-wg-on-oct-18-official-start-1215-pm-call-opens-by-1200-pm-1</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=8e320176-557e-4871-8740-0b61eb484c7f&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=8fe55192-49a7-4a82-8aa2-018b1b237420</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/focus-on-regulatory-canada-annual-meeting</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/focus-on-clinical-canada-annual-meeting-1</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/focus-on-clinical-canada-annual-meeting</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=7609baa2-0b34-4886-8979-ebff9b4a0041&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-canada-annual-meeting-save-with-advance-rates</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-join-our-medical-writing-shared-learning-session-this-wednesday-11-oct-2023</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-join-our-shared-learning-this-wednesday-11-oct-2023-1</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-join-our-shared-learning-this-wednesday-11-oct-2023</loc><lastmod>2023-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-oct-18-12-pm-fda-guidance-on-rx-drug-use-related-software-and-info-within-on-2253s</loc><lastmod>2023-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/personalized-clinical-trials-framework-free-webinar</loc><lastmod>2023-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-transparency-rules-for-the-eu-clinical-trials-information-system-ctis</loc><lastmod>2023-10-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-oct-18-12-pm-fda-guidance-on-rx-drug-use-related-software-and-info-within-on-2253s-1</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=4e447538-3a7e-4d38-845d-b090022d7d9f&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-transparency-rules-for-the-eu-clinical-trials-information-system-ctis-released-today-2</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-transparency-rules-for-the-eu-clinical-trials-information-system-ctis-released-today</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/revised-transparency-rules-for-the-eu-clinical-trials-information-system-ctis-released-today-1</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-act-eu-and-ctis-proposed-new-publication-rules-2</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-act-eu-and-ctis-proposed-new-publication-rules-3</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-act-eu-and-ctis-proposed-new-publication-rules</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-act-eu-and-ctis-proposed-new-publication-rules-1</loc><lastmod>2023-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-joint-pm-legal-community-capabilities-cafe-did-you-ever-wonder-what-regulatory-exclusivities-are-available-to-a-molecule-how-do-you-secure-them-and-why-do-they-matter</loc><lastmod>2023-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/at-last-the-tchotchke-awards-have-arrived</loc><lastmod>2023-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/at-last-the-tchotchke-awards-have-arrived-1</loc><lastmod>2023-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-ctis-forum-stakeholders-meeting-14-september-updates-to-transparency-rules-1</loc><lastmod>2023-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=4cd20bc9-17d4-49e1-9629-0a38dacf3235&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2023-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/zoom-link-now-avaiable-for-shared-learning-on-wed-11-oct-2023-1</loc><lastmod>2023-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rim-wg-meeting-oct-5-2023-at-12-eastern</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=6f1ea788-322c-41b1-993b-018afbb0e8e4</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-clinical-data-sharing-methodology-and-transparency-checklist-final-version-2</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-clinical-data-sharing-methodology-and-transparency-checklist-final-version-3</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-clinical-data-sharing-methodology-and-transparency-checklist-final-version</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-clinical-data-sharing-methodology-and-transparency-checklist-final-version-1</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/question-on-timing-of-deferral-period</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-presentations-and-recordings-of-eu-ctis-walk-in-clinics-and-bitesize-talks-2</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-presentations-and-recordings-of-eu-ctis-walk-in-clinics-and-bitesize-talks</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-presentations-and-recordings-of-eu-ctis-walk-in-clinics-and-bitesize-talks-1</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-shared-learning-save-the-date-wed-11-oct-2023-platform-trials-cdisc-glossary</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-shared-learning-save-the-date-wed-11-oct-2023-platform-trials-cdisc-glossary-1</loc><lastmod>2023-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinicaltrialsgovs-mini-tutorial-on-how-to-register-a-trial-using-the-modernised-interface-prs-beta</loc><lastmod>2023-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-ctis-forum-stakeholders-meeting-14-september-updates-to-transparency-rules-3</loc><lastmod>2023-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-ctis-forum-stakeholders-meeting-14-september-updates-to-transparency-rules-2</loc><lastmod>2023-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-ctis-forum-stakeholders-meeting-14-september-updates-to-transparency-rules</loc><lastmod>2023-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ra-cmc-community</loc><lastmod>2023-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-responsible-for-hiring-medical-writers-in-your-job-role-1</loc><lastmod>2023-10-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/are-you-responsible-for-hiring-medical-writers-in-your-job-role</loc><lastmod>2023-10-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/developing-standard-practice-for-brain-monitoring-in-clinical-trials-1</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=ed3cdd8c-0706-4576-b76b-018ae1414ca0</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-answers-clinical-trials-regulation-eu-no-5362014-v66-2</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-answers-clinical-trials-regulation-eu-no-5362014-v66-3</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=c13f3869-1e59-4a5a-bd2e-87ff83c6d1ce&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-answers-clinical-trials-regulation-eu-no-5362014-v66-1</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-ctr-quick-guide-for-sponsors-2</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/modernized-clinicaltrialsgov-updates</loc><lastmod>2023-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-tuesday-october-3-2023-11-am-et</loc><lastmod>2023-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-tuesday-october-3-2023-11-am-et-1</loc><lastmod>2023-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/developing-standard-practice-for-brain-monitoring-in-clinical-trials</loc><lastmod>2023-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-cci-guidance-document-taken-down</loc><lastmod>2023-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-ctr-quick-guide-for-sponsors</loc><lastmod>2023-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-ctr-quick-guide-for-sponsors-1</loc><lastmod>2023-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/emas-ich-e6r3-meeting-report</loc><lastmod>2023-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-meeting-september-19th-use-of-ai-in-rpi</loc><lastmod>2023-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/engagement-models-for-use-cases</loc><lastmod>2023-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=02fd3b3f-970e-4a53-89b6-018ace143c08</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-8</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-7</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-6</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-5</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-4</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-3</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-plan-survey-responses-requested-by-september-28th-1</loc><lastmod>2023-09-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recordings-from-the-september-2023-meeting</loc><lastmod>2023-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hras-participant-information-quality-standards-and-design-and-review-principles-1</loc><lastmod>2023-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/august-september-meeting-recordings</loc><lastmod>2023-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hras-participant-information-quality-standards-and-design-and-review-principles-2</loc><lastmod>2023-09-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hras-participant-information-quality-standards-and-design-and-review-principles</loc><lastmod>2023-09-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-sep-20-2023-deep-dive-into-recent-opdp-enforcement-letters-and-recent-fda-guidances</loc><lastmod>2023-09-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-sep-20-2023-deep-dive-into-recent-opdp-enforcement-letters-and-recent-fda-guidances-1</loc><lastmod>2023-09-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-mitigating-cancer-drug-shortages-summit-on-sept-26-from-9-am-to-11-am-est-1</loc><lastmod>2023-09-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/september-meeting-minutes</loc><lastmod>2023-09-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-rwe-conference-1</loc><lastmod>2023-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-privacy-methodology-for-data-sharing</loc><lastmod>2023-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-privacy-methodology-for-data-sharing-1</loc><lastmod>2023-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=349&amp;MessageKey=6a3eef76-eb5f-47b9-b237-b819218a33c0&amp;CommunityKey=761a544b-eee9-494f-b450-01894b896649</loc><lastmod>2023-09-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=85026af1-b37e-4b74-b4ea-1bd421dd5665&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2023-09-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=4e3e20a7-cc13-43d0-8274-a931a11f8360&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-sep-20-deep-dive-into-recent-enforcement-letters-and-the-final-rwdrwe-guidance-implications-for-cfl-1</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2024-call-for-abstracts-deadline-has-been-extended</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-register-for-innovative-trial-designs-conference-and-save-200-4</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-register-for-innovative-trial-designs-conference-and-save-200-2</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-register-for-innovative-trial-designs-conference-and-save-200-3</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-register-for-innovative-trial-designs-conference-and-save-200-1</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MessageKey=12889888-8237-436b-82af-a6b9b20050c2&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=721a66e5-8dd9-4253-a029-018a94108200</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=20c050fa-844a-4514-aeda-915b1f937160&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctcgs-latest-best-practice-guide-on-transition-trials-1</loc><lastmod>2023-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-pv-resource-kit</loc><lastmod>2023-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updates-to-2023-dei-workshop-series</loc><lastmod>2023-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updates-to-2023-dei-workshop-series-1</loc><lastmod>2023-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-this-thursday-sept-14-on-patient-engagement-in-pediatric-trials</loc><lastmod>2023-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-join-us-on-tuesday-september-12th-for-our-monthly-conference-call</loc><lastmod>2023-09-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-sep-20-guest-speaker-1</loc><lastmod>2023-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-sep-20-guest-speaker</loc><lastmod>2023-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/inform-duke-margolis-workshop-on-the-future-of-rx-drug-promotion-and-digital-marketing-sep-14-1230-500-pm-et</loc><lastmod>2023-09-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/inform-duke-margolis-workshop-on-the-future-of-rx-drug-promotion-and-digital-marketing-sep-14-1230-500-pm-et-1</loc><lastmod>2023-09-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2024-call-for-abstracts-closes-on-sept-14-submit-today</loc><lastmod>2023-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-sep-20-deep-dive-into-enforcement-letters-and-final-rwdrwe-guidance-1</loc><lastmod>2023-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=5ff9257a-ce9b-4128-91f3-53a6aa29012c&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-09-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-to-ai-in-healthcare-brand-new-at-dia-1</loc><lastmod>2023-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-announces-publication-of-full-risk-management-plans-rmps</loc><lastmod>2023-09-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-announces-publication-of-full-risk-management-plans-rmps-1</loc><lastmod>2023-09-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/february-2023-dia-japan-cdm-workshop</loc><lastmod>2023-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MessageKey=ef6de854-b92e-4ee7-b394-4223d845f485&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2023-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MessageKey=505b64f0-0b2a-4024-98a6-6585fee48c46&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2023-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-tuesday-september-5-2023-11-am-et-1</loc><lastmod>2023-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/asiyah-lins-presentation-of-ontologies-for-cdm-community-meeting-812023</loc><lastmod>2023-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/asiyah-lins-presentation-of-ontologies-for-cdm-community-meeting-812023-1</loc><lastmod>2023-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-to-ai-in-healthcare-brand-new-at-dia</loc><lastmod>2023-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=b831da04-ab7e-4821-ad14-b356b28245cc&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2023-08-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/decentralized-clinical-trials-dct</loc><lastmod>2023-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=9b63964f-2fe6-4c84-b131-13b067a66423&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-open-for-dias-global-labeling-conference</loc><lastmod>2023-08-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2024-call-for-abstracts-now-open</loc><lastmod>2023-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/european-commission-clinical-trial-advisory-group-meeting-june-2023-1</loc><lastmod>2023-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=53b18942-0087-4214-904a-8c4cbb188cbe&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2023-08-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-september-21st-meeting-of-the-community</loc><lastmod>2023-08-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recordings-from-the-august-2023-meeting-and-opportunities-to-comment</loc><lastmod>2023-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=acb9cd89-0d07-488a-b860-018a1cbf60e8</loc><lastmod>2023-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/german-patient-groups-call-for-clinical-trial-transparency-law</loc><lastmod>2023-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=48e8b3e3-6076-4c2a-b8d0-018a16ff5bef</loc><lastmod>2023-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=ae3511f6-fc1e-4770-a428-cb6508d15fa8&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2023-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-vjc-webinar-pediatric-therapeutics-development-8th-sep-1030-1200-est-1</loc><lastmod>2023-08-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-meeting-of-the-novel-and-exceptional-technology-and-research-advisory-committee</loc><lastmod>2023-08-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-meeting-of-the-novel-and-exceptional-technology-and-research-advisory-committee-1</loc><lastmod>2023-08-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=1bd8fdaa-a6ea-463d-9147-1f89c22b859d&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-08-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-brand-new-call-for-abstracts-2</loc><lastmod>2023-08-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-brand-new-call-for-abstracts-3</loc><lastmod>2023-08-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/masc-forum-brand-new-call-for-abstracts-1</loc><lastmod>2023-08-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/early-bird-rates-expiring-real-world-evidence-conference-1</loc><lastmod>2023-08-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=cfb0abec-0e7c-4a58-a19b-158e39aaab17&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-aug-16-2023-1</loc><lastmod>2023-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2024-global-annual-meeting-call-for-abstracts-is-open</loc><lastmod>2023-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cancelled-august-17th-edm-structured-reference-model-team-meeting</loc><lastmod>2023-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctrctis-wg-15-aug-meeting-reading-materials</loc><lastmod>2023-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cancelled-aug-16-rim-intelligent-automation-team-meeting</loc><lastmod>2023-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cancelled-aug-16-rim-intelligent-automation-team-meeting-1</loc><lastmod>2023-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/career-fair-hosted-by-dia</loc><lastmod>2023-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-aug-16-device-promotion-dos-and-donts-and-fda-final-guidance-review-quant-efficacy-risk-info-3</loc><lastmod>2023-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-aug-16-device-promotion-dos-and-donts-and-fda-final-guidance-review-quant-efficacy-risk-info-2</loc><lastmod>2023-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-global-pharmacovigilance-and-risk-management-strategies-conference-aggregate-safety-assessment-planning-training-short-course</loc><lastmod>2023-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-global-pharmacovigilance-and-risk-management-strategies-conference-aggregate-safety-assessment-planning-training-short-course-1</loc><lastmod>2023-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=120917ad-d873-4793-9056-0189f589aaf4</loc><lastmod>2023-08-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/want-to-learn-more-about-emas-policy-0070-or-hcs-prci-scope-timelines-redactions</loc><lastmod>2023-08-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=283&amp;MessageKey=627536bc-6928-4535-9576-28624fc6d232&amp;CommunityKey=fc80e507-13cd-4967-9d9c-9cd2b13faed8</loc><lastmod>2023-08-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-dia-csp-community-call-on-august-17th</loc><lastmod>2023-08-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-all-meeting-this-thursday-aug-10-on-patient-advocacy-in-clinical-research</loc><lastmod>2023-08-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MessageKey=78ecff10-5f45-4357-b7bc-0c1cf9954319&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2023-08-09</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=280f09b3-7332-46bc-b997-0189d68a610e&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2023-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=90cc93cb-76d0-4587-94df-3af6a1acf6eb&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstract-deadline-rsidm-2</loc><lastmod>2023-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstract-deadline-rsidm-1</loc><lastmod>2023-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-abstract-deadline-rsidm</loc><lastmod>2023-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-intelligence-and-policy-august-meeting-dial-in</loc><lastmod>2023-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-eu-ctrctis-wg-meeting-agenda-15-august-2023</loc><lastmod>2023-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=12095e25-0d30-48a4-b625-0189d20a65db</loc><lastmod>2023-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-to-register-and-save-early-bird-ends-august-8-for-innovative-trial-designs-conference-1</loc><lastmod>2023-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MessageKey=10571d46-4cd8-4ec2-9c1f-29627680244e&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2023-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=08f71ca6-3a05-4ca4-a26d-dfaebd710eff&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-08-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-aug-16-device-promotion-dos-and-donts-and-fda-final-guidance-review-quant-efficacy-risk-info</loc><lastmod>2023-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-aug-16-device-promotion-dos-and-donts-and-fda-final-guidance-review-quant-efficacy-risk-info-1</loc><lastmod>2023-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-03-aug-2023</loc><lastmod>2023-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=38a0975c-8aff-4858-9552-0189b831fa29</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/us-legal-requirements-and-regulatory-guidance-to-increase-clinical-trial-diversity</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=8564990a-3d4c-420b-8d17-858545b559cf&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-annual-2023-tchotchke-tank-update-no-awards-just-yet-but-getting-there-1</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-eudract-aug-01-2023</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=89611ac6-a059-4cfb-814a-d83ac3838cda&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-cdp-questions-and-answers-qas-on-external-guidance-for-ema-policy-0070</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-data-publication-cdp-questions-and-answers-qas-on-external-guidance-for-ema-policy-0070-1</loc><lastmod>2023-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=7754d8b3-3b05-4e94-a1db-4ab9de00afcb&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-pv-resource-kit-1</loc><lastmod>2023-07-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-resource-kit</loc><lastmod>2023-07-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-resource-kit-1</loc><lastmod>2023-07-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-in-person-event-new-jersey</loc><lastmod>2023-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-august-1-11-am-et</loc><lastmod>2023-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-understanding-case-reporting-transmission-networks-in-drug-safety-the-impact-of-replication</loc><lastmod>2023-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=3b99a2af-fd05-452c-9920-b0ff964e2861&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2023-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=c415ad78-818f-4d1c-8468-87a15f4fa7be&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2023-07-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-of-ctis-transparency-rules</loc><lastmod>2023-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-of-ctis-transparency-rules-1</loc><lastmod>2023-07-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-the-ich-e6-r3-workshop-on-13-14-july-2023</loc><lastmod>2023-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-consultation-on-who-guidance-for-best-practices-for-clinical-trials</loc><lastmod>2023-07-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-consultation-on-who-guidance-for-best-practices-for-clinical-trials-1</loc><lastmod>2023-07-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-version-65-july-2023-2</loc><lastmod>2023-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-document-regulation-eu-5362014-version-65-july-2023-1</loc><lastmod>2023-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=d225d6d8-5164-45d8-b106-44e32a75de23&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-dia-csp-community-on-july-20th</loc><lastmod>2023-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation</loc><lastmod>2023-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-sponsor-survey-on-ctr-implementation-1</loc><lastmod>2023-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=56aacf21-1da5-40be-8280-ee62f9cef750&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2023-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation-1</loc><lastmod>2023-07-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-to-attend-mentoring-back-to-the-basics-where-do-i-start-july-19-2023-noon-et</loc><lastmod>2023-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-to-attend-mentoring-back-to-the-basics-where-do-i-start-july-19-2023-noon-et-1</loc><lastmod>2023-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MessageKey=c17229f8-55f6-453c-90af-cd88d879f159&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2023-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/iso-approved-plain-language-standards-1</loc><lastmod>2023-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slide-presentations-clinical-trials-information-system-webinar-second-year-of-transition</loc><lastmod>2023-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slide-presentations-clinical-trials-information-system-webinar-second-year-of-transition-1</loc><lastmod>2023-07-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-jul-19-scm-genai-guest-speaker-3</loc><lastmod>2023-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-jul-19-scm-genai-guest-speaker-2</loc><lastmod>2023-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=4636351f-df4f-4b3a-8ec2-6a710e49022f&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-team-11am-jul-19-scm-genai-guest-speaker-1</loc><lastmod>2023-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=58655469-2034-4dfb-a4b8-01895020919b</loc><lastmod>2023-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=b12ee94b-fb7a-48bd-95bc-bce32c1b30f9&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2023-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-document-on-how-to-approach-the-protection-of-personal-data-and-commercially-confidential-information-while-using-the-clinical-trials-information-system-ctis-version-11</loc><lastmod>2023-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/guidance-document-on-how-to-approach-the-protection-of-personal-data-and-commercially-confidential-information-while-using-the-clinical-trials-information-system-ctis-version-11-1</loc><lastmod>2023-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-aug-16-no-meeting-in-july-aug-topics</loc><lastmod>2023-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-aug-16-no-meeting-in-july-aug-topics-1</loc><lastmod>2023-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-coordination-group-ctcg-best-practice-guide-and-cover-letter-template-1</loc><lastmod>2023-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-coordination-group-ctcg-best-practice-guide-and-cover-letter-template</loc><lastmod>2023-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-17-jul-2023-at-12pm-est-fda-csa-guidance-a-new-validation-paradigm-2</loc><lastmod>2023-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-17-jul-2023-at-12pm-est-fda-csa-guidance-a-new-validation-paradigm-3</loc><lastmod>2023-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MessageKey=83a4bc6f-ff7c-4e34-b6b3-b35a8e665e8b&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2023-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-17-jul-2023-at-12pm-est-fda-csa-guidance-a-new-validation-paradigm-1</loc><lastmod>2023-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-meeting-minutes</loc><lastmod>2023-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-fda-guidance-on-computer-software-assurance-csa-a-new-validation-paradigm</loc><lastmod>2023-07-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-rpi-june-13-meeting-notes</loc><lastmod>2023-07-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-enhancing-clarity-and-coherence-techniques-for-editing-scientific-articles</loc><lastmod>2023-07-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/emas-new-it-service-management-solution-servicenow-2</loc><lastmod>2023-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/emas-new-it-service-management-solution-servicenow</loc><lastmod>2023-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/emas-new-it-service-management-solution-servicenow-1</loc><lastmod>2023-06-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=97&amp;MessageKey=404e4d5b-051d-4841-8bfb-e500edbab591&amp;CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2023-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-comment-period-open-until-jun-30th-amcp-format-for-formulary-submissions-version-41-revision</loc><lastmod>2023-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/informal-get-together-at-the-annual-global-meeting</loc><lastmod>2023-06-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/june-ctd-meeting-recording-beckys-presentation-in-the-library</loc><lastmod>2023-06-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/gcp-qa-roundtable-at-annual-meeting</loc><lastmod>2023-06-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=36408fbe-4c0d-421d-b234-e3fa9ff4560f&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-06-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/theres-still-time-to-get-judgmental-at-dia-annual-next-week-2</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-enhancing-clarity-and-coherence-techniques-for-editing-scientific-articles</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-enhancing-clarity-and-coherence-techniques-for-editing-scientific-articles-1</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ukrainian-association-for-clinical-research-news-1</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MessageKey=fda4a0f8-fa6c-45ea-8f78-60a98ac19d91&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/theres-still-time-to-get-judgmental-at-dia-annual-next-week</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/theres-still-time-to-get-judgmental-at-dia-annual-next-week-1</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=1af32a0c-51b0-4abf-8ad7-0188d859a155</loc><lastmod>2023-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=1e815d2a-1720-46de-bf89-0188ad38a781</loc><lastmod>2023-06-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-ctis-downtime-windows</loc><lastmod>2023-06-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-ctis-downtime-windows-1</loc><lastmod>2023-06-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diversity-and-inclusion-community-at-dia-2023</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-workshop-series-this-fall</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=987bd745-c34c-43eb-8129-d6b37aca5984&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-aug-16-adpromo-wg-note-its-not-aug-14-1</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-is-now-open-submit-your-idea-by-june-30th-2</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-is-now-open-submit-your-idea-by-june-30th-1</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MessageKey=9ea4ba93-abf8-4a33-a94a-dfb81f15707e&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-information-day-1</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MessageKey=d7495733-fd35-41c7-844e-7c1b58c6e0ed&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2023-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-2023-06-adpromo-wg-cont-the-convo-on-changing-reviewers-1st-opdp-enforcement-letter-of-2023-proposed-rule-pmi</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-2023-06-adpromo-wg-cont-the-convo-on-changing-reviewers-1st-opdp-enforcement-letter-of-2023-proposed-rule-pmi-1</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invited-to-attend-mentoring-back-to-the-basics-where-do-i-start-july-19-2023-noon-et</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invited-to-attend-mentoring-back-to-the-basics-where-do-i-start-july-19-2023-noon-et-1</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/question-how-do-you-reviewapprove-sensitive-eu-ctr-part-ii-content</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/question-how-do-you-reviewapprove-sensitive-eu-ctr-part-ii-content-1</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/question-how-do-you-reviewapprove-sensitive-ctr-part-ii-documents</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=04f2f5d8-6511-4b91-9962-0aa4a83beff6&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-meeting-21-jun-11am-et-guest-speaker</loc><lastmod>2023-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-rim-intelligent-automation-meeting-21-jun-11am-et-guest-speaker-1</loc><lastmod>2023-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-responses-to-article-25-question-retrospective-registration-and-inclusion-in-authorization-and-trials-being-published-on-ctis</loc><lastmod>2023-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-june-14-12-pm-et-new-labeling-pmi-proposal-and-changing-reviewers-qa-1</loc><lastmod>2023-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-june-14-12-pm-et-new-labeling-pmi-proposal-and-changing-reviewers-qa</loc><lastmod>2023-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=05765648-12e7-4f5f-9fc7-7cc3f3eedcde&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2023-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/public-consultation-on-ich-draft-guidelines-1</loc><lastmod>2023-06-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/how-to-log-in-to-ctis-starting-1-june-2023-launch-of-multifactor-authentication-2</loc><lastmod>2023-06-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/how-to-log-in-to-ctis-starting-1-june-2023-launch-of-multifactor-authentication-1</loc><lastmod>2023-06-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/how-to-log-in-to-ctis-starting-1-june-2023-launch-of-multifactor-authentication</loc><lastmod>2023-06-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-at-the-pec-all-meeting-this-thursday-june-8</loc><lastmod>2023-06-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MessageKey=bd1df08e-82a1-46ee-a350-d2377c454afc&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2023-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-june-14-12-pm-et-continue-the-convochanging-reviewers-1</loc><lastmod>2023-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-june-14-12-pm-et-continue-the-convochanging-reviewers</loc><lastmod>2023-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=0f1d8c5f-61ca-47bc-b463-01889185e3e5</loc><lastmod>2023-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-csp-community-meeting-on-june-15th</loc><lastmod>2023-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/updated-icmje-recommendations</loc><lastmod>2023-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-june-2023-monthly-meeting-11-am-et</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-june-2023-monthly-meeting-11-am-et-1</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/psi-virtual-journal-club-propensity-scores-webinar-22nd-june-4pm-5pm-bst</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-second-year-of-transition-eu-ctr-5362014-1</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-second-year-of-transition-eu-ctr-5362014</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/scientific-evaluation-of-safety-data-and-aggregate-safety-assessment-planning-for-ind-safety-reporting</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/scientific-evaluation-of-safety-data-and-aggregate-safety-assessment-planning-for-ind-safety-reporting-1</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/safety-data-discussion-at-dia-boston-2023</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/safety-data-discussion-at-dia-boston-2023-1</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/statistics-and-data-science-virtual-journal-club-1</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MessageKey=88db0271-a1bf-49d2-8d4f-7c9b400acf08&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/psi-virtual-journal-club-propensity-scores-webinar-22nd-june-4pm-5pm-bst-1</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=d724b167-2e61-423f-b734-01888a4c53e5</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=6bbda90b-ce01-4d8f-981c-01888a41cb82</loc><lastmod>2023-06-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-policy-and-intelligence-notes</loc><lastmod>2023-06-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-policy-0070-re-launch-webinar-presentations-available-1</loc><lastmod>2023-06-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-policy-0070-re-launch-webinar-presentations-available</loc><lastmod>2023-06-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-proposes-new-easy-to-read-medication-guide-for-patients-patient-medication-information</loc><lastmod>2023-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MessageKey=4564cb36-5b6d-4ad4-802b-deeaaa71747d&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2023-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-etemplate-implementation-survey</loc><lastmod>2023-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerates-etemplate-implementation-survey-1</loc><lastmod>2023-05-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nhs-news-alert-informs-about-the-uk-government-response-to-the-lord-oshaughnessy-review-on-the-uk-commercial-clinical-trials-landscape-with-potential-impact-on-clinical-trial-disclosure</loc><lastmod>2023-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MessageKey=8f62c173-a550-4c14-9eb3-f14ff6ef4038&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2023-05-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-becomes-a-data-provider-for-who-1</loc><lastmod>2023-05-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MessageKey=dd16f1f4-b1fd-4b84-9e49-04e5f443f799&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2023-05-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-e6r3-released</loc><lastmod>2023-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-freelance-medical-writer</loc><lastmod>2023-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-freelance-medical-writer-1</loc><lastmod>2023-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-how-to-submit-a-transitional-trial-in-ctis</loc><lastmod>2023-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-how-to-submit-a-transitional-trial-in-ctis-1</loc><lastmod>2023-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-a-free-webinar-building-patient-engagement-in-your-organization-on-wednesday-june-7-at-1100am-et-1</loc><lastmod>2023-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-a-free-webinar-building-patient-engagement-in-your-organization-on-wednesday-june-7-at-1100am-et</loc><lastmod>2023-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-e6-r3-draft-released-for-consultation</loc><lastmod>2023-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ich-e6-r3-draft-released-for-consultation-1</loc><lastmod>2023-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-in-focus-newsletter</loc><lastmod>2023-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-in-focus-newsletter-1</loc><lastmod>2023-05-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/articles-of-interest</loc><lastmod>2023-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=cb2f01cb-4e30-48d2-a159-018834a4ac2d</loc><lastmod>2023-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-judges-at-the-dia-annual-the-tchotchke-tank-and-exhibit-hall-review-1</loc><lastmod>2023-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-meaningful-change-webinar-june-5-11am-et</loc><lastmod>2023-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-now-meaningful-change-webinar-june-5-11am-et-1</loc><lastmod>2023-05-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-version-12-1</loc><lastmod>2023-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/deferral-of-protocol-synopsis-as-a-separate-document</loc><lastmod>2023-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-sessions-on-translational-strategies-for-dose-optimization-at-dia-2023-annual-meeting-1</loc><lastmod>2023-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-sessions-on-translational-strategies-for-dose-optimization-at-dia-2023-annual-meeting-2</loc><lastmod>2023-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-sessions-on-translational-strategies-for-dose-optimization-at-dia-2023-annual-meeting-3</loc><lastmod>2023-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis-version-12</loc><lastmod>2023-05-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-may-17-changing-reviewers-opdp-research-and-more</loc><lastmod>2023-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-may-17-changing-reviewers-opdp-research-and-more-1</loc><lastmod>2023-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/community-questions-on-ema-policy-0070</loc><lastmod>2023-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-csp-community-meeting-on-may-18th</loc><lastmod>2023-05-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-sessions-on-translational-strategies-for-dose-optimization-at-dia-2023-annual-meeting</loc><lastmod>2023-05-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-community-webinar-digital-health-technology-and-meaningful-change</loc><lastmod>2023-05-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-direct-community-webinar-digital-health-technology-and-meaningful-change-1</loc><lastmod>2023-05-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/get-in-contact-with</loc><lastmod>2023-05-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/how-many-study-documents-are-writeen-by-collaborative-authoring-tools</loc><lastmod>2023-05-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-policy-and-intelligence-upcoming-meetings-may-16th</loc><lastmod>2023-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/action-points-fro-pec-all-hands-goal-setting-survey-until-monday-may-22nd-and-pec-charter</loc><lastmod>2023-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-thursday-511-join-the-pec-all-meeting-on-patient-preference-studies</loc><lastmod>2023-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-published-clinical-data-publication-policy-0070-re-launch-ema-webinar</loc><lastmod>2023-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-published-clinical-data-publication-policy-0070-re-launch-ema-webinar-1</loc><lastmod>2023-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-policy-and-intelligence-upcoming-meetings-may-and-june</loc><lastmod>2023-05-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/declaration-of-helsinki-update-expected-in-2024</loc><lastmod>2023-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/declaration-of-helsinki-update-expected-in-2024-1</loc><lastmod>2023-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/research-ethics-online-course-by-the-university-of-leuven</loc><lastmod>2023-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/research-ethics-online-course-by-the-university-of-leuven-1</loc><lastmod>2023-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-clinical-outsourcing-roundtable-recording-and-slides-available-in-library</loc><lastmod>2023-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-clinical-outsourcing-roundtable-recording-and-slides-available-in-library-1</loc><lastmod>2023-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-judges-at-the-dia-annual-the-tchotchke-tank-and-exhibit-hall-review</loc><lastmod>2023-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-may-17-12-pm-et-guest-presenter-changing-reviewers-and-hot-topics</loc><lastmod>2023-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-may-17-12-pm-et-guest-presenter-changing-reviewers-and-hot-topics-1</loc><lastmod>2023-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/pec-goal-setting-and-thursday-meeting-reminder</loc><lastmod>2023-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=4331f76b-80a4-4640-9265-01880048d9a4</loc><lastmod>2023-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/community-questions-on-ema-policy-0070-2</loc><lastmod>2023-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=19a25bdd-dbaf-42f6-921d-fe9450758e8d&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2023-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=6bad0293-e3c8-44eb-821f-0187fd62c999&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2023-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/events/event-description?CalendarEventKey=90e09b3e-3134-4c47-a225-d7674a0d467b&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f&amp;Home=%2fcommunities%2fcommunity-home%2frecent-community-events</loc><lastmod>2023-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-webinar-clinical-outsourcing-11-may-2023-at-7pm-est</loc><lastmod>2023-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-webinar-clinical-outsourcing-11-may-2023-at-7pm-est-1</loc><lastmod>2023-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/your-dia-professional-development-community-subscription-options</loc><lastmod>2023-05-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/community-questions-on-ema-policy-0070-1</loc><lastmod>2023-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-prs-may-04-2023</loc><lastmod>2023-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-crc-webinar-clinical-outsourcing-roundtable-getting-to-the-right-solution-for-you</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/april-working-group-meeting</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-working-group-call-may-2023</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctr-working-group-call-may-2023-1</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/edm-structured-reference-model-team-meeting</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/disclosure-of-licensed-questionnaires</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/review-of-transparency-rules-for-the-eu-ctis-comments-due-by-28-june-2023</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/interim-guidance-document-on-how-to-approach-the-ppd-and-cci-while-using-the-ctis-version-10-1</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/interim-guidance-document-on-how-to-approach-the-ppd-and-cci-while-using-the-ctis-version-10</loc><lastmod>2023-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mw-mentorship-program-2023</loc><lastmod>2023-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/may-agenda</loc><lastmod>2023-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/mentoring/mentoringinstructions</loc><lastmod>2023-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-policy-0070</loc><lastmod>2023-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-clinical-data-publication-policy-0070-1</loc><lastmod>2023-05-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-4</loc><lastmod>2023-04-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-may-17-12-pm-et-guest-presenter-and-hot-topics</loc><lastmod>2023-04-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-may-17-12-pm-et-guest-presenter-and-hot-topics-1</loc><lastmod>2023-04-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-highlights-april-24-2023</loc><lastmod>2023-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meeting-up-at-the-2023-global-annual-meeting</loc><lastmod>2023-04-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-8</loc><lastmod>2023-04-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-7</loc><lastmod>2023-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-6</loc><lastmod>2023-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-5</loc><lastmod>2023-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-2</loc><lastmod>2023-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-3</loc><lastmod>2023-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology-1</loc><lastmod>2023-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/seeking-volunteers-to-reveiw-writing-samples-and-posted-comments-for-graduate-mph-degree-in-epidemiology</loc><lastmod>2023-04-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=1885&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2023-04-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-crc-webinar-clinical-outsourcing-roundtable-getting-to-the-right-solution-for-you-2</loc><lastmod>2023-04-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-crc-webinar-clinical-outsourcing-roundtable-getting-to-the-right-solution-for-you-1</loc><lastmod>2023-04-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-edm-structured-reference-model-meeting-20-apr-2023</loc><lastmod>2023-04-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-updated-glossary-of-terms-and-definitions-version-30-published-today</loc><lastmod>2023-04-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-updated-glossary-of-terms-and-definitions-version-30-published-today-1</loc><lastmod>2023-04-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-tga-disclosures-diaadpromo-conf-medical-mobile-appsai-l-baumhardt</loc><lastmod>2023-04-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-tga-disclosures-diaadpromo-conf-medical-mobile-appsai-l-baumhardt-1</loc><lastmod>2023-04-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-apr-19-11am-et-hackathon-prep</loc><lastmod>2023-04-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-apr-19-11am-et-hackathon-prep-1</loc><lastmod>2023-04-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-apr-19-11am-et-hackathon-prep-2</loc><lastmod>2023-04-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-and-recording-available-leveraging-rwd-in-rcts-13apr2023</loc><lastmod>2023-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-and-recording-available-leveraging-rwd-in-rcts-13apr2023-1</loc><lastmod>2023-04-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-europe-clinical-project-management-course</loc><lastmod>2023-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-europe-clinical-project-management-course-1</loc><lastmod>2023-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=09487ced-277f-4fe1-8408-01878b5e26bd</loc><lastmod>2023-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-csa-guidance-webinars-dia-gcp-qa-community-with-sqa-postponed</loc><lastmod>2023-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-csa-guidance-webinars-dia-gcp-qa-community-with-sqa-postponed-1</loc><lastmod>2023-04-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/topic-for-the-csp-community-meeting-on-april-20th</loc><lastmod>2023-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-now-open-for-dias-innovative-trial-designs-conference-3</loc><lastmod>2023-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-now-open-for-dias-innovative-trial-designs-conference-4</loc><lastmod>2023-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-now-open-for-dias-innovative-trial-designs-conference-1</loc><lastmod>2023-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-now-open-for-dias-innovative-trial-designs-conference-2</loc><lastmod>2023-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-topics-now-open-for-dias-innovative-trial-designs-conference</loc><lastmod>2023-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-handbook-for-clinical-trial-sponsors-1</loc><lastmod>2023-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-updated-handbook-for-clinical-trial-sponsors</loc><lastmod>2023-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recent-developments-in-data-privacy-laws-and-their-impact-on-data-sharing</loc><lastmod>2023-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recent-developments-in-data-privacy-laws-and-their-impact-on-data-sharing-1</loc><lastmod>2023-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-intelligence-meeting-april-reminder</loc><lastmod>2023-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/publication-of-documents-once-deferral-period-is-expired-ctis</loc><lastmod>2023-04-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/3-part-csa-webinar-with-gcp-qa-and-sqa</loc><lastmod>2023-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-april-19-12-pm-et-includes-mobile-app-and-clinical-decision-support-current-fda-expectations-for-software-products</loc><lastmod>2023-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-april-19-12-pm-et-includes-mobile-app-and-clinical-decision-support-current-fda-expectations-for-software-products-1</loc><lastmod>2023-04-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-thursday-413-join-the-pec-all-meeting-on-patient-input-in-regulatory-decision-making</loc><lastmod>2023-04-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/edm-structured-refence-model-team-meeting-april-6th</loc><lastmod>2023-04-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-short-courses-kickoff-next-week-1</loc><lastmod>2023-04-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/virtual-short-courses-kickoff-next-week-2</loc><lastmod>2023-04-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-april-19-12-pm-et-meddev-apps-dia-adpromo-conference-debrief-cont-and-more</loc><lastmod>2023-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/prs-delayed-results-question</loc><lastmod>2023-04-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-now-available-shared-learning-29mar2023-plain-language-summary-for-patients-professionals</loc><lastmod>2023-04-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/japan-registry-of-clinical-trials-jrct-update-1</loc><lastmod>2023-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-mw-mentorship-program-panel-discussion</loc><lastmod>2023-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-mw-mentorship-program-panel-discussion-1</loc><lastmod>2023-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/recording-now-available-shared-learning-adopting-a-plain-language-summary-for-patients-professionals-sylvia-baedorf-kassis-29mar2023</loc><lastmod>2023-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/video-from-26th-annual-dia-japan-cdm-conference</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-april-4-2023</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/nih-posts-data-showing-improvement-in-results-reporting</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dias-real-world-evidence-conference-call-for-abstracts</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-march-28-2023</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-upcoming-webinars</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/japan-medical-association-clinical-trial-registration-system-jmacct-ctr-update</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-dr-rucha-rege-new-dia-india-mw-working-group-chair</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-dr-rucha-rege-new-dia-india-mw-working-group-chair-1</loc><lastmod>2023-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fyi-new-versions-v11-published-qa-on-the-protection-of-commercially-confidential-information-and-personal-data-while-using-ctis</loc><lastmod>2023-03-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/deadline-extended-dia-2023-patients-partner-application</loc><lastmod>2023-03-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-virtual-mentorship-program-is-back-for-2023-2</loc><lastmod>2023-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fyi-plos-medicine-article-on-clinical-trial-transparency-among-university-medical-centers-in-germany</loc><lastmod>2023-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-medical-writing-virtual-mentorship-program-is-back-for-2023-1</loc><lastmod>2023-03-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-webinar-leveraging-real-world-data-in-randomized-clinical-trials-novel-statistical-approaches-and-design-considerations</loc><lastmod>2023-03-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mhra-to-streamline-clinical-trial-process</loc><lastmod>2023-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-6</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-7</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-8</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-4</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-5</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-3</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-2</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th-1</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/implementation-of-estimands-ich-e9-r1-using-data-standards-survey-responses-requested-by-april-14th</loc><lastmod>2023-03-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-shared-learning-session-adopting-a-plain-language-resource-for-patients-and-professionals-the-mrct-center-clinical-research-glossary</loc><lastmod>2023-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/next-shared-learning-session-adopting-a-plain-language-resource-for-patients-and-professionals-the-mrct-center-clinical-research-glossary-1</loc><lastmod>2023-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/publication-of-imp-details-inc-max-dosage-in-the-ctis-for-cat-2-trials</loc><lastmod>2023-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/publication-of-imp-details-inc-max-dosage-in-the-ctis-for-cat-2-trials-1</loc><lastmod>2023-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-answers-community-questions-on-publication-of-content-for-withdrawn-or-rejected-applications</loc><lastmod>2023-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-community-roundtable-at-dia-global-in-june</loc><lastmod>2023-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/master-protocol</loc><lastmod>2023-03-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-electronic-systems-and-electronic-signatures</loc><lastmod>2023-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-march-15-2023-opdp-study-and-dia-adpromo-conf-highlights</loc><lastmod>2023-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-march-15-2023-opdp-study-and-dia-adpromo-conf-highlights-1</loc><lastmod>2023-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-16-edm-structured-reference-model-meeting-info-update</loc><lastmod>2023-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-16-edm-structured-reference-model-meeting-info-update-1</loc><lastmod>2023-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-16th-edm-component-reference-model-meeting</loc><lastmod>2023-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-16th-edm-component-reference-model-meeting-1</loc><lastmod>2023-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-answers-to-questions-on-results-and-ppdcci-guidance</loc><lastmod>2023-03-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-intelligence-meeting-updates-march-and-april</loc><lastmod>2023-03-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/see-you-at-dias-medical-affairs-and-scientific-communications-forum-2</loc><lastmod>2023-03-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-deadline-march-15-for-posters-round-tables-and-content-hubs</loc><lastmod>2023-03-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-join-us-on-tuesday-march-14th-for-our-monthly-conference-call</loc><lastmod>2023-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/deadline-approaching-march-15-call-for-content-hub-leaders-and-round-table-discussions</loc><lastmod>2023-03-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mar-15-11am-rim-intelligent-automation-team-meeting</loc><lastmod>2023-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mar-15-11am-rim-intelligent-automation-team-meeting-1</loc><lastmod>2023-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-new-guideline-on-computerised-systems-and-electronic-data-in-clinical-trials</loc><lastmod>2023-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-bayesian-scientific-working-group-kol-lecture-series-friday-03172023-free-and-no-registration-required-2</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meaningful-change-working-group-survey-4</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meaningful-change-working-group-survey-2</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meaningful-change-working-group-survey-3</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/last-chance-call-for-posters-closes-march-15</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-march-15-12-1-pm-et-hot-topics-and-guest-presenters</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-march-15-12-1-pm-et-hot-topics-and-guest-presenters-1</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-in-focus-newsletter-patient-engagement</loc><lastmod>2023-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/health-authority-requests-for-signal-analysis</loc><lastmod>2023-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/health-authority-requests-for-signal-analysis-1</loc><lastmod>2023-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/submission-of-marked-for-redaction-version-as-not-for-publication-version-in-ctis</loc><lastmod>2023-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-innovative-design-scientific-working-group-kol-lecture-series-friday-3102023-free-and-no-registration-required-1</loc><lastmod>2023-03-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/this-thursday-join-the-pec-all-meeting-on-data-privacy-and-data-sharing-in-clinical-trials</loc><lastmod>2023-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/see-you-at-dias-medical-affairs-and-scientific-communications-forum</loc><lastmod>2023-03-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meaningful-change-working-group-survey-1</loc><lastmod>2023-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/meaningful-change-working-group-survey</loc><lastmod>2023-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/international-traditional-medicine-clinical-trial-registry-itmctr</loc><lastmod>2023-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rim-intelligent-automation-topics-of-interest-for-2023</loc><lastmod>2023-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/denmark-update-march-02-2023</loc><lastmod>2023-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/japan-registry-of-clinical-trials-jrct-update</loc><lastmod>2023-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/march-meeting</loc><lastmod>2023-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/structured-content-authoring-key-concerns-or-questions</loc><lastmod>2023-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=5a3ee6a9-d24e-4f11-984f-01869ee22b7e</loc><lastmod>2023-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-gene-therapies-is-re-scheduled-watch-out-for-the-new-date</loc><lastmod>2023-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-gene-therapies-is-re-scheduled-watch-out-for-the-new-date-1</loc><lastmod>2023-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-calls-for-posters-content-hubs-and-round-tables-are-open</loc><lastmod>2023-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/literature-review-frequency-for-signal-detection</loc><lastmod>2023-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rim-intelligent-automation-topics-of-interest-for-2023-1</loc><lastmod>2023-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-gene-therapies</loc><lastmod>2023-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/february-meeting</loc><lastmod>2023-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/psi-eiwg-webinar-proposing-estimands-from-different-perspectives-thursday-30-march-2023-1400-1530-bst1500-1630-cest0900-1030-est</loc><lastmod>2023-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/psi-eiwg-webinar-proposing-estimands-from-different-perspectives-thursday-30-march-2023-1400-1530-bst1500-1630-cest0900-1030-est-1</loc><lastmod>2023-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/shared-learning-webinar-dia-medical-writing-community-mentorship-program-one-year-later-how-did-it-go</loc><lastmod>2023-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diafda-biostatistics-industry-and-regulator-forum-2</loc><lastmod>2023-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diafda-biostatistics-industry-and-regulator-forum-3</loc><lastmod>2023-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/volunteers-needed-to-reveiw-written-sample-for-graduate-school</loc><lastmod>2023-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/volunteers-needed-to-reveiw-written-sample-for-graduate-school-1</loc><lastmod>2023-02-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-gene-therapies-1</loc><lastmod>2023-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-foreign-regulatory-inspection-experiences-of-a-us-sponsor</loc><lastmod>2023-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-foreign-regulatory-inspection-experiences-of-a-us-sponsor-1</loc><lastmod>2023-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/hold-the-date-adpromo-wg-on-march-15-12-pm-et-hot-topics</loc><lastmod>2023-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/bswg-all-member-meeting-agenda-27february2023-1</loc><lastmod>2023-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-eudract-23-feb-2023</loc><lastmod>2023-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/question-associated-to-ema-article-25-regulation</loc><lastmod>2023-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-edm-structured-submission-reference-model-kick-off-at-rsidm-meeting</loc><lastmod>2023-02-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/3-part-csa-webinar-with-gcp-qa-and-sqa-1</loc><lastmod>2023-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-today-dia-reg-intel-with-2-guest-speakers-12pm-et</loc><lastmod>2023-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-bayesian-scientific-working-group-kol-lecture-series-friday-2242023-free-and-no-registration-required-2</loc><lastmod>2023-02-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qas-on-clinical-trials-regulation-v64-released-by-eu-commission-17-feb-2023</loc><lastmod>2023-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qas-on-clinical-trials-regulation-v64-released-by-eu-commission-17-feb-2023-1</loc><lastmod>2023-02-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/transcelerate-privacy-metholdogy-for-public-review-please-provide-feedback</loc><lastmod>2023-02-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-2023-is-a-patients-include-event-patients-partner-application-is-live-now</loc><lastmod>2023-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-feb-22-11am-et-guest-speaker</loc><lastmod>2023-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-rim-wg-intelligent-automation-feb-22-11am-et-guest-speaker-1</loc><lastmod>2023-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/jrct-data-migration-update-feb-16-2023</loc><lastmod>2023-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/early-bird-rates-expiring-medical-affairs-and-scientific-communications-forum</loc><lastmod>2023-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-professional-posters-open</loc><lastmod>2023-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-feb-15-2023-guest-presenter-a-minsk-agg-and-more</loc><lastmod>2023-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-feb-15-2023-guest-presenter-a-minsk-agg-and-more-1</loc><lastmod>2023-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-bitesize-talk-document-and-personal-data-in-ctis</loc><lastmod>2023-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fyi-questions-and-answers-clinical-trials-information-system-ctis-and-clinical-trials-regulation-ctr-prepared-by-the-query-management-working-group</loc><lastmod>2023-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-us-for-latin-america-annual-meeting-and-save-50</loc><lastmod>2023-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-community-round-table-discussions</loc><lastmod>2023-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dei-in-clinical-trials-community-meeting-1</loc><lastmod>2023-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-ctd-community-join-us-on-tuesday-february-14th-for-our-monthly-conference-call</loc><lastmod>2023-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-research-community-webinars-01-02-mar-2023</loc><lastmod>2023-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-research-community-webinars-01-02-mar-2023-1</loc><lastmod>2023-02-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/short-course-methods-to-support-patient-focused-medical-product-development-key-concepts-from-fdas-patient-focused-drug-development-guidance-series</loc><lastmod>2023-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/important-round-table-to-be-rescheduled-due-to-illness</loc><lastmod>2023-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fyi-bfarm-publishes-several-articles-relating-to-eu-ctr-and-ctis</loc><lastmod>2023-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fyi-ema-recently-published-ctis-risk-mitigation-plan</loc><lastmod>2023-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-and-eu-ctr-frequently-asked-questions-january-31-2023</loc><lastmod>2023-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/call-for-content-hub-leaders</loc><lastmod>2023-02-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/whats-new-on-clinicaltrialsgov-feb-08-2023-and-clinicaltrialsgov-prs-feb-15-2023</loc><lastmod>2023-02-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-dei-in-clinical-trials-community-meeting-on-tuesday-feb-14-11-am-et</loc><lastmod>2023-02-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-round-table-this-friday-210-11-am-12-pm-est</loc><lastmod>2023-02-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/reminder-adpromo-wg-on-feb-15-12-pm-et-guest-presenter-alan-minsk-agg-i-cant-believe-what-youre-saying-a-review-of-some-recent-fda-and-ftc-actions-in-the-drug-promotion-world</loc><lastmod>2023-02-08</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-innovative-design-scientific-working-group-kol-lecture-series-friday-2102023-free-and-no-registration-required-1</loc><lastmod>2023-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/accelerated-approval-promotion-question</loc><lastmod>2023-02-07</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-dei-in-clinical-trials-community-meeting</loc><lastmod>2023-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dei-in-clinical-trials-community-meeting</loc><lastmod>2023-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-and-eu-ctr-frequently-asked-questions-january-31-2023-1</loc><lastmod>2023-02-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-database-result-functionalities-issues</loc><lastmod>2023-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-tuesday-february-7-at-11-am-et</loc><lastmod>2023-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cdm-monthly-meeting-tuesday-february-7-at-11-am-et-1</loc><lastmod>2023-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcement-for-duke-industry-statistics-symposium-2023</loc><lastmod>2023-02-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-fda-guidanceconsiderations-for-the-design-and-conduct-of-externally-controlled-trials-for-drug-and-biological-products</loc><lastmod>2023-02-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/qa-on-the-protection-of-cci-and-personal-data-while-using-ctis</loc><lastmod>2023-02-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update</loc><lastmod>2023-02-01</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/workshop-on-inclusive-participation-in-clinical-research</loc><lastmod>2023-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/workshop-on-inclusive-participation-in-clinical-research-1</loc><lastmod>2023-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-regulation-5362014-in-practice-eudralex-vol-10-1</loc><lastmod>2023-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/quick-guide-for-sponsors-regulation-5362014-in-practice-eudralex-vol-10</loc><lastmod>2023-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-training-update-january-30-2023-removing-personal-information-from-properties-of-cta-documents</loc><lastmod>2023-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/diafda-biostatistics-industry-and-regulator-forum</loc><lastmod>2023-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/many-pediatric-clinical-trials-failed-to-properly-report-results-on-clinicaltrialsgov</loc><lastmod>2023-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-appoints-marwan-fathallah-as-president-and-global-chief-executive</loc><lastmod>2023-01-30</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participate-in-ctti-research-on-use-of-clinicaltrialsgov</loc><lastmod>2023-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/save-the-date-bioethics-community-round-table-february-10-11-am-12-pm-eastern</loc><lastmod>2023-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/navigate-to-the-event-tab-t</loc><lastmod>2023-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mock-fda-ide</loc><lastmod>2023-01-26</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-25</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-26</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-17</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-18</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-19</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-20</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-22</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-23</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-24</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-14</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-15</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-12</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-10</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-11</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-feb-15-12-pm-et-guest-presenter-alan-minsk-agg-i-cant-believe-what-youre-saying-a-review-of-some-recent-fda-and-ftc-actions-in-the-drug-promotion-world</loc><lastmod>2023-01-25</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-bayesian-scientific-working-group-bswg-key-opinion-leader-kol-virtual-lecture-series-complex-innovative-design-cid-miniseries-1</loc><lastmod>2023-01-24</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rep-pallone-pushes-for-greater-clinicaltrialsgov-enforcement</loc><lastmod>2023-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/factual-summary-report-from-eu-survey-targeted-consultation-on-the-implementation-of-the-clinical-trials-regulation-eu-no-5362014-1</loc><lastmod>2023-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/factual-summary-report-from-eu-survey-targeted-consultation-on-the-implementation-of-the-clinical-trials-regulation-eu-no-5362014</loc><lastmod>2023-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-123-managing-your-corporate-reputation-1</loc><lastmod>2023-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-123-managing-your-corporate-reputation</loc><lastmod>2023-01-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-9</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-8</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-4</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-5</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-6</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-7</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-2</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire-3</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/participating-in-the-sustainable-dcts-questionnaire</loc><lastmod>2023-01-22</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/what-are-we-missing-moving-forward-in-cdm</loc><lastmod>2023-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/emas-management-board-ad-hoc-meeting-18-jan-2023</loc><lastmod>2023-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/please-help-set-the-agenda-topics-for-2023-and-beyond</loc><lastmod>2023-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/core-committee-meeting-minutes-06-jan-2023</loc><lastmod>2023-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-omnibus-and-diversity</loc><lastmod>2023-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/query-related-to-eu-end-of-trial-definition</loc><lastmod>2023-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/policy-43foiaprci-working-group-meeting-dates-for-2023</loc><lastmod>2023-01-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/edm-structure-submission-reference-model-kick-off-meeting-at-rsidm</loc><lastmod>2023-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-updated-glossary-of-terms-and-definitions-1</loc><lastmod>2023-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/cioms-updated-glossary-of-terms-and-definitions</loc><lastmod>2023-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/materials-available-adaptive-biomarker-designs-dia-and-psi-vjc-12-jan-2023</loc><lastmod>2023-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-ema-to-hold-crash-course-on-ich-m11-guideline-january-26th-webinar</loc><lastmod>2023-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-ema-to-hold-crash-course-on-ich-m11-guideline-january-26th-webinar-1</loc><lastmod>2023-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/euctr-5362014-protocol-synopsis-outputs-from-pls-working-group</loc><lastmod>2023-01-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-regulatory-affairs-community-ri-wg-china-series</loc><lastmod>2023-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/mdr-codes</loc><lastmod>2023-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/dia-monthly-pls-working-group</loc><lastmod>2023-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-from-ema-on-restarting-policy-0070-for-non-covid-trials</loc><lastmod>2023-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-attached-here-jan-2023-adpromo-wg-from-today</loc><lastmod>2023-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/legal-agreements-101</loc><lastmod>2023-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/check-out-the-dia-pm-community-event-on-27-jan</loc><lastmod>2023-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/questions-and-answers-on-clinical-trials-regulation-eu-no-5362014-update-december-22-2022</loc><lastmod>2023-01-10</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/announcements-displaying-last-years-meetings</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/advance-rates-expiring-regulatory-submissions-information-and-document-management-rsidm-forum-2</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/advance-rates-expiring-regulatory-submissions-information-and-document-management-rsidm-forum-1</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/advance-rates-expiring-regulatory-submissions-information-and-document-management-rsidm-forum</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-released-medical-affairs-and-scientific-communications-forum-1</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/agenda-released-medical-affairs-and-scientific-communications-forum-2</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/newsletter-updates-please-use-shared-file-on-google-docs</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/join-the-pec-all-event-on-decentralized-trials-january-12-2023</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/netherlands-ccmo-registry-update-patient-participation-program</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/register-of-observational-studies-rso-italy</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/update-on-japan-registry-of-clinical-trials-jrct-dec-27-2022</loc><lastmod>2023-01-06</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ema-publishes-november-kpis-on-clinical-trials-submitted-via-ctis-eudract</loc><lastmod>2023-01-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/fda-clinical-trial-diversity-update</loc><lastmod>2023-01-05</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/liaison-committee-networking-file-link-on-google-drive</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=241&amp;MID=2926&amp;CommunityKey=a88c328c-6fdc-4734-9694-653df40cbb6b</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-global-pharmacovigilance-and-risk-management-strategies-conference</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-23</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-21</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-19</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-20</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-17</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-18</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-15</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-16</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-13</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-14</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-12</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-10</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-9</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-8</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-6</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-7</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-5</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-3</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-2</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts-1</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/invitation-to-add-your-voice-to-effect-change-in-sustainable-dcts</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/adpromo-wg-on-jan-11-12-pm-et-agenda-topics-developing</loc><lastmod>2023-01-04</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/january-2023-pls-wg-meeting-canceled</loc><lastmod>2023-01-03</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eu-ctis-sponsor-handbook-v301-20-dec-2022</loc><lastmod>2022-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/patient-group-guidelines-for-patient-compensation</loc><lastmod>2022-12-21</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-recording-and-slides-available-visualization-as-a-diagnostic-tool-for-estimands-with-pairwise-matching-of-multiple-treatments-3</loc><lastmod>2022-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/good-cause-for-extension-to-delayed-results</loc><lastmod>2022-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-recording-and-slides-available-visualization-as-a-diagnostic-tool-for-estimands-with-pairwise-matching-of-multiple-treatments-1</loc><lastmod>2022-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/webinar-recording-and-slides-available-visualization-as-a-diagnostic-tool-for-estimands-with-pairwise-matching-of-multiple-treatments</loc><lastmod>2022-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-dutch-trial-register-landelijk-trial-register-ltr</loc><lastmod>2022-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/free-webinar-managing-your-corporate-reputation</loc><lastmod>2022-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-community-platform-is-great</loc><lastmod>2022-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/regulatory-intelligence-february-meeting-announcement</loc><lastmod>2022-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/slides-posted-adpromo-wg-on-dec-14-whats-new-in-eua-adpromo-tga-mhra-happenings-and-opdp-how-to-transfer-responsibility</loc><lastmod>2022-12-19</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/eudract-update-december-15-2022</loc><lastmod>2022-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/efpia-survey-results-efpia-phrma-principles-for-data-sharing</loc><lastmod>2022-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rescheduled-journal-club-webinar-with-psi-biomarker-adaptive-designs-12-jan-2023-1000-1130am-est</loc><lastmod>2022-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/rescheduled-journal-club-webinar-with-psi-biomarker-adaptive-designs-12-jan-2023-1000-1130am-est-1</loc><lastmod>2022-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/december-2022-japan-registry-update</loc><lastmod>2022-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/upcoming-eu-ctis-walk-in-clinics</loc><lastmod>2022-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-information-system-ctis-sponsor-end-user-training-program</loc><lastmod>2022-12-14</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/clinical-trials-transformation-initiative-ctti-survey</loc><lastmod>2022-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/ctis-update-from-newsflash-dec-12-2022</loc><lastmod>2022-12-13</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/test-hyperlink</loc><lastmod>2022-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/browse/announcements?AnnouncementKey=efc083f8-83a0-444d-8883-0184f7bfe036</loc><lastmod>2022-12-09</lastmod></url><url><loc>https://communities.diaglobal.org/browse/allrecentposts</loc><lastmod>2022-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/browse/communitylibraries</loc><lastmod>2022-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MID=3159&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2022-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=91&amp;MID=3158&amp;CommunityKey=c70a1db4-f59f-47ee-93c8-70d8cfae57fd</loc><lastmod>2022-12-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3157&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3149&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-12-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3156&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3155&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=3154&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-12-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3153&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-11-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3152&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3151&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-11-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3150&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=3148&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-11-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3147&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=3146&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3145&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3144&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3143&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3141&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3140&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3139&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3138&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3134&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=3135&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=3133&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3132&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3131&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3083&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3130&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3129&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-11-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3128&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3085&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3127&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-11-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3126&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=3121&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3099&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=3125&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=91&amp;MID=3124&amp;CommunityKey=c70a1db4-f59f-47ee-93c8-70d8cfae57fd</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3120&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MID=3119&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=97&amp;MID=3122&amp;CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=3118&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3116&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3114&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MID=3113&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=193&amp;MID=3115&amp;CommunityKey=bfd10c91-1da6-4e45-9ecb-0da2a47b9c8f</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=3111&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=3110&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3108&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=3109&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3106&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3107&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3105&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=3104&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MID=3103&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=3101&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3100&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3098&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3097&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3096&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3095&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3094&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3093&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3092&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3090&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3089&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3087&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3086&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3084&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-11-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3082&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3081&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3080&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3079&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=3078&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-11-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3077&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3074&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3073&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3070&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-11-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=3059&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3031&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3069&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-11-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3040&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-11-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3068&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3067&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-11-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3066&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-11-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3065&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-11-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=3064&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-11-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3063&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-11-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=3062&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-10-31</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/new-test-post-for-the-activity-feed</loc><lastmod>2022-10-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3061&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=3060&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3058&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-10-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=3057&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3056&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3055&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-10-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=3054&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=3053&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3051&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MID=3050&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3049&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=3048&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3047&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3046&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3045&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3044&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3043&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3042&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3041&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=3039&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3009&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3038&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-10-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=3037&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-10-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2966&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-10-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=3036&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-10-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3035&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=3034&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-10-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3033&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3032&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=3030&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-10-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3002&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3029&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3026&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3025&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2994&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-10-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3024&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-10-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=3021&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-10-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=3020&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3019&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3018&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3017&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=3016&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=3015&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=3014&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=3013&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3011&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=3012&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=3010&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-10-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3008&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=3007&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-10-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3006&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3005&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-10-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=3000&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=3004&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=3003&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=3001&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-10-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2999&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2998&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2997&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-10-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2996&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2995&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-10-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2993&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-10-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2992&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=2991&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2964&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2990&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2989&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2988&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2987&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2986&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-09-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2985&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2984&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2983&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-09-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2982&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2981&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-09-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2980&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2977&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2979&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2978&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2971&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2976&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2975&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2974&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2973&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2972&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2970&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2969&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2968&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2967&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-09-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2965&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2959&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2963&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-09-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2962&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-09-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2961&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2945&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2960&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2948&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MID=2958&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2957&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2956&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2955&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=2954&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2953&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2952&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2950&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-09-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2947&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2946&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2942&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-09-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2941&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-09-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2940&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2931&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2939&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MID=2938&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2022-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2887&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2937&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2876&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-09-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2936&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-09-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2935&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2934&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-09-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2933&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2932&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-09-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2930&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-09-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2929&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-09-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2928&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2873&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-08-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2927&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2890&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2925&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2924&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2923&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2922&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2921&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2920&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2919&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2918&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2917&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2916&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2915&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2914&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2913&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2912&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2910&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2909&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2908&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2905&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2904&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-08-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2903&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2902&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2901&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2900&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2899&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2898&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2897&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-08-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2894&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2893&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2892&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2891&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-08-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2889&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2888&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2885&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-08-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2882&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2881&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2878&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2879&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2880&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-08-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2877&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-08-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2875&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-08-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2855&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-08-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2874&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2642&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2872&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-08-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=97&amp;MID=2871&amp;CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2022-08-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2869&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=199&amp;MID=2868&amp;CommunityKey=ad750faa-ad65-4321-a7d3-132d1c579f24</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=2867&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2866&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=199&amp;MID=2865&amp;CommunityKey=ad750faa-ad65-4321-a7d3-132d1c579f24</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=2864&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2863&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=2862&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2861&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-08-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2860&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2859&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-08-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2858&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2857&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2856&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-08-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2834&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2854&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-08-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2852&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-08-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2845&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2853&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2851&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2840&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2850&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2849&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2848&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2847&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2846&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2844&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2843&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2842&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2841&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-07-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2839&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-07-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2838&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-07-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2837&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2836&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2832&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2835&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-07-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2833&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2831&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-07-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2830&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MID=2829&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2022-07-20</lastmod></url><url><loc>https://communities.diaglobal.org/discussion/welcome-to-your-higher-logic-community-site</loc><lastmod>2022-07-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2828&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2827&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2826&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=2825&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2824&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2823&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2822&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-07-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2821&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2820&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2819&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2818&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2817&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2816&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2797&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2815&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2814&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2758&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2813&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2812&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2811&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2810&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2809&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2808&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2807&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2806&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2804&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2805&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2803&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2802&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2801&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2800&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-07-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2799&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2798&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2790&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2787&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-07-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2794&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2793&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2792&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-07-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2791&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-07-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2786&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2785&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2760&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-07-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2784&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2781&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-07-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2783&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2782&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-07-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2780&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-07-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2772&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-07-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2778&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2762&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2519&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2779&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2775&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-06-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2774&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2773&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MID=2771&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2022-06-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2770&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2769&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2767&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-06-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2766&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2699&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2738&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2765&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2764&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2763&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2761&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2759&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MID=2757&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2022-06-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2756&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MID=2755&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2754&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2753&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2751&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2750&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2749&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2748&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2747&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2746&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=2745&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2744&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2743&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2742&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2741&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2740&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2739&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2737&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=2736&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2735&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2734&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-06-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2733&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2731&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2730&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-06-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2729&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2728&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2727&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2726&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-06-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2725&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2520&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-06-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MID=2724&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2022-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2721&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2723&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2722&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-06-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2720&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-06-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2719&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2718&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2717&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2716&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-06-07</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2715&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2700&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2714&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2713&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-06-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2712&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-06-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2711&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2710&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2709&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2708&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2706&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-06-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2707&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-06-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2705&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-06-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2704&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-06-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2703&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-06-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2702&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-06-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2701&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-06-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2698&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-05-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2691&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-05-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2697&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-05-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2694&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2696&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-05-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2689&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2695&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-05-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2693&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-05-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2692&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-05-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2690&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-05-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2688&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2687&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2686&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2685&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2684&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2683&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2681&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2680&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2679&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2678&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=55&amp;MID=2677&amp;CommunityKey=83e910da-ee53-4333-ae75-f6bae8b5f9a2</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2676&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2675&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=2674&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2673&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2672&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2671&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MID=2670&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2022-05-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2669&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2668&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2667&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-05-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2666&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MID=2665&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2022-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2664&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-05-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2660&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2663&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2662&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2661&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-05-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2659&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2658&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-05-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2498&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2657&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2656&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2655&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2644&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-05-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2654&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2653&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2652&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2651&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2650&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2649&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2648&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2647&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2646&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-04-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2645&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-04-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2639&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2643&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-04-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2641&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2640&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-04-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2638&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-04-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2637&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-04-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2636&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-04-19</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2613&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-04-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2635&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MID=2634&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2022-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2633&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2625&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2632&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2631&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2630&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2629&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2628&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2627&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-04-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MID=2624&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2623&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2622&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2620&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2621&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2619&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2618&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MID=2617&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=133&amp;MID=2616&amp;CommunityKey=42582927-2e26-4f37-a0eb-44f85819ad33</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2615&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2614&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2610&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2611&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=2609&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-04-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2608&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MID=2607&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2022-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2606&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2596&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-04-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2605&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-04-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2604&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-04-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2603&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-06</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2602&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-04-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2601&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-04-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2600&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2599&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MID=2598&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2022-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2597&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-03-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2595&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2594&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2593&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2556&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2592&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2591&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-03-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2590&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2589&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-21</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2588&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2587&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2586&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2585&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MID=2543&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2022-03-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=127&amp;MID=2584&amp;CommunityKey=04c6ab48-9d12-4a80-aebc-b6582a2bfed5</loc><lastmod>2022-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2583&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2582&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2580&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2581&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=97&amp;MID=2579&amp;CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2022-03-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2577&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2576&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2575&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2574&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-03-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2573&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2572&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2571&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2570&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2569&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2538&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-03-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2568&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2567&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2566&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2565&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2563&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2562&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2561&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2560&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2559&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2558&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2557&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2554&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2555&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2553&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-03-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MID=2552&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2022-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MID=2551&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2022-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2550&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=187&amp;MID=2549&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f</loc><lastmod>2022-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2548&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MID=2547&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2022-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2546&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-03-04</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2545&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2544&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2542&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2541&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2540&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-03-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2539&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-03-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2537&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2536&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2535&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-02-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MID=2534&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2022-02-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2533&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-02-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=97&amp;MID=2532&amp;CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2022-02-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2530&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-25</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2529&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2528&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2527&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2526&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=115&amp;MID=2525&amp;CommunityKey=629532d4-6f20-4775-9a33-7071bc1fc0a7</loc><lastmod>2022-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=7&amp;MID=2524&amp;CommunityKey=8a8dcca5-4a28-4395-a537-ed336ab712b1</loc><lastmod>2022-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2523&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2521&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2522&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2464&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2518&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2517&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2516&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2022-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2515&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2514&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=19&amp;MID=2513&amp;CommunityKey=82f7852e-c941-498f-8ee0-b6c313359014</loc><lastmod>2022-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2512&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2511&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2510&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2509&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2508&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2507&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-02-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2506&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=31&amp;MID=2467&amp;CommunityKey=aa0a8dec-6cbd-40af-a2e0-c81cf38f7320</loc><lastmod>2022-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2505&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-02-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2504&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2503&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2502&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2501&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2500&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2491&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2499&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-02-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2497&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-02-10</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2494&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-02-09</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2493&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2490&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2480&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-05</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=67&amp;MID=2482&amp;CommunityKey=dba835c5-b2aa-4796-9027-0d9442ff09e8</loc><lastmod>2022-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2489&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2488&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2487&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=313&amp;MID=2486&amp;CommunityKey=0d778c22-aa24-46a6-83c5-e00e65d89565</loc><lastmod>2022-02-03</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=49&amp;MID=2485&amp;CommunityKey=313336d4-3224-411a-ae28-279adf42aae8</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2484&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2483&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2481&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2476&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2479&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=217&amp;MID=2478&amp;CommunityKey=28a4f45b-ce06-4899-98e1-3863d649e288</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2477&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2475&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-02</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2474&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2473&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-02-01</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2472&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2471&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-31</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2470&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-01-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2469&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-28</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2468&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-27</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2466&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2465&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-01-26</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2463&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2462&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2461&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=139&amp;MID=2460&amp;CommunityKey=3062e0a8-f1f2-4768-9ff8-eb4d7ad54bb8</loc><lastmod>2022-01-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2459&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2458&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2457&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-01-18</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2456&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2455&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2454&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2453&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=85&amp;MID=2452&amp;CommunityKey=22045a51-797d-4cf0-8408-ee10cb4374eb</loc><lastmod>2022-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=157&amp;MID=2451&amp;CommunityKey=e8cc6d91-23c5-4211-b15b-d7d766fb7298</loc><lastmod>2022-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2450&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-14</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MID=2449&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2022-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=187&amp;MID=2448&amp;CommunityKey=207ea2c9-1be8-49ff-9215-07386359126f</loc><lastmod>2022-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2446&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=13&amp;MID=2436&amp;CommunityKey=79f4957e-7cbd-4dbb-86a8-6b162325402a</loc><lastmod>2022-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2447&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-13</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2445&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2022-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2443&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2444&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2022-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2442&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2441&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2022-01-12</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2440&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2022-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2439&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2022-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2438&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2437&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-11</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2435&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2022-01-08</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2434&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2021-12-30</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2433&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-29</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2432&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2431&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2021-12-24</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2425&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2021-12-23</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=121&amp;MID=2430&amp;CommunityKey=49dd7ccf-b1b5-48c9-91bd-a6bed9badb54</loc><lastmod>2021-12-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2429&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=163&amp;MID=2428&amp;CommunityKey=28432135-e05a-4cb0-8b96-51c0a7e9152f</loc><lastmod>2021-12-22</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2427&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2021-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2426&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2021-12-20</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=109&amp;MID=2424&amp;CommunityKey=10fe3fc6-5e6a-4977-b253-8e6670058860</loc><lastmod>2021-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=97&amp;MID=2423&amp;CommunityKey=d9090e97-f0a2-490e-8015-1647a433ec4f</loc><lastmod>2021-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2422&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-17</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2421&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2420&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=37&amp;MID=2419&amp;CommunityKey=e67e8fed-e1b6-4f76-b092-71e9470caa82</loc><lastmod>2021-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=151&amp;MID=2418&amp;CommunityKey=6bdcfc22-c03b-44a5-82b7-a6be5d5789e4</loc><lastmod>2021-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=61&amp;MID=2417&amp;CommunityKey=775aa05b-c3a1-46d8-bf73-1fbd791ff4d9</loc><lastmod>2021-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2416&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-16</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2415&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2403&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2021-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=43&amp;MID=2414&amp;CommunityKey=64298bd9-b757-4e85-abaa-c471891e0f9e</loc><lastmod>2021-12-15</lastmod></url><url><loc>https://communities.diaglobal.org/communities/community-home/digestviewer/viewthread?GroupId=181&amp;MID=2413&amp;CommunityKey=6f5d66a7-a0b8-4ecb-82e9-01847c313bfd</loc><lastmod>2021-12-14</lastmod></url></urlset>